Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
AARS2	"AARSL, bA444E17.1, KIAA1270"	ENSG00000124608	"Alanyl-tRNA synthetase 2, mitochondrial"	Q5JTZ9	6	44299654-44313326	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Cancer-related genes, Cardiomyopathy, Disease mutation, Neurodegeneration, Premature ovarian failure, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 11.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035636, HPA061396"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA035636: AB_10670837, HPA061396: AB_2684502"	"unprognostic (1.56e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.69e-1)"	"unprognostic (8.83e-3)"	"unprognostic (5.12e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.02e-1)"	8.6	10.7	15.9	16.2	11.8	11.4	9.9	23.5	19.8	11.4	14.5	11.4	13.0	15.3	14.1	10.4	17.2	13.4	15.9	10.4	13.2	8.9	10.3	12.6	10.9	13.4	12.4	14.3	17.1	13.8	16.2	14.2	10.1	11.1	13.2	9.8	11.2	14.4	14.6	10.2	16.8	18.3	12.1	8.8	14.1	12.3	12.9	14.1	14.7	12.3	10.4	13.4	10.2	13.9	7.1	3.2	3.7	3.4	3.7	5.5	2.8	9.7	7.3	9.6	17.6	5.7	5.2	12.7	8.0	4.1	8.5	8.2	7.9	5.3	10.7	12.8	3.5	9.0	7.3	10.6	11.5	3.3	7.5	16.9	12.4	7.1	9.3	3.7	11.5	11.1	4.4	7.3	6.8	7.3	5.2	7.2	15.0	14.6	10.5	4.5	10.9	9.6	9.9	7.1	28.1	7.1	11.5	5.8	7.3	4.4	8.8	22.8	8.2	6.9	7.8	10.7	6.7	7.2	15.0	6.1	9.2	9.3	5.7	10.0	6.2	5.7	11.0	5.2	10.2	15.9	3.7	2.4	0.0	3.4	3.3	5.5	3.6	4.8	4.4	2.6	7.1	4.7	4.3	0.7	3.7	3.4	3.2	3.0	2.8	15.9	11.8	23.5	19.8	13.2	8.9	12.4	14.3	11.1	14.1	6.0	3.5	2.4	1.9	0.6	6.3	2.8	7.6	4.0	3.4	0.0	11.8	4.4	0.0	2.1	2.2	2.9	4.4	0.0	0.3	4.4	1.4	1.2	0.0	2.4	2.7	0.0	0.0	3.7	2.8	0.4	4.4	1.6	0.0	5.4	1.4	1.5	1.1	0.0	4.2	0.8	6.7	0.0	1.4	3.3	7.0	0.4	4.5	2.2	3.3	1.4
AASS	"LKRSDH, LORSDH"	ENSG00000008311	"Aminoadipate-semialdehyde synthase"	Q9UDR5	7	122075647-122144280	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Hepatocytes: 98.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.5"	"Group enriched"	"Detected in many"	4	"B-cells: 1.0;granulocytes: 3.5;T-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 25.6;NTERA-2: 25.0;SuSa: 21.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020637, HPA020728, HPA020734"	Enhanced		Enhanced	Vesicles,Mitochondria		Yes	No		17000	Mitochondria	Vesicles	"HPA020637: AB_1844415, HPA020728: AB_1844416, HPA020734: AB_1844417"	"unprognostic (4.84e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.91e-4)"	"unprognostic (6.08e-2)"	"unprognostic (1.49e-2)"	"unprognostic (8.00e-2)"	"prognostic favorable (9.81e-4)"	"unprognostic (4.48e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.76e-3)"	"unprognostic (8.56e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.67e-1)"	13.9	9.5	7.4	4.8	11.8	1.6	11.2	2.7	9.8	16.0	8.1	12.5	8.2	2.2	16.8	11.6	6.4	14.9	6.7	12.6	8.8	3.7	14.4	35.8	9.1	3.3	15.2	5.0	36.7	10.7	14.9	10.4	7.1	9.9	9.2	3.8	9.2	5.4	10.4	11.3	4.4	5.5	9.3	12.1	5.2	9.0	5.1	13.2	0.8	7.8	8.3	3.1	11.0	9.0	1.0	0.4	3.5	0.1	0.3	1.2	0.1	0.1	0.0	15.8	25.6	13.3	8.5	6.2	4.3	4.6	4.5	6.5	7.3	0.2	0.0	0.2	3.0	5.1	2.7	18.3	8.2	6.2	0.0	6.7	5.5	3.5	4.7	10.8	0.0	1.8	7.5	0.2	5.4	5.7	12.6	10.8	7.3	1.4	10.1	3.1	0.0	0.5	0.0	25.0	0.0	1.0	8.3	8.4	0.3	2.1	1.7	1.6	0.5	1.4	0.0	2.6	21.7	0.4	0.0	4.9	8.8	2.7	4.1	4.1	2.2	1.6	0.0	3.2	0.5	3.4	3.5	0.1	0.0	0.7	0.0	0.1	0.5	0.8	0.0	0.4	1.0	1.2	0.5	0.0	0.3	0.0	0.0	0.7	0.1	7.4	11.8	2.7	7.3	8.8	3.7	15.2	5.0	9.9	13.2	8.9	28.6	1.5	8.9	5.6	6.3	8.1	7.6	0.0	7.9	14.0	15.7	9.1	0.0	1.8	9.2	9.2	1.0	0.0	1.5	2.5	9.3	5.2	3.5	98.3	1.2	11.1	2.9	19.6	1.8	5.4	17.5	1.5	11.8	0.0	2.4	8.7	2.6	2.9	23.0	7.8	2.2	19.4	21.6	6.4	1.5	4.1	4.2	2.2	1.5	3.7
ACAD9	"MGC14452, NPD002"	ENSG00000177646	"Acyl-CoA dehydrogenase family member 9"	Q9H845	3	128879596-128916067	"Disease related genes, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037716, HPA046720"	Supported		Enhanced	Mitochondria		No	No			Mitochondria		"HPA037716: AB_10673638, HPA046720: AB_2679773"	"unprognostic (1.04e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (3.61e-1)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (3.67e-6)"	"unprognostic (1.30e-1)"	"unprognostic (3.74e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.96e-3)"	"prognostic favorable (4.32e-8)"	"unprognostic (1.52e-1)"	"unprognostic (2.64e-2)"	"unprognostic (6.56e-2)"	"unprognostic (9.96e-2)"	18.1	20.6	14.0	13.1	15.4	8.0	15.4	14.7	17.9	13.6	13.4	15.9	21.1	11.3	16.9	13.1	21.6	15.6	16.4	21.6	10.7	13.2	15.8	24.0	11.6	10.4	13.6	17.8	13.1	21.1	30.6	14.2	13.8	13.6	13.0	12.4	16.0	19.0	16.0	30.8	45.0	10.1	13.8	10.2	12.1	14.6	19.5	10.8	13.9	14.8	18.2	14.9	12.6	14.0	7.2	14.0	4.1	18.1	5.0	7.5	8.9	25.1	13.2	10.6	7.9	16.4	11.6	11.3	12.5	13.8	24.1	20.7	18.5	15.3	18.7	11.7	15.7	16.3	21.1	18.5	24.5	16.0	12.3	12.6	17.0	26.7	13.1	12.0	13.3	7.9	12.6	9.6	14.0	15.8	13.9	19.4	14.9	8.0	9.1	16.0	25.4	19.6	11.1	6.4	26.0	18.9	15.2	10.0	19.0	16.9	16.1	12.3	7.9	19.5	18.3	12.1	10.0	24.2	28.8	11.5	10.1	8.8	10.2	11.9	9.1	4.4	16.3	16.1	12.4	12.7	3.1	12.0	4.1	7.5	14.7	7.2	7.2	6.8	6.4	14.0	4.9	5.7	7.3	1.0	5.0	18.1	7.9	6.5	8.9	14.0	15.4	14.7	17.9	10.7	13.2	13.6	17.8	13.6	10.8	14.9	23.7	9.7	10.0	5.6	14.5	26.4	7.6	10.7	11.4	14.0	9.8	22.7	18.3	18.4	14.9	9.8	8.1	0.0	15.5	15.2	10.1	7.5	16.1	23.3	26.7	9.5	5.2	17.8	9.5	12.6	9.5	8.4	15.1	16.2	6.3	15.8	13.0	7.6	13.8	18.0	10.9	12.9	13.3	15.6	10.0	12.4	25.6	7.5	14.1	6.0
ACADM	"ACAD1, MCAD, MCADH"	ENSG00000117054	"Acyl-CoA dehydrogenase medium chain"	P11310	1	75724347-75787575	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 89.7;skeletal muscle: 82.8"	"Group enriched"	"Detected in many"	4	"Cardiomyocytes: 330.8;Ciliated cells: 152.6;Distal tubular cells: 291.8;Hepatocytes: 232.4;Proximal tubular cells: 350.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 77.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006198, HPA026542"	Enhanced		Enhanced	Mitochondria		NA	NA		1200000	Mitochondria		"HPA006198: AB_1078087, HPA026542: AB_1844469"	"unprognostic (9.04e-3)"	"unprognostic (2.36e-1)"	"prognostic favorable (7.30e-4)"	"unprognostic (5.09e-3)"	"unprognostic (1.61e-3)"	"unprognostic (5.68e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.02e-2)"	"unprognostic (4.95e-2)"	"unprognostic (9.40e-3)"	"unprognostic (3.35e-1)"	"prognostic favorable (3.83e-8)"	"unprognostic (1.27e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.24e-1)"	18.1	25.0	12.3	11.3	13.0	3.9	18.0	12.0	10.8	8.4	21.6	8.3	10.1	25.1	6.7	8.6	21.9	7.6	6.7	49.7	10.5	11.2	71.1	89.7	6.3	9.4	13.0	9.2	10.5	10.3	8.1	12.0	4.2	14.3	9.2	12.1	8.0	9.0	11.7	82.8	5.6	25.1	9.8	10.7	12.3	12.0	8.5	11.0	11.0	12.2	42.1	10.0	9.5	8.1	29.7	16.7	14.1	13.8	16.8	20.0	13.2	7.0	5.6	17.7	7.8	15.3	12.6	5.0	13.3	10.9	13.0	11.0	10.5	11.3	77.6	11.8	9.5	11.2	6.6	15.1	11.3	16.3	30.0	7.4	25.4	17.3	16.2	10.7	21.7	7.1	14.5	6.5	11.4	6.8	10.1	10.2	16.9	25.9	17.5	14.0	2.6	25.4	10.2	14.3	21.5	13.6	33.2	23.4	8.1	21.6	18.7	9.6	12.1	10.8	32.1	27.7	12.8	9.5	27.5	5.5	8.9	8.8	7.6	21.7	11.4	16.3	34.5	7.5	17.7	10.1	10.7	9.6	14.1	13.2	13.8	20.0	29.7	13.8	15.9	14.3	18.0	15.8	17.6	0.8	16.8	12.7	16.7	13.8	13.2	12.3	13.0	12.0	10.8	10.5	11.2	13.0	9.2	14.3	11.0	53.6	43.4	62.8	34.2	24.3	36.0	330.8	53.5	152.6	51.2	55.8	23.6	30.2	291.8	28.7	45.7	27.1	38.4	23.3	23.5	17.3	29.9	27.0	42.8	232.4	67.1	28.6	39.0	43.6	39.4	18.0	43.4	40.9	49.0	30.7	34.0	51.0	23.3	33.6	42.8	350.1	27.0	0.0	32.5	64.2	67.3	23.6	12.8	30.5	42.5	35.5
ACADS	"ACAD3, SCAD"	ENSG00000122971	"Acyl-CoA dehydrogenase short chain"	P16219	12	120725735-120740008	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 58.4;skeletal muscle: 50.7"	"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 312.7;Hepatocytes: 154.5;Paneth cells: 154.3;Undifferentiated cells: 144.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 23.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004799, CAB019284, HPA022271"	Enhanced		Enhanced	Nucleoplasm,Centrosome,Mitochondria		NA	NA		15000	Mitochondria	"Nucleoplasm, Centrosome"	"CAB019284: , HPA004799: AB_1844471, HPA022271: AB_1844472"	"unprognostic (7.14e-2)"	"unprognostic (3.03e-3)"	"unprognostic (8.15e-2)"	"prognostic favorable (5.05e-4)"	"unprognostic (1.11e-3)"	"unprognostic (5.75e-2)"	"prognostic favorable (2.43e-4)"	"unprognostic (5.65e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.69e-2)"	"unprognostic (4.04e-2)"	"prognostic favorable (3.33e-6)"	"unprognostic (1.23e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (6.34e-5)"	19.5	14.5	5.7	10.0	5.2	5.3	18.0	2.3	4.6	2.9	26.2	4.7	4.5	35.8	2.8	5.3	5.0	2.9	9.1	32.6	3.7	3.3	13.2	58.4	5.6	7.8	5.0	4.1	2.3	14.4	3.0	2.4	4.3	3.8	4.1	9.0	5.6	8.9	4.6	50.7	3.4	35.3	6.5	3.8	8.6	9.5	10.7	5.4	4.0	8.1	16.8	4.3	5.0	3.2	6.8	11.4	7.2	14.0	15.3	14.7	10.0	2.0	7.2	0.4	6.3	8.6	3.4	7.2	3.0	3.0	3.9	2.9	5.6	5.1	0.2	7.8	2.5	1.8	3.3	4.2	1.3	0.5	10.5	5.3	5.2	2.2	11.9	6.2	0.4	23.6	10.3	2.0	1.7	0.1	1.2	3.9	13.3	4.2	0.0	1.7	4.2	7.2	12.0	1.3	6.6	3.0	5.3	2.7	1.4	7.3	11.5	0.7	4.0	6.2	0.0	9.8	0.6	5.0	8.2	4.4	0.1	3.1	3.0	0.5	10.0	5.6	2.5	6.7	4.4	2.6	7.2	13.0	6.4	12.4	14.0	8.8	5.9	11.3	13.0	11.4	6.8	14.7	13.2	1.3	15.3	8.7	9.5	11.9	10.0	5.7	5.2	2.3	4.6	3.7	3.3	5.0	4.1	3.8	5.4	11.9	10.7	10.2	10.2	6.0	1.1	32.5	30.6	2.7	5.7	17.4	0.0	60.7	43.1	26.8	15.8	14.2	312.7	23.3	28.4	26.2	16.9	7.1	19.5	154.5	47.4	1.6	43.8	12.9	27.2	26.3	19.8	11.1	16.9	32.5	94.5	13.0	25.9	154.3	17.0	74.9	0.7	6.5	13.0	29.1	8.3	4.0	63.2	20.3	144.6	9.0
ACAT1	"ACAT, THIL"	ENSG00000075239	"Acetyl-CoA acetyltransferase 1"	P24752	11	108121516-108147776	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 267.1"	"Cell type enhanced"	"Detected in all"	10	"Distal tubular cells: 591.9;Hepatocytes: 643.6;Proximal tubular cells: 1104.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 86.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004428, HPA007569"	Enhanced		Enhanced	Mitochondria		NA	NA		870000	Mitochondria		"HPA004428: AB_1078088, HPA007569: AB_1844482"	"unprognostic (3.70e-3)"	"unprognostic (2.23e-2)"	"unprognostic (7.84e-3)"	"unprognostic (4.65e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (1.43e-5)"	"unprognostic (3.59e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.13e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.96e-1)"	"unprognostic (1.68e-1)"	"unprognostic (8.06e-2)"	"unprognostic (6.62e-3)"	18.8	28.5	8.9	6.9	9.5	5.4	16.9	5.6	11.6	8.5	16.8	8.5	9.4	15.5	8.8	8.9	8.8	7.6	5.1	53.8	7.4	7.4	88.8	267.1	7.3	6.0	9.9	9.9	10.3	27.3	14.3	6.3	3.8	22.4	7.6	13.1	10.6	27.1	15.9	65.0	8.2	10.9	16.4	8.1	7.7	13.9	14.2	7.2	1.7	10.1	32.1	5.2	12.3	6.9	18.8	20.2	2.3	14.7	7.7	20.7	11.6	16.1	13.3	10.5	30.2	34.0	30.1	5.9	15.5	16.7	16.9	19.7	36.5	16.8	8.9	26.7	17.3	26.5	17.1	30.4	14.7	18.4	17.9	24.9	25.8	15.1	33.1	23.5	24.3	15.3	27.2	16.3	14.7	27.6	19.4	17.9	20.5	35.8	13.3	26.8	9.3	14.4	22.8	10.3	21.0	29.7	20.1	20.7	86.8	23.1	10.6	16.8	20.0	25.3	32.9	17.0	9.2	28.0	20.0	19.9	18.1	10.6	16.5	18.6	4.5	13.2	16.8	8.1	48.9	12.8	0.8	9.8	2.3	15.6	14.7	17.7	18.8	17.6	17.5	20.2	10.2	15.5	14.3	1.0	7.7	14.4	7.0	20.7	11.6	8.9	9.5	5.6	11.6	7.4	7.4	9.9	9.9	22.4	7.2	50.6	77.4	72.9	45.6	38.2	28.8	404.6	79.0	85.6	26.1	99.5	25.5	38.2	591.9	37.4	319.5	68.1	61.5	93.5	53.3	35.3	44.8	27.3	26.6	643.6	86.3	36.5	28.8	95.8	65.2	38.7	61.5	42.1	55.6	58.7	33.3	35.0	46.6	90.8	77.4	1104.9	23.8	64.7	64.3	159.1	28.1	42.3	21.1	42.4	83.1	20.7
ALDH18A1	"GSAS, P5CS, PYCS, SPG9"	ENSG00000059573	"Aldehyde dehydrogenase 18 family member A1"	P54886	10	95605929-95656706	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Proline biosynthesis"	"Kinase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Disease mutation, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 68.8"	"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 58.2;Paneth cells: 54.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008333, HPA012604"	Approved		Enhanced	Mitochondria		NA	NA		23000	Mitochondria		"HPA008333: AB_1078125, HPA012604: AB_1844721"	"unprognostic (5.97e-3)"	"unprognostic (2.08e-2)"	"unprognostic (5.75e-2)"	"prognostic favorable (4.20e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.30e-3)"	"unprognostic (7.08e-2)"	"unprognostic (4.06e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (3.60e-9)"	"unprognostic (1.02e-3)"	"unprognostic (6.57e-2)"	"unprognostic (1.29e-3)"	"unprognostic (6.43e-2)"	6.3	10.4	7.1	10.4	7.9	5.2	7.7	7.3	9.3	13.7	20.1	7.2	20.5	33.8	9.3	12.3	12.8	8.5	15.2	7.2	6.2	7.1	13.0	28.9	6.6	7.4	6.7	5.3	14.5	40.7	12.7	17.4	14.3	7.7	9.6	19.4	7.9	68.8	20.5	3.5	9.6	45.4	10.0	5.4	8.6	15.2	8.4	5.4	12.7	25.9	9.7	15.9	8.6	8.2	13.1	5.2	0.3	4.0	13.0	16.3	8.0	18.3	17.4	16.8	44.0	22.6	21.8	18.1	21.5	32.3	21.9	27.6	34.9	14.7	62.6	20.1	33.8	10.6	24.4	33.6	22.1	24.9	17.7	26.4	19.8	12.4	49.5	14.8	34.6	22.2	22.9	13.6	17.8	34.9	36.4	22.9	23.6	18.5	13.2	16.3	26.4	31.2	22.3	19.8	30.5	17.4	29.4	19.2	21.4	25.5	14.0	16.8	16.6	17.1	13.6	15.8	20.1	20.3	16.2	18.9	9.1	14.5	23.4	24.6	15.3	11.3	38.3	17.7	40.1	11.6	0.0	1.4	0.1	15.5	2.7	16.3	13.1	14.2	16.0	5.2	9.0	12.1	13.4	0.3	13.0	4.0	3.1	13.3	8.0	7.1	7.9	7.3	9.3	6.2	7.1	6.7	5.3	7.7	5.4	6.0	8.6	11.5	6.6	10.0	5.7	4.3	10.2	16.0	14.8	19.2	0.0	36.1	1.7	12.5	0.7	5.4	58.2	0.0	18.4	25.8	17.5	15.6	8.1	23.1	10.1	9.5	19.0	4.9	3.2	0.4	8.6	3.1	15.1	2.8	37.5	5.2	12.4	54.7	11.3	7.9	2.8	0.0	5.6	5.1	9.0	7.0	25.3	8.7	30.7	8.1
ALDH1L2	"FLJ38508, mtFDH"	ENSG00000136010	"Aldehyde dehydrogenase 1 family member L2"	Q3SY69	12	105019784-105084577	"Enzymes, Predicted intracellular proteins"	"One-carbon metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"pancreas: 48.9;salivary gland: 31.6"	"Cell type enhanced"	"Detected in many"	6	"Exocrine glandular cells: 8.3;monocytes: 6.4;Pancreatic endocrine cells: 5.6;Peritubular cells: 6.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 1.3"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 1.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 23.0;ASC TERT1: 31.5;fHDF/TERT166: 35.7;HHSteC: 20.3;HSkMC: 25.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039481, HPA059282"	Approved		Enhanced	Mitochondria		No	No			Mitochondria		"HPA039481: AB_10795465, HPA059282: AB_2732633"	"unprognostic (5.99e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.76e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.92e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.19e-8)"	"unprognostic (3.21e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.52e-5)"	4.2	1.2	3.2	2.7	1.9	0.7	2.7	5.3	2.7	5.5	2.2	0.9	3.3	2.4	2.9	3.2	1.5	2.6	2.7	2.9	1.6	2.0	0.7	0.4	2.7	2.0	2.0	2.1	1.0	48.9	0.7	2.8	1.1	2.5	3.6	2.3	4.8	31.6	4.5	1.0	1.5	1.3	5.4	5.3	1.2	3.7	0.8	1.3	0.0	2.2	1.4	3.0	3.9	2.2	0.2	1.3	0.0	0.1	0.0	0.1	0.1	4.4	0.4	0.2	9.6	23.0	31.5	0.5	14.2	9.2	1.8	4.9	0.5	0.0	0.0	0.6	35.7	0.0	0.0	0.0	0.3	2.3	0.0	0.1	0.2	0.0	1.1	20.3	1.8	0.0	25.5	1.1	4.8	9.1	0.0	1.0	0.0	0.7	12.9	3.7	0.0	0.0	0.1	0.6	0.0	0.1	0.0	0.0	1.3	0.0	0.0	3.3	1.6	0.0	2.9	7.2	0.1	2.1	15.2	0.1	1.4	1.4	0.0	0.7	16.0	4.2	0.0	5.8	6.6	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.1	3.2	1.9	5.3	2.4	1.6	2.0	2.0	2.1	2.5	1.3	0.0	1.1	0.0	0.1	0.5	1.5	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	3.7	0.1	0.0	0.0	8.3	0.3	4.3	0.3	0.0	0.0	0.4	4.8	0.0	1.8	0.3	4.5	3.4	1.1	5.0	6.4	0.0	1.2	5.6	0.0	6.3	0.0	0.5	0.0	3.1	0.4	0.0	0.5	0.2	0.0	0.0	0.1
ALDH6A1	MMSDH	ENSG00000119711	"Aldehyde dehydrogenase 6 family member A1"	Q02252	14	74056850-74084493	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"kidney: 140.0;liver: 134.5"	"Cell type enhanced"	"Detected in many"	15	"Hepatocytes: 453.8;Proximal tubular cells: 730.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 25.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 29.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029072, HPA029073, HPA029074, HPA029075"	Enhanced		Enhanced	Mitochondria		No	No		9100	Mitochondria		"HPA029072: AB_10599176, HPA029073: AB_10601877, HPA029074: AB_10601000, HPA029075: AB_10602005"	"unprognostic (1.45e-1)"	"unprognostic (5.38e-2)"	"unprognostic (6.89e-2)"	"unprognostic (6.95e-3)"	"unprognostic (1.46e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.11e-3)"	"prognostic favorable (4.22e-4)"	"unprognostic (1.58e-1)"	"unprognostic (9.10e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.13e-1)"	"prognostic favorable (2.00e-15)"	"unprognostic (4.59e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.05e-3)"	"unprognostic (1.12e-1)"	14.1	6.9	31.3	2.8	30.9	2.3	6.7	11.6	26.4	8.0	11.0	20.1	4.6	11.0	5.5	5.5	5.0	6.2	4.8	15.6	21.1	14.2	140.0	134.5	4.7	3.0	19.4	18.5	12.3	11.8	16.4	3.2	4.0	14.8	11.0	7.2	7.1	7.8	7.8	10.5	3.4	9.3	5.6	13.1	3.1	9.6	7.4	18.7	2.0	12.1	4.0	3.1	6.3	3.3	4.5	5.6	25.5	3.8	5.5	6.7	2.8	4.6	4.0	5.7	12.1	20.9	10.2	9.2	3.2	6.1	3.5	6.0	9.1	5.2	5.4	7.2	6.9	2.9	2.7	13.0	3.6	7.7	4.8	1.8	2.5	4.2	9.9	23.8	1.3	1.2	15.0	6.6	4.5	11.4	9.2	6.2	12.2	4.0	7.5	2.4	17.8	3.7	2.0	4.5	17.2	2.7	7.6	5.9	7.1	5.6	3.5	2.3	3.6	10.7	11.6	2.8	10.1	29.7	4.8	1.9	4.0	4.9	6.2	1.2	5.1	9.2	5.5	5.2	1.6	3.8	13.3	3.8	25.5	4.5	2.9	6.7	4.5	5.1	5.3	5.6	3.6	6.5	4.6	1.5	5.5	2.4	3.2	3.6	2.8	31.3	30.9	11.6	26.4	21.1	14.2	19.4	18.5	14.8	18.7	35.7	48.4	23.6	21.0	8.1	17.6	73.0	48.4	25.4	29.6	62.8	3.9	22.5	170.8	8.1	19.8	13.5	22.3	0.0	2.7	12.8	13.1	38.6	7.0	453.8	14.9	11.1	16.3	58.3	22.2	15.8	26.7	9.0	23.6	20.8	37.9	90.4	5.6	10.5	45.3	730.1	15.1	12.9	21.7	10.5	3.9	6.5	25.6	6.9	37.0	15.2
ARMC10	"MGC3195, SVH"	ENSG00000170632	"Armadillo repeat containing 10"	Q8N2F6	7	103074881-103099764	"Predicted intracellular proteins, Predicted membrane proteins"	"Growth regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011036, HPA011057"	Enhanced		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA011036: AB_1080139, HPA011057: AB_1080137"	"unprognostic (7.03e-3)"	"unprognostic (2.44e-1)"	"unprognostic (8.18e-2)"	"unprognostic (3.53e-1)"	"prognostic unfavorable (8.90e-6)"	"unprognostic (3.85e-3)"	"prognostic unfavorable (3.58e-4)"	"unprognostic (5.57e-2)"	"unprognostic (3.49e-2)"	"unprognostic (7.90e-2)"	"prognostic unfavorable (2.49e-6)"	"unprognostic (1.02e-1)"	"unprognostic (5.78e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.14e-2)"	"unprognostic (5.67e-2)"	21.6	21.7	28.0	12.6	25.0	9.1	24.5	11.4	28.0	24.4	18.6	24.7	20.8	14.0	20.4	24.2	22.2	23.2	20.0	16.7	26.2	26.2	27.4	30.2	15.0	15.7	26.3	24.2	26.5	28.7	26.0	12.0	15.4	19.7	22.2	18.8	17.6	15.7	23.4	15.8	21.6	12.8	20.3	25.5	14.4	19.8	14.1	19.6	21.5	30.7	15.6	15.7	22.3	20.5	5.1	6.8	6.6	5.4	3.9	4.7	2.2	12.6	10.8	6.4	12.4	13.4	12.8	6.4	8.9	9.7	6.4	7.8	5.8	15.0	22.8	19.3	7.8	18.4	11.4	9.0	9.9	9.2	8.5	10.3	8.0	4.6	2.8	13.5	22.0	9.6	8.3	17.5	8.1	13.3	19.6	14.6	12.9	19.6	14.1	11.4	23.4	16.1	17.1	14.3	21.7	11.7	9.8	6.7	29.6	16.3	8.9	7.2	9.9	12.1	18.3	13.4	11.6	7.4	11.0	9.7	10.0	9.5	23.4	13.3	21.7	33.9	18.3	11.3	20.5	12.4	0.0	4.4	6.6	2.6	5.4	4.5	4.0	4.1	4.4	6.8	5.1	4.6	4.7	0.9	3.9	2.8	5.3	4.2	2.2	28.0	25.0	11.4	28.0	26.2	26.2	26.3	24.2	19.7	19.6	23.8	17.0	26.1	49.5	69.9	22.6	15.4	22.9	6.7	15.9	26.2	13.7	38.2	56.3	15.6	10.1	27.0	15.3	0.0	13.3	39.5	28.9	60.5	17.3	34.7	41.8	7.9	14.5	25.2	32.4	6.3	31.4	31.1	43.9	2.8	33.1	24.5	20.4	10.5	32.2	71.6	26.5	32.3	47.6	11.6	30.8	91.1	37.6	30.5	39.3	65.2
ATAD3A	FLJ10709	ENSG00000197785	"ATPase family, AAA domain containing 3A"	Q9NVI7	1	1512151-1534687	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA058968, HPA064867, HPA065305"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA058968: AB_2683864, HPA064867: AB_2685375, HPA065305: AB_2685459"	"unprognostic (8.42e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.74e-2)"	"prognostic unfavorable (5.90e-5)"	"unprognostic (6.62e-2)"	"unprognostic (9.53e-2)"	"unprognostic (5.81e-2)"	"unprognostic (4.09e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.09e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.87e-3)"	10.8	13.9	11.2	16.3	11.3	25.0	9.3	9.3	14.8	9.2	11.0	11.1	12.5	16.4	10.4	7.6	16.8	9.3	11.9	15.9	9.2	8.2	12.9	26.7	9.7	13.9	10.5	13.3	8.5	20.4	8.1	16.6	11.3	8.3	10.7	6.2	9.6	19.5	9.5	31.1	13.3	12.2	8.9	8.5	12.4	13.0	12.7	9.1	14.0	12.4	21.1	14.3	9.3	9.4	3.3	4.7	1.3	6.2	5.1	4.0	2.1	21.1	11.9	5.3	13.5	2.7	3.2	12.6	17.5	5.2	15.5	9.4	30.5	14.6	11.7	12.1	6.9	5.7	18.1	7.4	10.3	2.6	11.2	32.0	20.4	29.3	20.4	5.1	29.3	13.1	3.7	3.4	12.5	5.2	2.0	6.7	12.9	31.8	9.0	5.5	14.9	22.0	26.8	10.8	7.1	25.6	24.0	10.0	24.2	4.2	8.9	26.7	10.5	10.8	16.5	13.7	1.9	7.2	14.5	9.1	15.8	12.3	24.1	21.3	13.5	13.2	47.1	15.4	44.0	7.0	0.2	4.0	1.3	3.3	2.9	2.5	3.3	3.8	4.0	4.7	3.0	3.4	1.5	0.1	5.1	6.2	4.4	2.8	2.1	11.2	11.3	9.3	14.8	9.2	8.2	10.5	13.3	8.3	9.1	3.0	7.0	11.9	8.0	18.1	10.3	9.5	7.6	1.4	4.5	7.0	5.9	16.8	6.6	21.0	7.6	11.1	10.0	0.0	18.2	36.3	8.9	11.6	9.2	13.1	19.8	22.3	13.2	4.3	5.0	8.2	5.2	7.7	15.1	5.4	13.0	10.2	20.6	5.8	7.4	9.7	9.0	0.0	10.3	5.4	25.6	21.2	16.5	5.3	20.7	12.2
ATAD3B	"KIAA1273, TOB3"	ENSG00000160072	"ATPase family, AAA domain containing 3B"	Q5T9A4	1	1471769-1497848	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 3.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA058968, HPA064867, HPA065305"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA058968: AB_2683864, HPA064867: AB_2685375, HPA065305: AB_2685459"	"unprognostic (6.05e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.54e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.68e-1)"	"prognostic unfavorable (1.81e-5)"	"unprognostic (1.51e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.17e-2)"	"unprognostic (8.24e-3)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (5.48e-9)"	"unprognostic (2.38e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.68e-1)"	13.7	7.6	7.5	18.9	9.5	24.3	10.4	11.6	10.8	7.4	9.6	8.7	8.2	12.1	10.0	7.0	11.3	8.1	8.4	6.4	7.5	6.5	9.9	14.5	9.8	17.3	9.5	8.1	10.1	16.5	3.2	13.6	10.3	7.6	11.0	3.8	8.8	16.3	16.5	9.9	15.8	12.3	8.8	6.8	14.5	15.4	9.3	8.2	7.9	9.3	6.6	13.1	5.9	10.0	0.3	0.8	1.4	3.7	0.2	2.0	0.5	6.9	0.0	2.1	11.6	0.6	0.9	15.9	11.2	2.6	11.0	8.4	25.7	20.5	9.8	3.5	4.3	6.6	12.8	14.1	7.0	2.3	8.3	13.3	6.8	16.8	15.7	2.6	11.3	8.0	2.5	0.4	18.1	1.1	0.2	3.8	3.2	20.2	2.2	4.0	3.5	13.4	13.2	22.6	4.6	25.7	10.8	3.4	7.1	3.2	4.6	8.9	7.2	8.3	10.7	9.5	1.4	1.6	4.0	4.7	3.0	6.4	17.4	11.8	6.4	8.8	23.8	9.5	18.8	3.3	0.0	0.7	1.4	1.6	3.7	2.0	0.3	1.0	1.4	0.8	0.0	0.3	0.1	0.0	0.2	1.9	0.5	0.0	0.5	7.5	9.5	11.6	10.8	7.5	6.5	9.5	8.1	7.6	8.2	6.0	26.1	12.0	6.7	23.4	14.1	4.0	10.2	1.4	7.9	8.7	19.6	10.1	1.7	7.4	3.2	6.8	8.4	0.0	6.5	33.5	8.1	6.7	11.5	7.6	10.8	12.7	6.9	4.9	2.8	1.8	4.0	6.3	10.1	3.6	9.1	7.8	9.4	8.0	2.8	1.7	15.6	6.5	8.2	5.1	9.6	20.6	14.9	8.4	10.6	10.2
ATP5F1B	"ATP5B, ATPSB"	ENSG00000110955	"ATP synthase F1 subunit beta"	P06576	12	56638175-56646068	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 693.2;Distal tubular cells: 1049.5;Proximal tubular cells: 698.1;Syncytiotrophoblasts: 952.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA001520, HPA001528, CAB017527"	Enhanced		Enhanced	Mitochondria		NA	NA		100000000	Mitochondria		"CAB017527: AB_1121153, HPA001520: AB_1078243, HPA001528: AB_1078242"	"prognostic unfavorable (7.17e-6)"	"unprognostic (5.69e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.24e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.12e-3)"	"unprognostic (1.92e-2)"	"unprognostic (8.19e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.11e-2)"	"prognostic favorable (1.43e-9)"	"unprognostic (2.79e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.30e-2)"	41.3	66.2	32.4	34.1	53.4	39.3	33.1	55.4	92.6	26.1	73.0	34.4	36.1	68.1	27.9	28.5	58.6	28.5	36.9	225.0	33.2	34.9	95.2	85.7	28.3	39.2	40.5	35.5	25.1	42.7	85.2	30.1	31.3	69.6	29.0	78.5	42.8	64.7	38.1	236.2	42.3	74.6	35.5	24.9	33.5	51.0	31.4	18.3	47.5	38.4	123.6	45.8	36.6	32.8	41.2	91.7	40.2	90.1	36.3	46.6	105.6	66.5	81.0	64.4	99.3	58.1	62.1	113.8	67.7	63.2	117.1	66.8	131.5	74.3	118.4	73.4	83.4	49.0	89.2	135.6	82.1	106.1	55.5	93.9	129.9	75.6	80.6	72.0	145.2	92.0	76.1	82.9	91.5	118.2	89.2	96.2	88.4	116.9	136.5	98.2	61.7	107.5	85.4	108.4	88.2	156.0	103.7	72.1	150.9	127.5	118.6	73.7	65.5	103.5	148.2	115.1	70.7	139.1	109.8	65.2	46.1	51.4	67.3	73.1	65.9	81.9	122.5	69.4	97.2	70.6	40.2	64.6	34.6	40.2	80.6	44.9	41.2	38.0	42.7	91.7	31.7	31.1	36.7	17.8	36.3	90.1	46.3	46.6	105.6	32.4	53.4	55.4	92.6	33.2	34.9	40.5	35.5	69.6	18.3	125.0	160.8	0.0	0.0	0.0	0.0	0.0	0.0	188.7	149.0	263.5	0.0	693.2	1049.5	441.8	0.0	0.0	0.0	0.0	323.3	482.8	0.0	0.0	133.7	0.0	535.7	0.0	0.0	0.0	0.0	0.0	0.0	117.6	0.0	490.5	0.0	0.0	298.7	0.0	0.0	698.1	0.0	0.0	0.0	0.0	0.0	0.0	952.2	0.0	0.0	0.0
ATP5IF1	"ATPI, ATPIF1, ATPIP, IP, MGC1167, MGC8898"	ENSG00000130770	"ATP synthase inhibitory factor subunit 1"	Q9UII2	1	28236109-28246906	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 1141.6;Distal tubular cells: 877.0;Exocrine glandular cells: 585.4;Proximal tubular cells: 988.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027999	Supported		Enhanced	Mitochondria		NA	NA		1800000	Mitochondria		"HPA027999: AB_10600984"	"unprognostic (2.80e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.95e-1)"	"prognostic favorable (6.38e-8)"	"unprognostic (2.04e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.40e-2)"	"prognostic favorable (8.20e-4)"	"unprognostic (5.94e-2)"	"unprognostic (3.52e-1)"	"unprognostic (6.15e-3)"	"unprognostic (4.68e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.48e-3)"	17.1	35.1	65.9	32.1	64.0	58.5	20.9	41.8	71.7	24.6	54.5	15.7	33.8	78.2	18.6	24.1	26.4	31.9	38.4	135.2	51.8	60.7	60.2	55.4	20.1	28.7	46.8	58.7	20.5	33.8	20.7	37.6	19.4	53.0	30.4	30.5	24.8	34.5	34.4	135.2	26.3	58.7	15.4	31.0	25.9	45.0	72.4	26.2	24.3	25.0	44.6	23.5	17.9	18.6	56.5	64.2	35.7	35.2	39.1	64.8	55.2	45.6	23.7	13.9	13.2	10.5	11.5	16.6	20.5	10.2	17.6	17.3	22.8	33.5	32.3	30.9	12.4	6.6	27.9	15.9	20.4	13.9	24.1	53.6	27.6	102.7	30.7	11.4	21.0	28.0	13.3	33.9	15.6	12.6	17.2	16.8	38.6	48.8	29.5	12.5	30.3	31.2	38.9	46.3	17.2	29.3	29.9	15.4	45.6	34.2	30.4	28.2	20.3	25.4	26.5	26.1	14.2	39.3	23.3	17.3	5.7	15.7	22.2	24.1	76.4	46.0	44.6	27.0	57.7	6.6	30.3	35.2	35.7	46.5	31.7	46.2	56.5	49.6	49.1	42.3	43.7	46.7	45.0	30.9	39.1	28.3	64.2	64.8	55.2	65.9	64.0	41.8	71.7	51.8	60.7	46.8	58.7	53.0	26.2	190.6	249.0	0.0	0.0	0.0	0.0	0.0	0.0	1141.6	276.4	518.2	0.0	390.3	877.0	342.1	0.0	0.0	0.0	0.0	585.4	173.6	0.0	0.0	159.3	0.0	316.5	0.0	0.0	0.0	0.0	0.0	0.0	64.5	0.0	214.6	0.0	0.0	472.8	0.0	0.0	988.7	0.0	0.0	0.0	0.0	0.0	0.0	210.5	0.0	0.0	0.0
BAD	"BBC2, BCL2L8"	ENSG00000002330	"BCL2 associated agonist of cell death"	Q92934	11	64269830-64284704	"Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004205, HPA028185, HPA062105"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"CAB004205: AB_626717, HPA028185: AB_10603445, HPA062105: AB_2684684"	"unprognostic (1.47e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.24e-3)"	"unprognostic (2.60e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.26e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.48e-1)"	"unprognostic (7.95e-2)"	23.1	23.2	35.3	12.6	30.7	17.7	20.6	15.9	43.9	21.2	25.7	22.7	20.1	24.0	18.3	19.7	18.8	23.2	22.5	30.3	32.7	23.8	21.4	22.3	17.7	14.3	29.6	20.2	18.8	26.9	19.4	15.2	24.9	18.4	22.9	13.6	23.1	39.9	27.0	23.9	20.4	21.1	17.2	22.9	14.9	37.8	18.6	14.8	19.3	29.2	15.8	14.1	18.2	14.4	26.5	42.0	43.5	32.3	24.0	30.7	23.1	32.3	30.4	8.9	13.4	10.8	13.2	13.1	13.8	16.1	21.2	16.9	18.5	18.6	6.9	24.8	12.8	16.6	17.2	5.8	21.7	4.2	27.0	21.3	8.6	27.6	8.8	16.7	7.5	16.2	12.7	18.7	16.3	10.0	16.2	13.4	15.3	3.3	15.0	9.2	32.1	16.7	16.9	3.5	9.3	38.9	15.9	5.2	19.5	12.9	15.3	18.4	24.7	13.9	16.5	16.8	3.5	24.7	11.2	11.0	26.0	17.6	40.3	15.1	28.6	21.2	7.1	21.3	5.4	14.2	32.5	32.3	43.5	25.3	24.0	25.8	26.0	26.9	24.6	22.5	26.5	19.4	20.0	41.7	24.0	22.6	42.0	30.7	23.1	35.3	30.7	15.9	43.9	32.7	23.8	29.6	20.2	18.4	14.8	29.8	43.4	37.4	59.5	91.7	63.3	42.1	63.7	49.5	20.5	50.6	17.7	138.0	116.0	88.3	29.3	45.0	146.4	23.3	96.2	163.4	112.5	51.0	24.2	45.0	63.9	44.5	99.9	51.0	25.6	67.7	68.7	35.1	104.6	69.5	94.0	52.4	95.9	140.3	80.2	115.9	36.1	58.2	78.3	87.6	27.7	104.1	213.3	43.6	85.3	55.6
BCL2L13	"BCL-RAMBO, MIL1"	ENSG00000099968	"BCL2 like 13"	Q9BXK5	22	17628855-17730855	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 182.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002052, HPA030994, HPA050377"	Uncertain		Enhanced	Mitochondria		NA	NA			Mitochondria		"CAB002052: AB_563431, HPA030994: AB_10795024, HPA050377: AB_2681107"	"unprognostic (1.59e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.86e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.69e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.97e-2)"	"unprognostic (5.04e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.45e-2)"	"unprognostic (8.21e-2)"	"prognostic favorable (1.96e-8)"	"unprognostic (3.20e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.27e-1)"	"unprognostic (2.81e-1)"	15.3	17.4	13.3	7.6	14.2	10.9	17.3	13.0	17.4	9.2	11.9	14.8	8.8	8.3	10.5	10.7	14.5	11.7	10.0	18.9	12.7	12.2	18.9	20.9	10.6	9.3	14.4	13.4	10.4	22.0	25.8	12.3	14.1	12.2	11.1	14.1	15.2	12.4	9.5	61.2	15.5	12.4	11.7	13.0	8.3	11.2	22.9	11.5	12.1	13.5	14.5	12.3	14.6	10.2	6.5	11.3	4.7	17.3	10.4	8.3	9.5	13.8	6.2	9.9	9.4	16.6	15.9	13.2	9.9	17.4	14.7	16.8	7.0	9.2	12.0	7.2	14.2	14.8	19.0	11.4	15.3	15.4	11.5	8.7	11.3	5.6	3.6	20.6	15.7	9.8	12.9	17.9	12.6	34.1	18.4	12.8	10.0	28.1	11.3	16.0	9.3	8.0	5.0	7.8	22.4	7.7	8.4	15.3	4.5	15.3	9.6	14.1	8.8	13.1	13.3	23.7	25.8	9.1	15.6	12.8	8.8	4.5	12.5	9.5	9.7	8.8	10.3	13.1	12.1	15.0	3.8	17.3	4.7	4.6	15.6	5.7	6.5	6.2	5.7	11.3	5.4	5.5	4.5	4.4	10.4	11.0	5.7	8.3	9.5	13.3	14.2	13.0	17.4	12.7	12.2	14.4	13.4	12.2	11.5	20.8	11.8	21.7	29.2	21.9	182.7	38.9	12.7	14.7	29.6	17.4	11.8	42.2	44.7	26.6	26.6	14.3	28.3	23.3	27.5	28.8	15.8	31.6	8.1	30.6	23.9	46.1	22.4	12.9	27.2	9.5	13.0	22.7	15.1	58.7	26.7	45.9	28.7	14.4	14.5	33.8	30.9	0.0	15.5	21.7	21.4	23.7	80.2	19.1	22.9	31.8
BNIP3L	"BNIP3a, Nix"	ENSG00000104765	"BCL2 interacting protein 3 like"	O60238	8	26382898-26505636	"Cancer-related genes, Predicted membrane proteins, Transporters"	"Apoptosis, Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Erythroid cells: 467.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015652, CAB025371"	Enhanced		Supported	"Nuclear speckles,Mitochondria"		NA	NA			Mitochondria	"Nuclear speckles"	"CAB025371: , HPA015652: AB_1845406"	"unprognostic (1.02e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.00e-1)"	"unprognostic (8.36e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.46e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.06e-2)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (5.92e-5)"	"unprognostic (8.72e-3)"	"unprognostic (5.16e-2)"	"prognostic unfavorable (3.95e-4)"	"unprognostic (7.59e-3)"	61.7	27.8	32.7	18.2	39.1	79.4	40.1	26.1	39.0	35.0	19.9	32.3	30.7	11.5	27.3	34.0	26.7	26.4	28.0	36.0	36.0	27.4	39.9	22.9	31.3	20.7	43.1	31.9	63.4	10.4	26.8	16.0	51.2	41.0	23.7	14.9	20.9	22.1	39.2	21.0	38.1	14.5	26.5	47.9	19.5	16.7	33.0	43.9	17.8	21.5	12.4	25.2	48.3	30.8	14.2	30.4	68.7	53.9	7.8	17.6	36.3	17.9	6.9	16.4	11.1	45.7	28.8	13.9	18.2	53.5	17.1	37.9	3.1	8.7	5.5	17.2	34.2	23.9	9.2	8.1	23.4	57.0	3.6	4.5	22.9	7.1	5.4	25.5	2.0	39.8	34.6	18.4	19.3	11.6	56.7	21.8	13.7	10.3	13.4	35.8	7.8	14.2	7.6	5.3	11.3	7.5	7.6	20.8	10.9	17.7	11.7	17.5	15.6	8.8	1.7	13.8	18.8	9.0	4.3	28.6	32.1	13.9	20.0	4.1	19.7	8.9	7.4	48.9	4.1	7.2	49.9	53.9	32.1	7.6	27.8	6.7	12.4	11.4	8.3	30.4	14.2	17.6	12.8	68.7	7.8	17.4	6.9	15.0	36.3	32.7	39.1	26.1	39.0	36.0	27.4	43.1	31.9	41.0	43.9	80.4	113.7	54.1	47.2	87.7	108.8	31.1	30.6	89.7	69.4	97.7	31.4	24.2	41.4	101.3	153.2	88.4	28.4	467.2	33.9	141.0	136.5	90.8	116.8	23.2	118.2	77.9	115.7	155.9	197.5	155.5	296.6	132.1	101.3	70.3	45.5	412.0	125.0	28.8	326.7	215.8	62.1	142.3	150.4	113.3	98.5	110.7	135.9	55.4	28.1	62.0
CCDC90B	"MDS011, MDS025"	ENSG00000137500	"Coiled-coil domain containing 90B"	Q9GZT6	11	83259097-83286407	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 347.8;Spermatocytes: 279.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011130, HPA011931"	Supported		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA011130: AB_1846170, HPA011931: AB_2072332"	"unprognostic (5.85e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.34e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.48e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.57e-3)"	"unprognostic (5.76e-3)"	"unprognostic (3.53e-2)"	"unprognostic (6.01e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.41e-1)"	15.8	32.0	25.0	11.1	23.3	11.6	18.0	14.3	17.9	15.4	14.5	14.6	17.2	12.1	12.6	29.3	14.3	13.5	15.2	18.2	22.3	25.6	16.4	31.3	11.0	15.0	29.9	14.9	19.4	16.6	15.2	29.5	18.3	24.5	16.3	14.9	8.4	14.5	14.8	12.2	11.6	18.2	14.9	43.9	17.1	13.6	42.2	28.3	15.5	21.6	12.3	13.5	14.8	13.0	18.5	12.7	32.6	19.0	22.5	21.1	12.4	7.2	10.8	18.4	5.9	25.0	18.9	11.3	14.8	12.7	9.4	10.0	12.6	25.3	17.7	19.5	21.9	19.4	9.3	8.1	19.0	12.5	12.4	6.4	10.9	7.3	10.4	21.1	11.0	9.5	21.0	25.7	12.0	34.7	18.5	21.3	19.6	16.1	15.2	34.1	12.9	11.0	14.1	15.2	31.7	13.5	12.8	16.6	15.2	19.4	10.8	9.0	20.8	10.4	8.4	9.6	25.9	21.7	10.3	20.4	18.4	11.6	34.5	10.0	14.8	19.3	18.0	7.4	8.9	18.1	30.8	8.9	32.6	12.3	19.0	15.6	18.5	17.9	17.0	12.7	16.9	15.5	15.5	4.5	22.5	19.0	9.3	21.1	12.4	25.0	23.3	14.3	17.9	22.3	25.6	29.9	14.9	24.5	28.3	11.9	12.5	34.2	43.7	20.9	33.7	49.1	15.3	24.1	15.9	34.9	13.7	62.9	58.0	53.7	347.8	38.6	19.2	0.0	42.7	46.4	36.0	35.2	47.4	39.9	56.5	39.7	32.2	26.4	28.8	188.9	39.4	41.6	20.3	61.3	31.8	23.0	58.7	35.1	24.1	57.7	44.3	25.8	30.1	279.8	83.5	25.3	43.3	28.8	30.4	38.0
CCM2	"C7orf22, MGC4607, OSM"	ENSG00000136280	"CCM2 scaffolding protein"	Q9BSQ5	7	44999475-45076469	"Disease related genes, Predicted intracellular proteins"		"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"monocytes: 208.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020273, HPA021669, HPA065815"	Supported		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA020273: AB_1846185, HPA021669: AB_1846186, HPA065815: AB_2685562"	"unprognostic (4.30e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (3.17e-1)"	"prognostic unfavorable (2.45e-4)"	"unprognostic (4.85e-2)"	"unprognostic (1.55e-2)"	"unprognostic (7.37e-3)"	"unprognostic (3.92e-1)"	"unprognostic (2.65e-1)"	"prognostic favorable (1.16e-4)"	"unprognostic (3.03e-1)"	"prognostic unfavorable (5.06e-7)"	"unprognostic (2.45e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.81e-2)"	"unprognostic (2.48e-1)"	16.7	18.3	31.6	20.7	52.0	11.2	8.6	21.3	36.1	9.7	12.5	13.9	8.6	10.5	7.2	7.0	10.6	8.4	9.1	13.7	29.8	23.1	7.9	31.6	12.4	30.7	29.0	14.2	8.2	17.9	16.5	11.2	11.5	17.8	7.7	8.8	6.9	13.6	12.6	27.0	13.4	10.6	13.3	14.7	20.8	11.2	10.5	11.5	37.5	7.4	8.2	23.4	15.4	12.6	14.8	7.3	32.4	13.8	17.6	50.6	11.1	13.6	15.1	9.1	18.0	17.2	15.1	6.7	16.6	13.7	11.9	16.1	10.9	14.2	19.3	12.8	21.0	37.8	17.9	5.6	21.4	7.9	21.5	10.8	8.5	12.1	7.7	15.2	3.5	23.1	17.0	14.1	20.9	9.0	11.1	21.6	28.3	9.8	15.7	23.8	20.6	16.9	46.8	10.5	11.4	16.8	9.0	5.2	15.6	12.1	13.2	17.5	13.6	13.6	10.7	7.3	12.3	12.3	16.1	16.3	16.2	13.8	16.2	15.8	28.1	22.0	38.9	15.9	12.7	19.5	27.1	10.5	31.2	17.3	12.1	11.6	13.6	20.5	18.7	7.2	14.8	19.9	14.7	32.4	17.6	13.8	7.3	50.6	11.1	31.6	52.0	21.3	36.1	29.8	23.1	29.0	14.2	17.8	11.5	17.9	20.8	51.3	20.1	41.6	18.3	12.5	17.8	6.7	21.6	14.0	3.9	22.8	21.6	27.6	5.8	25.3	21.7	0.0	33.3	31.3	26.3	15.3	34.7	50.4	43.3	77.9	15.0	27.0	34.3	8.0	19.5	45.2	32.1	208.2	13.4	21.4	35.1	11.5	19.1	17.0	11.9	19.4	27.8	16.2	36.4	20.1	8.7	56.6	13.5	16.1
CCR7	"BLR2, CD197, CDw197, CMKBR7, EBI1"	ENSG00000126353	"C-C motif chemokine receptor 7"	P32248	17	40553769-40565472	"Cancer-related genes, CD markers, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"blood: 252.3;lymphoid tissue: 110.6"	"Cell type enriched"	"Detected in many"	6	"monocytes: 2758.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 252.3"	"Lineage enriched"	"Detected in many"	4	"T-cells: 252.3"	"Cell line enriched"	"Detected in some"	79	"HDLM-2: 175.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB003796, HPA031383, HPA074467"	Enhanced		Enhanced	Mitochondria		NA	NA			Mitochondria		"CAB003796: AB_562261, HPA031383: AB_2673854, HPA074467: AB_2686693"	"prognostic favorable (3.84e-4)"	"prognostic favorable (8.03e-6)"	"unprognostic (2.26e-3)"	"unprognostic (1.32e-3)"	"unprognostic (2.35e-3)"	"prognostic favorable (7.61e-7)"	"unprognostic (2.71e-4)"	"unprognostic (2.58e-2)"	"unprognostic (4.48e-2)"	"unprognostic (4.68e-4)"	"unprognostic (1.10e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.08e-3)"	"unprognostic (3.12e-1)"	"prognostic unfavorable (7.72e-4)"	"unprognostic (1.02e-1)"	"unprognostic (7.95e-2)"	2.8	0.4	0.2	26.0	0.2	5.2	1.7	0.2	0.3	2.2	1.2	0.3	0.8	0.3	1.2	0.5	1.4	2.3	2.0	1.9	0.2	0.2	1.5	1.7	3.4	110.6	0.3	0.2	1.5	0.3	0.0	1.0	1.0	0.4	1.3	2.1	0.7	8.4	0.2	0.2	1.1	16.2	0.2	0.4	20.3	1.8	1.2	0.3	57.1	2.0	1.2	53.8	4.2	1.3	58.8	2.9	2.3	0.3	44.1	252.3	109.3	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	175.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	1.0	0.1	1.1	0.2	0.0	0.0	1.1	0.3	0.2	3.1	0.1	3.6	37.2	53.3	15.3	0.2	58.8	252.3	133.9	2.3	44.1	0.2	2.9	30.3	109.3	0.2	0.2	0.2	0.3	0.2	0.2	0.3	0.2	0.4	0.3	0.0	5.9	116.5	1.4	4.4	0.0	0.3	0.0	0.0	2.3	1.8	0.0	111.5	0.0	0.4	0.1	0.1	0.0	0.0	6.9	6.3	3.3	0.0	2.3	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	12.9	15.1	2758.4	0.0	0.7	0.7	0.0	0.0	0.1	0.0	0.0	3.9	0.2	0.5	3.9	432.7	16.2	0.0	3.3
CHCHD2	C7orf17	ENSG00000106153	"Coiled-coil-helix-coiled-coil-helix domain containing 2"	Q9Y6H1	7	56101569-56106576	"Disease related genes, Predicted intracellular proteins"	Transcription	Activator	"Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 224.0"	"Low region specificity"	"Detected in all"							"HPA027407, HPA052510"	Uncertain		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA027407: AB_10959659, HPA052510: AB_2681856"	"unprognostic (8.68e-3)"	"unprognostic (2.79e-1)"	"unprognostic (8.48e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.90e-2)"	"prognostic unfavorable (1.90e-5)"	"prognostic unfavorable (9.41e-5)"	"unprognostic (4.38e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.60e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.40e-2)"	41.5	112.8	57.2	33.0	59.5	73.0	46.0	39.3	56.9	38.0	46.6	33.2	45.5	51.9	34.2	53.8	50.1	39.2	44.3	75.3	46.8	50.2	56.2	66.9	34.2	62.6	58.3	49.0	43.8	77.8	28.4	42.8	38.4	42.3	41.3	40.1	45.3	56.5	70.0	147.2	33.0	49.3	45.7	42.6	34.1	44.2	27.1	28.1	48.9	62.1	65.9	38.8	38.5	30.9	63.2	107.7	52.6	69.1	51.5	72.8	121.3	224.0	39.2	25.9	53.4	20.5	28.3	19.2	33.0	31.3	42.5	41.2	35.9	37.5	65.7	43.7	20.2	55.1	38.2	32.7	36.1	34.3	42.7	59.6	38.8	33.1	51.1	38.1	52.2	62.7	25.2	41.4	31.9	39.1	23.1	31.7	58.1	81.3	40.0	34.6	31.1	70.3	161.7	56.0	61.6	62.6	47.4	25.2	107.9	38.1	29.3	49.4	61.5	26.0	64.1	41.4	18.5	73.2	74.7	25.3	26.3	61.6	108.7	48.5	37.0	52.6	117.2	41.4	56.4	32.5	40.5	69.1	52.6	53.1	61.0	54.8	63.2	57.2	56.3	79.5	57.8	51.6	52.8	37.0	51.5	59.5	107.7	72.8	121.3	57.2	59.5	39.3	56.9	46.8	50.2	58.3	49.0	42.3	28.1	238.2	265.3	489.1	766.8	637.3	337.7	148.9	461.1	385.4	275.3	392.6	58.9	829.8	1576.7	867.5	105.9	435.3	847.1	303.7	1153.3	1054.3	581.8	939.9	386.6	693.4	849.1	465.6	519.8	355.4	420.9	153.5	568.7	575.0	723.7	764.7	720.0	545.6	1044.9	757.6	475.6	1300.4	258.3	420.4	656.7	417.0	565.7	628.8	1027.6	495.9	809.6	1069.0
COA3	"CCDC56, COX25, HSPC009, MITRAC12"	ENSG00000183978	"Cytochrome c oxidase assembly factor 3"	Q9Y2R0	17	42795147-42798704	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Distal tubular cells: 601.8;Proximal tubular cells: 547.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031966, HPA071122"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA031966: AB_10602115, HPA071122: "	"unprognostic (1.20e-1)"	"prognostic favorable (3.40e-4)"	"unprognostic (5.65e-2)"	"prognostic favorable (8.93e-4)"	"unprognostic (7.62e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.25e-2)"	"unprognostic (8.44e-3)"	"unprognostic (1.52e-1)"	"prognostic favorable (6.62e-4)"	"unprognostic (1.64e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.01e-2)"	13.4	17.8	34.5	11.1	26.7	4.6	20.6	19.5	31.8	18.7	33.7	18.0	18.2	35.9	14.0	62.6	30.2	26.2	20.0	26.3	29.3	26.0	57.2	44.1	13.7	14.1	31.2	22.2	17.0	97.0	16.2	15.0	17.8	26.1	22.0	31.6	14.9	30.3	25.1	28.7	12.6	33.5	14.5	21.6	12.2	27.1	9.5	17.1	13.1	22.8	28.6	19.8	14.1	18.1	56.1	49.2	46.0	59.1	46.2	50.5	59.7	16.2	55.2	25.4	13.9	23.5	20.0	15.6	12.8	19.6	30.7	27.8	21.7	20.6	0.9	36.4	15.5	28.9	15.9	19.5	31.3	29.1	15.9	51.3	11.0	26.0	68.6	16.6	14.8	13.3	20.3	23.6	28.9	16.6	15.7	24.3	7.9	17.5	14.1	27.1	26.7	4.8	32.4	11.6	33.5	19.9	19.4	37.1	27.9	31.1	22.5	19.0	15.9	13.1	13.9	22.2	22.9	43.2	19.4	14.8	33.5	17.5	14.1	16.9	16.7	18.0	8.7	25.1	14.8	22.6	46.0	59.1	36.8	39.8	54.9	41.6	56.1	41.4	40.2	49.2	51.2	38.4	38.2	6.3	46.2	45.5	32.9	50.5	59.7	34.5	26.7	19.5	31.8	29.3	26.0	31.2	22.2	26.1	17.1	26.8	53.5	65.9	51.4	32.6	33.1	216.0	178.3	105.7	47.8	253.0	19.6	126.9	601.8	110.3	8.4	56.1	184.6	0.0	208.4	149.1	56.0	56.9	34.6	366.5	106.3	42.9	76.7	73.6	73.2	15.0	51.8	46.4	84.4	81.2	165.8	62.7	139.6	178.9	42.5	547.1	26.6	38.8	61.8	48.1	47.3	48.6	85.5	37.4	224.0	60.3
COQ8B	"ADCK4, COQ8, FLJ12229"	ENSG00000123815	"Coenzyme Q8B"	Q96D53	19	40691529-40718207	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 11.9;Ciliated cells: 16.0;Collecting duct cells: 12.2;Ductal cells: 12.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027229, HPA027277, HPA027279, HPA028303"	Supported		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA027229: AB_10600100, HPA027277: AB_10599857, HPA027279: AB_10601219, HPA028303: AB_2672551"	"unprognostic (7.57e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.93e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.17e-2)"	"unprognostic (2.65e-2)"	13.6	17.8	21.1	13.1	16.4	11.5	10.0	24.1	19.2	13.6	13.6	18.6	14.8	17.9	15.0	13.2	16.6	26.5	16.7	14.7	15.7	10.7	11.8	15.6	12.1	12.2	15.5	12.1	16.3	19.4	12.6	32.7	7.9	13.2	15.1	5.7	12.3	16.8	17.6	10.3	12.9	18.6	16.2	15.6	12.1	17.5	12.5	16.7	16.8	15.5	6.9	13.2	14.8	11.8	12.9	15.0	17.7	15.6	9.7	13.1	10.5	8.3	34.3	7.0	13.5	6.3	6.1	6.5	7.8	8.5	5.9	6.3	10.7	15.2	11.2	15.1	4.5	7.0	7.3	4.9	8.7	2.1	13.4	10.2	10.7	20.9	5.9	10.8	3.7	16.8	8.0	9.3	4.3	5.2	6.7	6.6	13.9	5.7	6.2	4.1	5.1	4.8	4.5	5.4	9.2	3.6	8.0	9.9	8.5	10.2	14.2	12.6	10.3	10.5	16.1	16.9	4.5	14.4	14.0	6.2	5.1	17.3	3.6	4.6	6.8	5.5	5.7	19.3	4.2	7.0	15.8	15.6	14.6	11.6	15.4	13.1	12.9	9.0	12.4	15.0	11.7	8.9	9.1	17.7	9.7	13.7	8.7	8.8	10.5	21.1	16.4	24.1	19.2	15.7	10.7	15.5	12.1	13.2	16.7	11.9	4.6	0.0	0.0	0.0	0.0	0.0	0.0	16.0	4.5	12.2	0.0	9.4	10.0	12.4	0.0	0.0	0.0	0.0	9.5	7.9	0.0	0.0	1.1	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	10.4	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0
COX20	"FAM36A, FLJ43269"	ENSG00000203667	"COX20, cytochrome c oxidase assembly factor"	Q5RI15	1	244835322-244845057	"Disease related genes, Predicted membrane proteins"			"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA043617, HPA045490"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA043617: AB_10965694, HPA045490: AB_10962869"	"unprognostic (5.84e-3)"	"unprognostic (1.20e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.62e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.03e-1)"	"prognostic favorable (3.13e-4)"	"unprognostic (1.99e-1)"	"unprognostic (6.38e-2)"	"unprognostic (3.44e-2)"	"unprognostic (2.54e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.10e-1)"	"unprognostic (7.02e-3)"	13.1	37.9	30.2	17.5	28.9	12.5	14.9	22.0	25.8	11.8	20.5	11.8	9.3	18.2	17.5	16.9	20.6	11.4	16.2	35.4	22.8	27.7	36.7	23.6	11.1	13.4	32.1	18.3	26.7	15.1	14.3	15.1	15.0	19.2	20.2	11.8	27.9	11.3	15.5	33.3	8.1	19.4	42.5	22.0	10.1	17.9	21.1	17.0	10.4	17.5	20.2	10.7	23.0	16.5	18.2	16.3	11.6	18.4	12.2	22.5	10.5	36.7	9.2	9.3	29.0	6.4	4.8	21.9	15.5	10.3	8.9	8.0	26.2	25.7	5.6	19.7	10.4	17.3	9.6	4.9	12.4	12.0	15.6	3.4	10.8	13.5	24.1	8.6	26.4	16.6	4.3	6.0	13.1	9.2	12.8	10.1	6.3	22.2	23.3	18.3	9.1	14.2	11.8	24.6	26.6	19.2	10.5	11.5	34.0	16.5	8.7	5.4	14.9	19.4	10.2	20.1	9.8	18.9	7.6	19.6	19.8	26.0	17.2	33.2	37.0	50.7	11.9	25.2	29.5	18.9	5.7	8.8	11.6	15.4	18.4	15.1	18.2	18.3	16.8	15.0	16.0	11.0	16.9	1.7	12.2	17.8	16.3	22.5	10.5	30.2	28.9	22.0	25.8	22.8	27.7	32.1	18.3	19.2	17.0	17.9	46.2	77.5	98.6	75.7	105.2	57.3	178.3	52.2	58.0	181.5	43.2	203.1	351.5	126.1	26.1	56.2	109.3	93.5	164.5	133.4	54.1	70.8	70.6	249.2	109.9	84.2	59.4	39.3	60.1	57.2	64.5	84.0	69.2	129.8	72.2	94.2	142.7	87.5	75.3	253.1	99.4	64.7	95.9	66.9	97.5	66.0	221.2	70.2	105.2	80.4
COX5B		ENSG00000135940	"Cytochrome c oxidase subunit 5B"	P10606	2	97646040-97648383	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 336.2"	"Cell type enhanced"	"Detected in all"	5	"Cardiomyocytes: 3263.7;Distal tubular cells: 3068.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA034517	Supported		Enhanced	Mitochondria		NA	NA		2200000	Mitochondria		"HPA034517: AB_10603561"	"unprognostic (4.61e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.20e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (2.73e-4)"	39.8	25.3	54.5	20.8	46.1	27.6	23.9	22.6	46.4	19.5	58.6	16.0	27.6	44.5	13.1	22.3	31.9	19.4	24.0	160.6	39.9	36.0	44.8	52.5	13.8	16.1	48.1	32.5	17.7	24.6	19.9	17.5	18.1	39.0	21.5	31.5	14.3	36.5	29.2	336.2	18.9	38.6	19.9	30.8	17.9	40.4	13.4	23.0	14.2	25.8	65.4	15.3	19.4	16.7	85.1	111.2	115.8	122.5	48.1	83.6	145.2	19.9	23.3	14.4	23.9	17.0	15.5	62.3	25.7	14.4	17.1	19.1	64.4	20.9	33.7	55.3	16.4	27.0	30.5	16.6	25.8	7.8	26.2	70.6	45.4	25.8	76.9	32.7	43.0	33.3	28.7	22.9	16.4	12.8	17.5	14.6	27.0	33.3	14.9	13.2	49.4	27.1	62.4	28.4	34.1	122.6	26.7	24.8	50.4	23.0	30.7	28.6	30.6	25.0	30.2	48.2	20.0	16.1	45.1	26.5	15.6	26.6	25.0	16.5	38.9	36.8	25.7	28.3	37.0	16.1	96.9	122.5	99.8	54.7	114.1	52.6	85.1	66.3	57.1	111.2	68.8	64.5	57.5	115.8	48.1	95.9	75.8	83.6	145.2	54.5	46.1	22.6	46.4	39.9	36.0	48.1	32.5	39.0	23.0	205.4	224.6	375.1	495.2	343.3	204.5	3263.7	647.1	369.4	268.4	759.0	214.0	640.2	3068.8	479.5	156.4	370.1	2132.4	140.2	527.3	778.4	340.5	424.2	320.2	1125.6	767.8	133.5	711.5	338.8	489.5	270.1	325.7	488.5	865.4	798.1	1204.0	259.4	460.5	1508.0	286.4	1849.4	303.9	439.8	473.4	213.2	290.0	419.6	512.8	265.9	1320.1	744.1
COX7A2L	"COX7AR, COX7RP, EB1, SIG81"	ENSG00000115944	"Cytochrome c oxidase subunit 7A2 like"	O14548	2	42333546-42425088	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059124, CAB073545"			Enhanced	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"CAB073545: , HPA059124: AB_2683912"	"unprognostic (3.90e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.45e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.27e-2)"	"prognostic unfavorable (4.13e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.43e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.76e-1)"	"unprognostic (5.53e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.02e-1)"	25.1	73.3	47.3	24.4	63.3	47.7	45.4	35.2	58.2	33.4	33.8	21.0	28.8	31.7	30.2	37.9	20.9	31.2	27.1	49.8	40.4	45.3	50.9	48.9	24.0	28.1	42.6	35.6	49.8	49.3	24.9	42.7	24.0	34.9	29.5	36.2	32.3	37.0	30.3	24.4	21.5	32.1	28.4	33.1	23.1	29.4	24.8	20.5	28.0	35.8	35.8	30.9	24.5	31.1	45.1	59.7	57.2	48.7	40.5	53.7	100.9	38.3	24.6	27.3	29.6	46.9	66.9	32.7	31.8	46.5	29.1	37.2	26.9	27.8	34.0	31.9	36.4	37.3	17.2	32.5	33.7	42.6	52.2	25.0	23.0	17.6	47.7	55.3	34.5	25.6	65.6	67.9	28.4	68.8	42.2	40.9	26.7	33.4	58.4	45.0	31.2	41.1	57.4	26.8	45.4	25.6	22.5	47.4	28.8	41.6	31.1	32.5	37.1	13.3	33.6	91.2	31.7	24.1	40.3	30.8	26.4	34.6	31.9	31.0	48.0	53.6	25.5	37.4	37.5	22.4	57.2	48.7	27.2	39.0	42.0	50.0	45.1	47.9	45.3	53.1	37.6	53.7	46.1	21.6	40.5	46.3	59.7	52.8	100.9	47.3	63.3	35.2	58.2	40.4	45.3	42.6	35.6	34.9	20.5	29.8	61.2	171.1	166.3	235.9	115.5	140.5	132.5	96.4	51.2	141.3	35.3	190.2	547.2	206.3	15.8	157.6	103.8	23.3	199.6	263.9	167.1	184.8	86.4	193.0	204.8	123.9	277.2	113.5	243.6	17.7	149.8	177.9	209.2	287.7	202.3	182.8	197.6	161.4	149.2	386.1	95.5	109.9	206.0	195.8	267.6	214.7	275.6	186.4	235.2	168.4
CPOX	"CPO, CPX, HCP"	ENSG00000080819	"Coproporphyrinogen oxidase"	P36551	3	98521132-98593723	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 42.9"	"Cell type enhanced"	"Detected in many"	13	"Erythroid cells: 140.2;Extravillous trophoblasts: 67.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEL: 58.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015736, HPA054448"			Enhanced	Mitochondria		No	No		140000	Mitochondria		"HPA015736: AB_1847194, HPA054448: AB_2682490"	"unprognostic (2.14e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.07e-2)"	"unprognostic (6.09e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.34e-2)"	"unprognostic (8.58e-3)"	"unprognostic (7.14e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.86e-2)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (1.62e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.57e-1)"	6.6	8.9	12.6	9.0	29.9	30.2	6.6	10.1	21.1	7.5	8.2	29.6	5.7	17.7	8.8	6.4	14.1	6.4	7.2	6.9	17.5	11.7	5.6	29.3	6.3	9.1	42.9	16.2	9.5	6.9	9.9	5.5	14.8	23.7	7.4	10.3	3.4	7.2	7.2	8.5	10.8	12.3	7.7	32.8	9.1	7.7	3.9	36.0	7.7	6.2	7.0	9.8	8.5	10.4	1.7	1.7	0.0	2.1	2.1	3.0	0.7	16.6	8.1	7.2	12.7	13.5	10.0	20.7	10.8	7.8	11.1	12.7	13.4	5.2	1.7	12.1	5.7	12.3	12.1	8.9	11.6	19.0	5.3	7.8	58.1	4.6	17.3	6.9	12.2	13.8	7.8	9.8	10.5	4.4	13.1	10.6	7.2	11.1	7.5	10.4	5.1	12.3	10.5	8.5	9.3	14.8	8.8	16.4	7.7	9.4	6.9	4.8	4.7	11.4	3.9	32.3	8.4	6.1	7.9	8.8	16.6	16.3	9.5	7.8	11.6	9.1	9.4	16.5	13.5	12.1	0.0	2.1	0.0	1.4	1.0	2.5	1.7	2.4	2.9	1.7	1.5	0.8	3.0	0.0	2.1	0.7	1.1	1.1	0.7	12.6	29.9	10.1	21.1	17.5	11.7	42.9	16.2	23.7	36.0	3.0	8.3	6.9	4.0	6.5	3.4	7.1	2.5	1.4	0.0	3.5	7.9	21.7	1.7	3.0	0.0	5.8	6.4	140.2	1.6	67.8	9.9	4.4	1.1	30.1	11.2	0.0	8.1	11.6	10.8	0.0	6.9	8.9	11.8	10.8	8.6	6.0	2.8	0.0	7.4	5.1	5.3	12.9	9.0	0.0	3.2	8.9	8.9	10.7	9.7	3.7
CS		ENSG00000062485	"Citrate synthase"	O75390	12	56271699-56300392	"Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Tricarboxylic acid cycle"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 125.9"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 207.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA038460, HPA038461, CAB075750, CAB075751, CAB075752, CAB075753, CAB075754"	Enhanced		Enhanced	Mitochondria		NA	NA		4400000	Mitochondria		"CAB075750: AB_2665756, CAB075751: AB_2665757, CAB075752: AB_2665758, CAB075753: AB_2665759, CAB075754: AB_2665760, HPA038460: AB_2676023, HPA038461: AB_2676024"	"unprognostic (7.67e-3)"	"unprognostic (3.80e-1)"	"unprognostic (2.59e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.09e-3)"	"unprognostic (3.34e-2)"	"unprognostic (2.43e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.97e-2)"	"prognostic favorable (1.17e-4)"	"unprognostic (1.20e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.02e-1)"	37.1	35.5	11.9	16.3	20.4	19.3	55.6	28.5	43.8	17.2	27.4	14.1	11.3	25.3	19.9	10.8	31.7	16.5	14.0	79.2	11.2	14.5	26.7	12.3	17.3	30.8	12.3	14.2	16.9	20.7	28.1	14.3	11.9	24.8	16.2	32.7	19.8	23.1	17.5	125.9	22.8	27.0	21.2	15.0	18.4	21.4	7.9	11.1	20.7	17.9	48.2	26.1	22.9	19.1	19.5	37.1	59.6	27.8	15.9	19.7	18.2	35.8	38.8	31.7	41.1	42.1	39.2	20.6	29.9	29.4	52.7	36.8	54.7	35.2	70.1	29.4	37.7	22.6	38.9	87.5	45.0	50.4	24.3	44.5	48.1	28.2	39.4	23.6	58.8	34.6	43.1	43.0	41.3	50.1	43.4	59.1	36.6	49.8	42.1	45.9	28.8	48.7	18.1	25.2	27.2	56.1	47.5	37.2	52.9	32.6	36.4	41.6	27.3	38.7	46.1	30.3	30.8	64.1	34.3	39.2	26.6	37.3	37.5	31.5	27.8	42.3	45.6	24.5	43.4	24.9	14.5	22.0	59.6	15.2	27.8	19.7	19.5	18.3	14.3	37.1	16.7	19.4	15.4	9.8	15.9	27.0	20.5	19.3	18.2	11.9	20.4	28.5	43.8	11.2	14.5	12.3	14.2	24.8	11.1	14.9	33.2	16.0	18.6	34.7	21.7	207.5	22.9	10.7	19.4	12.2	58.9	15.6	29.9	31.3	5.1	27.0	51.5	0.0	38.6	26.0	18.2	26.3	27.6	26.2	31.0	9.5	16.3	17.2	29.2	3.6	18.7	33.5	10.1	27.1	43.6	15.1	37.2	23.0	18.7	17.3	36.0	12.9	25.9	18.4	24.7	45.7	14.1	18.1	64.8	26.5
CYCS	"CYC, HCS"	ENSG00000172115	"Cytochrome c, somatic"	P99999	7	25120091-25125361	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Electron transport, Respiratory chain, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 109.6;skeletal muscle: 103.7"	"Cell type enhanced"	"Detected in all"	5	"Distal tubular cells: 1409.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB004222, CAB005126, CAB018597"	Enhanced		Supported	Mitochondria		NA	NA		190000000	Mitochondria		"CAB004222: AB_627385, CAB005126: AB_2090472, CAB018597: AB_627383"	"unprognostic (3.06e-2)"	"unprognostic (3.39e-1)"	"unprognostic (3.32e-2)"	"unprognostic (4.11e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (2.81e-4)"	"unprognostic (4.44e-2)"	"unprognostic (7.04e-3)"	"unprognostic (5.67e-2)"	"unprognostic (6.22e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.52e-1)"	"prognostic favorable (1.30e-5)"	"unprognostic (1.18e-1)"	"unprognostic (4.94e-2)"	"unprognostic (8.75e-3)"	"unprognostic (7.04e-2)"	20.3	29.3	29.8	20.0	44.8	17.1	14.7	25.1	41.1	12.1	62.1	13.3	9.6	35.4	11.4	10.7	26.6	11.0	13.1	109.6	30.2	26.4	39.8	37.0	13.4	13.8	30.7	34.7	12.2	9.3	24.8	18.6	10.3	29.9	13.7	58.5	13.5	14.9	15.7	103.7	11.3	30.2	21.8	28.0	15.6	24.3	23.5	18.1	17.3	18.3	41.2	20.0	15.9	14.3	35.5	38.0	17.1	38.3	25.2	31.0	25.2	41.7	23.4	25.3	35.2	14.6	11.2	26.1	40.3	16.6	30.2	35.1	38.7	28.6	48.1	19.8	17.6	89.2	49.7	51.4	37.9	53.3	14.2	23.0	40.0	27.8	27.4	22.9	91.5	35.7	14.9	34.0	30.1	65.4	13.1	27.0	29.5	73.3	51.0	32.0	19.3	49.9	35.6	47.4	94.1	44.3	35.2	30.4	46.0	47.0	41.0	51.4	24.4	21.0	89.6	32.4	46.5	46.4	54.8	19.4	27.8	50.5	42.8	74.3	52.8	61.1	107.5	37.0	66.7	76.8	17.1	20.0	14.0	25.3	38.3	31.0	35.5	23.4	26.8	38.0	26.0	22.4	26.8	3.0	25.2	33.6	27.8	29.5	25.2	29.8	44.8	25.1	41.1	30.2	26.4	30.7	34.7	29.9	18.1	77.4	123.3	298.1	610.6	612.7	158.0	675.3	165.6	120.5	170.6	174.5	72.6	180.3	1409.2	260.2	374.4	142.6	539.3	116.8	187.6	286.9	225.4	312.0	210.9	174.2	320.2	125.5	369.3	82.3	121.9	99.1	83.4	292.4	560.1	339.0	300.1	181.9	228.9	349.1	88.1	469.8	154.2	135.8	467.2	297.7	184.8	625.2	292.1	228.4	388.1	691.0
DAP3	"bMRP-10, DAP-3, DKFZp686G12159, MGC126058, MGC126059, MRP-S29, MRPS29"	ENSG00000132676	"Death associated protein 3"	P51398	1	155687960-155739010	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	Apoptosis	"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023687	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA023687: AB_1847472"	"unprognostic (2.60e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (1.80e-1)"	"unprognostic (5.63e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (4.14e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.00e-1)"	27.8	36.5	22.9	26.3	25.9	28.9	34.2	19.5	23.6	23.5	33.4	19.5	22.8	29.4	28.7	28.1	31.3	21.8	23.2	56.3	27.0	26.4	32.8	52.2	23.9	49.0	24.9	23.0	23.3	38.5	20.7	27.1	20.5	23.0	27.9	32.1	24.5	28.0	27.1	64.0	30.9	26.5	36.0	23.2	30.8	30.3	31.6	21.1	44.4	27.6	28.4	38.0	38.0	24.1	39.0	41.1	15.9	35.2	34.0	56.5	39.6	32.4	21.1	17.2	27.3	25.5	32.3	42.5	27.4	29.0	28.2	24.7	38.9	40.0	46.3	55.9	22.3	18.1	33.2	25.6	23.9	30.8	29.0	18.7	28.2	18.8	35.2	34.9	38.6	25.2	27.0	34.3	35.9	47.6	22.1	27.7	43.0	60.9	33.0	29.3	43.2	33.9	45.2	30.5	51.1	34.5	28.0	21.6	49.2	33.5	31.2	20.1	35.6	26.3	77.6	47.2	33.4	48.2	63.5	23.6	24.0	25.3	29.6	45.9	36.1	53.9	53.4	23.9	34.6	30.8	13.9	30.1	15.9	31.3	35.2	51.4	39.0	45.1	38.0	41.1	32.2	56.5	48.4	13.0	34.0	31.9	26.8	45.0	39.6	22.9	25.9	19.5	23.6	27.0	26.4	24.9	23.0	23.0	21.1	41.7	35.8	49.1	58.4	48.8	26.0	99.7	45.9	68.3	58.0	15.7	19.6	67.1	56.3	62.2	13.1	35.0	35.4	93.5	68.2	87.5	44.8	51.6	61.1	48.1	67.9	12.7	24.6	34.4	47.0	10.6	30.0	61.0	33.7	88.4	35.3	13.3	67.0	31.6	23.7	57.4	46.0	12.9	47.2	38.7	26.6	55.2	118.4	64.7	54.9	62.6
DEPTOR	"DEP.6, DEPDC6, FLJ12428"	ENSG00000155792	"DEP domain containing MTOR interacting protein"	Q8TB45	8	119873717-120050913	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 67.6;skeletal muscle: 65.0"	"Cell type enhanced"	"Detected in many"	9	"Distal tubular cells: 72.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	11	"myeloid DC: 17.1"	"Lineage enriched"	"Detected in many"	11	"dendritic cells: 17.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 30.3;RPMI-8226: 54.0;RPTEC TERT1: 44.7;U-698: 15.9"	"Low region specificity"	"Detected in all"							"CAB020841, HPA023938, HPA023945, HPA024011"	Enhanced		Supported	Nucleoplasm,Mitochondria		No	No			Mitochondria	Nucleoplasm	"CAB020841: , HPA023938: AB_1847606, HPA023945: AB_1847607, HPA024011: AB_1847608"	"unprognostic (3.41e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.13e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.24e-2)"	"unprognostic (6.02e-2)"	"unprognostic (7.29e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.84e-2)"	8.1	30.2	6.4	5.2	11.0	1.1	9.7	5.1	9.2	18.9	12.7	17.8	5.7	7.8	16.0	5.7	7.2	12.7	6.1	4.3	7.3	6.3	22.7	7.5	2.7	8.5	9.5	6.1	12.5	5.6	13.3	13.6	4.4	7.5	6.4	4.8	0.7	67.6	7.9	65.0	4.3	7.4	7.7	8.2	5.3	20.0	2.1	11.5	0.7	45.0	20.7	2.7	4.8	5.7	0.1	17.1	0.3	1.5	0.3	0.8	0.8	0.0	1.0	0.1	0.3	6.4	1.9	0.1	0.0	0.1	0.1	0.1	0.7	0.1	30.3	0.7	0.3	0.0	0.1	1.6	0.0	0.1	0.6	0.8	4.1	0.2	0.1	3.9	0.8	7.1	1.7	2.9	0.2	0.1	0.0	0.0	0.5	0.0	5.0	0.1	2.0	0.0	0.7	0.4	13.2	1.0	0.1	1.4	54.0	44.7	1.2	0.9	0.2	0.5	3.3	0.9	0.9	2.9	0.1	0.0	0.1	0.2	6.4	0.1	13.4	3.1	15.9	1.9	1.1	0.2	0.0	0.8	0.0	0.2	1.5	0.7	0.1	0.3	0.6	17.1	0.1	0.8	0.5	0.3	0.3	0.1	0.8	0.3	0.8	6.4	11.0	5.1	9.2	7.3	6.3	9.5	6.1	7.5	11.5	6.0	9.4	4.5	12.1	4.6	2.2	2.2	15.3	0.0	5.7	24.4	0.0	0.5	72.9	3.3	1.3	3.6	3.9	0.0	10.6	1.5	8.2	11.1	11.5	10.5	2.8	0.0	16.0	4.3	11.8	1.1	10.9	7.6	13.5	1.8	2.9	0.9	1.3	20.9	3.2	24.6	0.4	0.0	1.7	3.2	3.2	4.8	0.3	0.0	14.7	16.9
DHODH		ENSG00000102967	"Dihydroorotate dehydrogenase (quinone)"	Q02127	16	72008588-72027664	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Pyrimidine biosynthesis"	Oxidoreductase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 72.4"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 106.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA010123, HPA011942"	Approved		Enhanced	Nucleoplasm,Mitochondria,Cytosol		NA	NA			Mitochondria	"Nucleoplasm, Cytosol"	"HPA010123: AB_1847648, HPA011942: AB_1847649"	"unprognostic (4.88e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.10e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.40e-2)"	"unprognostic (9.26e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.81e-1)"	5.9	4.2	4.7	8.8	5.1	2.9	5.0	2.7	5.0	5.9	4.4	6.1	1.4	3.4	6.6	2.3	5.1	5.2	2.3	11.5	4.3	3.0	6.6	72.4	3.4	5.5	4.8	2.7	6.2	9.9	7.1	4.0	2.6	5.2	3.9	4.8	5.9	6.0	4.4	11.7	4.0	3.0	7.5	4.0	3.5	3.4	4.3	5.4	4.0	3.6	7.1	5.1	3.5	3.3	11.2	13.4	3.9	8.1	9.3	12.9	6.8	7.4	15.5	4.5	7.5	2.4	3.2	8.6	6.4	2.6	9.7	7.5	12.2	6.8	16.8	8.7	3.5	5.4	7.9	8.9	6.9	11.5	3.8	8.4	9.2	7.5	12.0	6.8	12.7	6.8	3.1	7.1	11.7	12.3	3.1	7.0	11.4	14.0	3.1	5.9	19.8	12.0	12.2	10.2	12.7	6.1	15.2	5.9	17.7	5.8	4.9	5.4	6.3	8.6	9.2	4.2	5.8	8.2	6.4	3.0	8.9	5.5	8.4	9.3	5.9	10.9	28.4	4.6	14.0	8.1	3.9	8.1	0.9	9.3	7.7	12.7	11.2	8.9	9.0	13.3	10.6	12.4	12.9	2.1	9.3	5.6	13.4	7.1	6.8	4.7	5.1	2.7	5.0	4.3	3.0	4.8	2.7	5.2	5.4	3.0	9.6	9.5	6.4	4.9	5.7	12.1	7.6	9.4	1.2	7.0	3.9	12.0	5.0	6.6	2.1	6.7	0.7	0.0	4.4	9.6	6.0	5.0	8.1	106.1	6.9	3.2	1.2	2.5	5.3	2.3	2.6	3.4	11.8	3.6	4.4	4.8	5.2	2.9	2.1	20.1	4.2	0.0	9.9	7.9	8.0	3.3	2.4	5.0	6.2	4.1
DIABLO	"DFNA64, DIABLO-S, FLJ10537, FLJ25049, SMAC"	ENSG00000184047	"Diablo IAP-binding mitochondrial protein"	Q9NR28	12	122207663-122226568	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis		"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"Cytotrophoblasts: 9.3;Extravillous trophoblasts: 9.1;Hofbauer cells: 5.7;Syncytiotrophoblasts: 11.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA001825, CAB003857, CAB016688"	Supported		Enhanced	Mitochondria		NA	Yes		21000	Mitochondria		"CAB003857: AB_365498, CAB016688: AB_1615783, HPA001825: AB_1857247"	"unprognostic (3.67e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.10e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.40e-3)"	"unprognostic (5.06e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.05e-2)"	"prognostic unfavorable (5.35e-4)"	"unprognostic (6.68e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.40e-1)"	17.2	29.7	21.9	15.5	24.0	26.7	24.8	21.9	30.1	20.4	25.9	29.0	14.3	20.6	22.2	36.6	23.5	21.8	19.2	20.3	21.2	26.8	31.7	37.2	15.8	20.9	28.3	23.6	22.4	32.6	22.9	30.6	28.5	27.0	21.1	24.2	22.4	22.2	20.2	25.8	18.2	21.3	21.8	29.2	18.5	19.8	62.7	21.8	23.2	26.9	23.0	22.8	20.5	17.9	32.8	35.0	27.5	29.1	29.9	32.1	26.8	19.2	38.3	27.1	18.4	19.5	19.1	20.8	20.1	19.8	23.7	21.3	33.1	10.1	23.6	18.9	18.1	17.6	19.2	29.5	24.0	28.1	20.4	23.0	25.9	15.8	30.3	27.7	27.8	10.8	26.3	17.1	27.9	41.9	26.9	27.3	23.6	29.6	10.0	23.0	28.8	22.7	40.9	21.8	27.7	36.0	20.7	27.0	25.9	26.7	30.1	25.7	26.2	26.8	10.8	21.8	31.9	36.3	19.6	18.6	18.3	22.5	20.7	18.1	21.9	36.6	33.8	23.3	21.5	24.0	23.6	28.9	27.5	30.4	29.1	29.1	32.8	28.4	28.4	35.0	26.0	27.9	28.2	12.7	29.9	26.5	26.8	32.1	26.8	21.9	24.0	21.9	30.1	21.2	26.8	28.3	23.6	27.0	21.8	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0
ECHS1	SCEH	ENSG00000127884	"Enoyl-CoA hydratase, short chain 1"	P30084	10	133362480-133373689	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Lyase	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 148.2"	"Cell type enhanced"	"Detected in all"	11	"Hepatocytes: 1338.6;Proximal tubular cells: 2021.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003783, HPA021995, HPA022476"	Enhanced		Enhanced	Mitochondria		NA	NA		1500000	Mitochondria		"CAB003783: , HPA021995: AB_1847974, HPA022476: AB_1847975"	"unprognostic (3.68e-1)"	"unprognostic (2.46e-3)"	"unprognostic (9.57e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.51e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (8.57e-5)"	"unprognostic (2.84e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.50e-2)"	36.5	18.7	16.6	9.1	16.6	5.0	15.2	8.2	18.3	8.8	21.8	13.0	34.7	22.8	9.5	14.1	16.5	12.2	17.4	29.8	14.6	11.5	62.1	148.2	6.3	7.8	14.8	10.3	11.6	16.3	9.2	11.0	12.8	11.1	13.9	14.0	11.0	40.2	38.4	35.7	8.8	32.1	9.9	11.9	7.3	11.0	10.2	10.2	3.9	16.2	17.5	13.0	11.2	7.8	39.4	53.7	18.3	45.7	33.5	32.1	44.5	28.9	36.3	19.8	49.3	28.7	18.6	18.1	21.3	28.2	29.8	25.2	79.7	28.1	21.8	18.5	23.9	15.6	27.2	25.7	21.6	21.6	16.7	45.0	21.8	22.0	56.6	24.2	28.1	15.5	20.7	18.7	19.7	25.2	26.5	26.3	15.9	19.6	19.2	28.9	68.6	14.0	55.0	13.8	45.9	43.6	24.2	24.0	11.6	36.8	37.1	12.8	20.3	22.0	36.6	27.7	11.9	28.5	27.2	21.1	13.4	19.5	27.9	28.0	14.4	8.8	24.8	31.9	15.4	11.1	17.0	41.7	18.3	24.9	45.7	32.1	39.4	28.1	27.1	53.7	32.2	28.9	27.9	4.4	33.5	34.3	23.2	26.0	44.5	16.6	16.6	8.2	18.3	14.6	11.5	14.8	10.3	11.1	10.2	41.7	72.4	78.2	79.8	60.7	58.8	224.4	180.9	62.9	56.9	165.7	5.9	406.8	479.1	144.4	24.0	65.0	374.4	46.7	88.5	126.6	74.8	83.9	89.0	1338.6	193.8	42.9	126.4	78.5	88.6	29.7	71.9	72.7	128.2	149.7	152.5	112.9	99.9	252.6	86.3	2021.6	42.1	84.1	76.9	50.6	40.1	66.7	250.1	49.0	276.7	103.8
ECI1	DCI	ENSG00000167969	"Enoyl-CoA delta isomerase 1"	P42126	16	2239395-2252300	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 90.3"	"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 255.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041746, HPA043227"	Enhanced		Enhanced	Mitochondria		NA	NA		11000000	Mitochondria		"HPA041746: AB_10960693, HPA043227: AB_10960273"	"unprognostic (4.99e-2)"	"prognostic favorable (3.04e-5)"	"unprognostic (3.75e-1)"	"unprognostic (2.92e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.85e-2)"	"prognostic favorable (1.07e-4)"	"unprognostic (1.98e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.14e-3)"	"unprognostic (6.32e-2)"	"unprognostic (2.66e-2)"	"prognostic favorable (8.99e-8)"	"unprognostic (2.61e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.97e-1)"	"unprognostic (6.08e-3)"	15.7	12.5	12.5	9.8	10.8	9.1	16.8	12.8	11.3	10.9	27.6	9.7	20.3	30.9	10.6	16.7	15.5	13.4	17.3	56.4	10.1	10.3	36.5	57.4	10.3	10.7	12.4	8.8	10.8	30.4	11.1	11.9	10.6	13.0	13.4	8.4	16.3	40.9	19.1	90.3	10.4	31.2	14.1	10.1	8.0	17.2	8.4	9.6	10.4	38.7	25.4	10.5	14.4	11.5	7.6	6.5	3.9	7.1	5.8	6.7	1.7	7.3	17.7	6.8	27.8	2.6	3.7	25.5	7.4	5.2	6.2	9.1	31.1	22.7	10.7	18.7	4.6	4.4	18.3	7.9	7.1	0.8	18.5	40.7	3.3	16.5	38.4	23.8	9.6	1.5	6.8	16.8	5.1	11.1	4.4	6.1	0.2	17.7	22.7	2.1	30.4	0.9	14.4	15.7	11.9	17.9	33.6	7.3	51.4	11.7	8.4	23.4	14.8	18.1	34.1	22.5	3.5	22.0	17.1	5.0	4.8	18.1	5.2	8.3	25.2	14.8	17.4	6.3	8.9	6.8	3.2	6.8	2.7	3.8	7.1	6.0	7.6	5.5	2.9	5.5	7.4	6.7	5.6	3.9	5.8	4.2	6.5	6.7	1.7	12.5	10.8	12.8	11.3	10.1	10.3	12.4	8.8	13.0	9.6	3.0	23.3	31.8	94.0	18.9	51.2	90.1	94.3	9.4	14.8	73.3	41.2	151.4	255.4	28.6	6.2	23.5	150.2	0.0	31.7	67.6	25.6	72.7	5.7	199.4	41.4	20.6	43.7	26.4	26.7	4.2	22.7	23.7	37.1	14.4	73.5	52.4	28.1	70.2	22.6	187.7	57.7	0.0	30.2	2.5	15.8	19.4	91.9	17.5	89.4	98.4
ECI2	"ACBD2, DRS1, HCA88, PECI"	ENSG00000198721	"Enoyl-CoA delta isomerase 2"	O75521	6	4115689-4135597	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 102.3"	"Cell type enhanced"	"Detected in all"	8	"Distal tubular cells: 363.1;Proximal tubular cells: 504.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA022130, HPA031626"	Enhanced		Enhanced	Peroxisomes,Mitochondria		NA	NA			"Peroxisomes, Mitochondria"		"HPA022130: AB_1855176, HPA031626: AB_2673965"	"unprognostic (2.36e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.00e-2)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (1.17e-3)"	"unprognostic (4.97e-2)"	"unprognostic (9.49e-2)"	"unprognostic (3.95e-3)"	"unprognostic (3.17e-2)"	"unprognostic (5.75e-2)"	"prognostic favorable (2.04e-6)"	"unprognostic (1.40e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.34e-1)"	17.9	29.2	13.2	7.3	17.4	4.5	17.0	8.9	9.5	15.7	18.0	10.7	14.9	16.2	15.2	26.2	10.6	12.7	12.4	32.1	10.3	11.1	56.8	102.3	7.4	8.9	13.3	7.2	19.0	59.2	8.9	17.2	11.1	10.3	14.6	14.0	13.3	9.0	10.5	45.7	5.6	22.7	10.3	11.9	10.1	23.2	11.9	9.3	13.3	17.7	26.6	7.5	12.6	8.9	20.6	25.1	7.0	16.2	25.5	27.7	16.7	17.8	9.7	16.3	35.3	20.5	30.5	2.0	25.3	25.9	27.6	24.7	7.3	2.7	0.7	31.9	27.5	25.1	9.4	18.4	14.7	40.2	6.7	21.1	9.4	13.7	39.3	11.9	8.5	4.7	20.9	9.0	23.5	13.2	37.6	57.5	30.4	30.8	6.9	26.1	7.1	24.0	21.2	11.0	1.7	34.8	23.3	20.2	0.3	14.9	3.6	0.3	7.6	1.5	10.6	22.3	30.8	24.5	4.0	58.0	20.8	11.4	18.4	15.0	10.5	18.8	1.8	10.7	7.5	16.1	6.9	15.5	7.0	18.9	11.5	25.9	19.9	22.3	26.4	25.1	20.6	27.7	27.1	0.4	25.5	16.2	19.2	23.6	16.7	13.2	17.4	8.9	9.5	10.3	11.1	13.3	7.2	10.3	9.3	26.8	25.1	23.1	44.0	16.3	13.3	158.2	86.6	121.8	59.1	34.9	11.8	242.5	363.1	46.4	49.2	44.3	33.7	46.7	154.5	15.1	57.4	23.5	22.0	167.8	55.4	17.5	50.1	41.7	22.4	39.8	58.7	24.7	33.7	36.1	38.2	54.7	71.1	41.2	47.7	504.9	43.8	25.8	23.7	25.7	33.2	11.2	85.2	49.0	60.0	20.4
EFEMP1	"DHRD, FBLN3, FBNL, MTLV, S1-5"	ENSG00000115380	"EGF containing fibulin extracellular matrix protein 1"	Q12805	2	55865967-55924139	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 1167.9;Syncytiotrophoblasts: 744.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 64.6;hTERT-RPE1: 129.3;HUVEC TERT2: 263.2;TIME: 233.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB016368, HPA049806, HPA070841, HPA071588"	Supported		Supported	Mitochondria	"Secreted to extracellular matrix"	NA	NA		1800000000	Mitochondria		"CAB016368: AB_2277777, HPA049806: , HPA070841: AB_2686319, HPA071588: "	"unprognostic (8.21e-2)"	"unprognostic (7.68e-2)"	"unprognostic (9.01e-3)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.46e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (3.89e-8)"	"unprognostic (3.15e-3)"	"unprognostic (4.94e-2)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (6.68e-5)"	63.1	14.1	13.6	14.1	35.1	0.1	45.5	8.0	12.8	14.8	20.4	22.0	16.6	6.2	20.1	31.9	22.0	38.6	37.1	55.4	8.2	9.7	16.3	3.5	38.5	24.5	12.5	15.5	52.9	10.9	3.3	6.6	84.5	25.8	47.5	22.9	116.9	26.8	40.5	15.6	13.8	12.0	29.9	8.6	10.1	12.6	9.3	13.5	0.9	57.4	18.1	7.3	45.5	41.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.0	0.2	0.4	0.0	20.0	13.0	0.0	12.5	13.4	1.5	1.1	0.0	1.2	0.0	8.1	15.1	1.3	20.9	0.0	15.0	0.5	0.0	0.0	0.0	5.3	0.0	55.0	0.0	0.0	64.6	6.9	1.5	17.2	129.3	263.2	0.0	0.0	0.0	5.6	1.9	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.1	0.0	17.3	6.5	0.0	0.4	20.2	0.0	233.1	0.1	7.0	25.8	8.0	0.7	0.0	0.0	4.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	35.1	8.0	8.8	8.2	9.7	12.5	15.5	25.8	13.5	232.3	83.7	0.0	78.5	70.5	1.6	12.3	10.2	99.0	89.9	26.2	0.0	1167.9	8.3	27.4	0.3	12.2	0.0	0.0	23.4	127.3	186.9	9.1	2.3	0.4	83.0	0.0	0.0	68.7	0.6	0.8	39.4	4.3	16.9	1.0	0.0	149.0	2.2	0.0	0.0	6.9	3.9	0.0	22.5	0.0	0.2	27.7	744.0	0.0	0.0	3.9
EIF4E2	"4EHP, EIF4EL3, IF4e"	ENSG00000135930	"Eukaryotic translation initiation factor 4E family member 2"	O60573	2	232550052-232583644	"Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019253, HPA077074"			Enhanced	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA019253: AB_1848092, HPA077074: "	"unprognostic (3.44e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (2.38e-4)"	"unprognostic (1.42e-1)"	"unprognostic (5.62e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.36e-2)"	"unprognostic (7.74e-2)"	"unprognostic (3.34e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.38e-2)"	19.0	22.9	27.9	24.0	24.4	25.4	19.4	27.1	38.1	17.6	30.7	18.4	17.0	24.4	26.2	18.2	32.1	18.5	20.0	21.3	25.8	14.8	29.8	43.2	20.4	21.0	18.6	27.2	22.0	26.2	16.3	25.0	26.8	26.3	19.9	35.7	16.1	27.3	15.9	77.6	23.8	25.2	25.3	27.0	25.4	26.7	25.2	21.5	18.1	19.1	24.8	27.1	20.0	21.2	13.5	38.9	49.6	46.8	14.1	24.1	29.7	27.9	23.2	28.4	21.0	20.9	28.6	43.9	37.7	20.4	26.0	26.6	25.6	26.5	27.4	10.7	36.7	30.7	23.9	32.0	32.8	32.7	24.5	26.4	37.5	25.1	33.9	25.4	52.4	35.5	24.5	24.6	27.3	19.7	26.5	42.2	13.4	35.2	9.3	29.3	45.1	21.3	44.5	45.3	31.0	19.4	18.4	63.2	17.9	52.1	33.4	27.7	37.9	20.1	23.3	24.0	32.0	22.2	36.8	38.5	24.4	32.1	25.4	27.8	17.5	16.6	36.1	27.3	28.9	21.1	49.6	45.1	40.7	14.8	46.8	11.8	13.5	15.1	15.4	38.9	12.2	12.9	13.1	29.5	14.1	41.7	15.2	24.1	29.7	27.9	24.4	27.1	38.1	25.8	14.8	18.6	27.2	26.3	21.5	38.7	52.3	42.4	59.6	33.8	19.5	33.6	71.4	34.8	31.8	33.2	17.7	120.6	63.0	146.2	103.8	31.0	104.8	0.0	131.7	170.6	55.5	66.8	42.7	102.9	110.3	19.1	63.4	46.1	84.3	214.1	35.4	81.8	28.7	140.7	94.2	22.7	139.4	87.7	36.4	98.2	18.3	25.8	36.6	47.9	59.9	44.7	152.5	45.7	76.5	86.7
ERAL1	HERA-B	ENSG00000132591	"Era like 12S mitochondrial rRNA chaperone 1"	O75616	17	28854938-28861067	"Disease related genes, Predicted intracellular proteins"	"Ribosome biogenesis"	"RNA-binding, rRNA-binding"	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"monocytes: 110.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021425, HPA024423"	Supported		Enhanced	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA021425: AB_1848228, HPA024423: AB_1848229"	"unprognostic (1.03e-1)"	"unprognostic (9.16e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.77e-2)"	"unprognostic (3.55e-1)"	"unprognostic (8.37e-3)"	"prognostic unfavorable (3.59e-4)"	"unprognostic (8.20e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.70e-1)"	"unprognostic (8.57e-3)"	"unprognostic (5.76e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.79e-2)"	16.2	24.8	24.1	13.3	31.6	12.7	19.4	25.1	47.9	18.4	20.9	27.1	15.8	18.0	21.5	19.2	20.6	22.2	17.2	24.5	23.0	22.0	24.9	33.7	14.8	16.0	21.3	20.2	22.0	18.1	29.3	15.4	24.7	27.6	18.0	23.4	17.3	28.2	21.2	34.1	18.3	19.7	21.8	18.4	17.0	18.2	17.3	15.5	20.4	20.3	21.5	23.8	16.1	14.8	20.1	29.0	11.1	23.1	20.8	18.2	14.9	16.2	31.5	18.4	20.9	20.4	14.0	18.0	12.9	18.6	39.4	32.4	30.7	10.5	20.8	15.8	22.3	29.8	18.0	33.7	29.5	32.9	20.6	39.5	16.8	21.0	31.0	26.1	19.9	15.3	18.2	26.4	31.9	30.3	15.5	32.1	26.5	33.3	13.2	21.9	25.4	20.7	30.7	17.0	29.8	15.1	19.1	29.3	26.9	23.8	18.5	19.6	15.8	21.2	52.1	16.7	28.6	36.7	23.4	12.9	16.1	18.1	17.7	27.3	10.6	19.3	22.3	17.5	17.4	16.3	11.1	17.9	7.1	17.8	23.1	13.4	20.1	15.2	13.0	29.0	18.6	17.6	18.2	1.4	20.8	15.6	15.0	16.3	14.9	24.1	31.6	25.1	47.9	23.0	22.0	21.3	20.2	27.6	15.5	6.0	3.2	11.5	12.7	7.1	9.6	6.0	22.9	5.3	3.4	10.4	5.9	59.5	31.5	26.1	1.1	10.9	16.0	23.3	18.8	44.1	11.4	11.1	4.7	20.3	31.0	11.1	20.7	9.8	8.2	3.6	13.3	8.0	10.1	110.0	12.7	14.5	17.0	10.5	14.9	25.0	6.5	19.4	9.5	18.9	22.2	10.2	43.3	10.9	25.2	8.4
ETFA	"EMA, GA2, MADD"	ENSG00000140374	"Electron transfer flavoprotein alpha subunit"	P13804	15	76215355-76311472	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"		"Disease mutation, Glutaricaciduria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018990, HPA018993, HPA018996, HPA024089"	Enhanced		Enhanced	Mitochondria		NA	NA		6300000	Mitochondria		"HPA018990: AB_1848277, HPA018993: AB_1848275, HPA018996: AB_1848276, HPA024089: AB_1848278"	"unprognostic (3.44e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.71e-3)"	"unprognostic (5.99e-2)"	"unprognostic (6.81e-3)"	"unprognostic (3.02e-1)"	"unprognostic (5.01e-2)"	"unprognostic (6.01e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.99e-1)"	"prognostic favorable (5.04e-8)"	"unprognostic (2.87e-1)"	"unprognostic (4.90e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.90e-2)"	18.8	39.9	12.8	16.4	13.6	10.7	26.1	7.6	13.4	8.6	26.4	7.3	9.6	27.5	10.1	11.1	18.9	7.7	12.6	84.4	13.3	8.5	36.4	78.3	9.8	15.7	11.9	12.9	7.8	28.1	7.6	11.0	24.0	11.8	11.2	26.0	9.4	15.8	10.8	84.0	12.3	29.2	17.3	11.8	11.7	18.5	9.7	10.8	10.8	11.9	37.9	12.8	14.8	11.5	24.6	50.7	25.2	38.8	36.0	29.3	39.4	21.7	35.9	23.8	24.9	26.9	28.7	37.5	26.4	30.5	34.2	30.7	31.8	40.7	36.6	26.5	26.2	25.9	55.9	92.3	36.6	39.9	43.8	18.0	39.8	26.1	36.7	21.9	37.9	29.7	21.4	34.7	17.3	28.9	18.8	34.5	11.8	37.6	38.0	35.0	34.3	7.8	31.7	18.5	40.5	10.8	34.4	29.6	48.9	37.7	70.2	24.9	12.6	39.9	91.2	36.1	57.7	46.9	40.2	20.2	33.4	22.7	29.2	31.8	18.6	38.1	45.1	24.1	50.5	23.6	11.2	38.8	25.2	22.1	34.5	20.8	24.6	20.8	22.7	50.7	20.2	17.0	21.1	9.9	36.0	28.4	20.3	29.3	39.4	12.8	13.6	7.6	13.4	13.3	8.5	11.9	12.9	11.8	10.8	53.6	38.2	49.8	84.3	47.5	12.6	330.7	79.0	33.5	34.2	34.9	21.6	240.1	177.4	96.7	9.4	51.7	207.6	70.0	73.2	147.6	65.4	64.8	37.0	330.0	115.9	50.9	62.8	52.2	76.6	5.4	55.0	77.4	54.0	158.7	117.7	20.6	89.9	152.0	54.8	301.8	18.1	45.3	63.7	39.6	31.3	49.9	251.0	56.8	156.2	138.0
ETFB		ENSG00000105379	"Electron transfer flavoprotein beta subunit"	P38117	19	51345169-51366418	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"		"Disease mutation, Glutaricaciduria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 108.6;liver: 106.6"	"Cell type enhanced"	"Detected in all"	6	"Hepatocytes: 1022.8;Proximal tubular cells: 1001.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 183.6;OE19: 84.6"					"Low region specificity"	"Detected in all"			"HPA018910, HPA018921, HPA018923"	Supported		Enhanced	Mitochondria		NA	NA		640000	Mitochondria		"HPA018910: AB_1848280, HPA018921: AB_1848281, HPA018923: AB_1848282"	"unprognostic (1.44e-1)"	"prognostic favorable (6.45e-4)"	"unprognostic (8.66e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.94e-2)"	"unprognostic (3.20e-1)"	"unprognostic (6.93e-3)"	"unprognostic (2.63e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.75e-1)"	"prognostic favorable (6.45e-5)"	"unprognostic (2.19e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.83e-1)"	"unprognostic (1.99e-1)"	35.8	28.7	26.1	12.0	30.7	14.3	16.7	9.4	19.5	9.1	27.2	17.7	11.3	33.2	9.8	10.1	24.2	13.2	31.5	108.6	22.2	19.2	32.1	106.6	10.2	12.3	27.9	17.1	11.1	23.0	12.8	11.7	10.5	18.1	12.9	10.1	18.4	46.7	10.2	72.9	13.6	30.6	16.6	22.2	10.6	19.1	7.7	15.9	17.7	14.2	47.7	14.6	11.4	9.9	66.0	62.5	27.0	49.3	46.2	50.7	31.9	13.0	33.8	4.7	12.9	15.0	17.6	7.5	8.9	6.9	7.2	7.2	28.4	21.5	13.1	9.1	14.3	3.8	11.6	9.3	19.0	2.2	19.5	36.2	10.3	20.7	183.6	16.5	9.8	7.7	27.3	5.7	9.8	10.1	9.1	6.1	12.9	15.4	14.7	9.3	26.5	10.2	9.3	3.0	84.6	41.9	11.4	12.6	24.5	9.9	15.0	10.5	5.1	19.7	5.6	10.1	3.5	14.7	9.5	8.6	7.6	7.9	8.1	8.1	22.6	13.7	11.6	38.5	14.6	19.4	26.7	46.9	27.0	26.4	49.3	34.4	63.9	39.6	33.7	53.5	66.0	42.2	35.0	23.6	46.2	36.6	62.5	50.7	31.9	26.1	30.7	9.4	19.5	22.2	19.2	27.9	17.1	18.1	15.9	74.5	84.5	90.8	84.9	57.8	71.3	216.3	254.8	84.3	67.1	115.1	29.5	201.1	484.1	142.6	109.5	67.1	494.9	140.2	122.3	163.1	89.1	73.5	87.6	1022.8	188.0	41.3	161.8	136.9	151.1	228.9	99.5	69.4	271.7	69.5	259.6	93.2	146.4	263.1	107.5	1001.5	53.3	97.0	80.2	54.2	48.9	55.7	133.9	91.6	302.4	92.8
ETHE1	"HSCO, YF13H12"	ENSG00000105755	"ETHE1, persulfide dioxygenase"	O95571	19	43506719-43527244	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 80.7"	"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 485.2;Paneth cells: 571.2;Undifferentiated cells: 334.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 49.1;OE19: 77.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028360, HPA029028, HPA029029"	Enhanced		Enhanced	Mitochondria		No	No		13000	Mitochondria		"HPA028360: AB_10599297, HPA029028: AB_10602092, HPA029029: AB_10601998"	"unprognostic (8.04e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.45e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.58e-1)"	"prognostic unfavorable (9.58e-4)"	"unprognostic (7.75e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.72e-3)"	"unprognostic (2.73e-2)"	7.7	10.5	5.2	28.3	6.3	13.1	8.8	4.5	6.7	10.9	80.7	4.6	9.6	27.4	7.1	12.2	28.2	7.1	18.4	8.9	4.4	4.1	19.0	21.3	11.4	15.5	5.6	4.9	7.4	12.7	3.0	7.2	16.7	5.1	12.0	72.1	5.6	18.5	6.7	9.4	9.1	40.3	11.8	4.5	11.0	13.2	3.3	4.7	12.0	26.2	23.3	24.4	10.9	13.3	7.9	35.8	7.4	24.3	9.9	20.2	15.1	11.5	15.3	3.1	10.9	17.1	11.6	1.2	18.0	49.1	15.5	15.9	4.5	11.8	0.0	13.5	17.2	4.9	9.4	4.5	27.1	4.1	5.8	1.4	2.9	6.6	12.7	7.7	4.3	4.1	11.9	21.3	6.0	16.8	20.5	11.5	11.2	1.9	19.5	7.6	7.8	5.0	4.0	0.8	77.6	7.4	5.7	1.3	2.5	33.7	24.1	0.0	3.9	4.6	16.5	10.8	5.3	5.0	7.2	9.6	2.5	10.7	3.0	3.3	5.5	4.3	0.3	10.9	17.9	12.9	7.4	24.3	0.6	17.2	12.7	20.0	7.9	20.2	16.3	35.8	3.4	15.6	14.8	0.7	9.9	8.5	7.1	19.4	15.1	5.2	6.3	4.5	6.7	4.4	4.1	5.6	4.9	5.1	4.7	20.8	18.9	42.5	70.4	30.7	9.5	8.3	53.5	14.7	17.0	52.4	0.0	162.0	46.4	62.5	0.4	49.6	485.2	0.0	56.4	70.8	54.7	70.7	36.9	78.8	100.9	4.8	61.2	36.8	100.2	1.6	16.4	79.3	75.9	58.7	224.1	9.4	73.6	571.2	15.2	90.3	4.6	19.4	61.2	1.8	5.5	20.3	77.3	53.3	334.8	123.3
FAHD1	"C16orf36, DKFZP566J2046"	ENSG00000180185	"Fumarylacetoacetate hydrolase domain containing 1"	Q6P587	16	1826941-1840207	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Proximal tubular cells: 175.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025530, HPA043226, HPA043534"	Enhanced		Enhanced	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"CAB025530: , HPA043226: AB_2678370, HPA043534: AB_2678535"	"unprognostic (3.71e-1)"	"unprognostic (1.25e-2)"	"prognostic favorable (8.27e-4)"	"unprognostic (1.99e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.89e-2)"	"unprognostic (4.32e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (2.80e-14)"	"unprognostic (1.02e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.31e-2)"	10.4	17.0	10.4	6.7	9.9	6.5	9.2	8.6	12.7	6.8	21.7	9.3	8.2	26.7	9.8	10.9	14.8	5.8	10.2	15.8	10.9	11.4	46.8	43.6	5.6	5.2	10.1	9.4	7.9	17.4	9.0	11.1	10.4	9.9	8.1	11.1	8.5	9.1	9.8	20.2	12.4	24.8	6.9	8.8	6.3	14.9	6.9	9.5	4.7	12.5	19.0	5.7	9.9	7.9	18.5	23.1	8.6	27.5	19.6	16.0	13.7	8.4	19.1	9.1	16.1	12.1	8.8	5.7	13.9	6.9	9.3	10.2	12.2	8.8	5.4	11.7	8.6	14.4	17.4	7.1	11.2	8.4	8.2	16.9	4.8	16.5	28.1	11.8	8.3	9.4	11.6	14.7	8.5	5.7	7.9	12.1	6.6	5.0	5.7	11.6	38.7	4.5	12.6	5.4	7.8	14.3	10.4	12.4	15.2	33.4	10.6	17.8	14.8	18.2	14.7	21.8	6.4	21.5	5.7	17.6	15.3	10.9	9.0	7.5	8.2	17.2	6.4	9.7	6.1	6.5	6.5	23.5	8.6	14.4	27.5	13.0	18.5	14.5	15.7	23.1	16.9	16.0	14.9	2.0	19.6	19.1	17.9	14.7	13.7	10.4	9.9	8.6	12.7	10.9	11.4	10.1	9.4	9.9	9.5	23.8	16.0	12.3	12.4	12.5	20.0	37.0	22.9	17.4	17.0	40.1	25.5	18.6	43.1	43.5	88.6	14.7	72.1	23.3	34.0	12.3	14.7	9.4	4.7	30.5	26.4	17.5	28.2	8.0	8.1	38.9	13.6	18.2	15.1	23.4	22.1	16.9	34.9	30.9	14.5	175.3	22.4	12.9	14.1	7.0	8.3	21.0	12.8	10.7	41.2	8.1
FAM162A	"C3orf28, E2IG5"	ENSG00000114023	"Family with sequence similarity 162 member A"	Q96A26	3	122384176-122412334	"Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035856, HPA058113"	Approved		Enhanced	Mitochondria,Cytosol		NA	NA		29000	"Mitochondria, Cytosol"		"HPA035856: AB_10611965, HPA058113: AB_2683609"	"unprognostic (1.17e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.99e-1)"	"unprognostic (7.84e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.91e-3)"	"unprognostic (8.74e-2)"	"unprognostic (1.95e-2)"	"unprognostic (7.91e-3)"	"unprognostic (4.75e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.10e-2)"	"prognostic favorable (3.93e-4)"	13.6	32.8	24.9	18.6	49.9	14.1	18.7	10.7	44.8	21.8	57.8	11.5	19.6	22.7	17.0	25.5	58.7	13.8	25.4	54.2	40.2	21.7	35.9	78.1	12.2	16.5	23.6	27.7	30.2	71.5	24.6	16.1	7.3	31.0	27.3	61.3	16.2	17.7	23.1	56.6	29.2	21.2	27.2	24.4	10.9	25.7	16.9	18.8	8.6	17.9	48.6	16.7	34.6	36.0	26.8	29.4	25.3	24.4	16.4	33.1	12.9	28.8	6.2	9.2	17.1	16.9	15.7	4.7	11.8	10.6	11.3	28.8	15.4	13.3	31.4	20.6	4.0	9.3	20.2	16.6	28.8	30.2	16.2	12.4	25.4	10.7	27.5	11.1	24.8	9.1	18.1	15.1	10.7	22.7	38.0	14.9	31.0	17.1	12.6	16.1	11.3	25.2	30.2	13.6	65.2	32.8	15.2	13.2	40.9	32.7	70.4	13.8	11.0	8.8	21.0	24.1	14.4	13.1	12.2	10.5	11.2	8.0	6.5	12.2	25.0	8.5	31.8	33.2	24.3	5.1	2.6	9.3	25.3	21.7	23.0	32.1	26.8	29.8	27.1	29.4	23.9	32.6	33.1	3.0	16.4	24.4	24.6	27.1	12.9	24.9	49.9	10.7	44.8	40.2	21.7	23.6	27.7	31.0	18.8	26.8	42.4	71.1	131.6	113.8	30.4	312.0	96.8	46.8	43.3	123.9	45.2	42.9	457.6	109.5	73.0	47.4	279.5	23.3	152.7	35.4	52.8	85.5	85.3	207.9	83.9	36.5	102.7	38.1	49.4	23.4	124.5	76.0	99.5	146.9	326.4	45.5	161.9	325.6	139.7	345.2	28.5	103.5	89.6	141.1	55.3	116.1	39.5	54.9	245.2	156.6
FDX1	"ADX, FDX"	ENSG00000137714	"Ferredoxin 1"	P10109	11	110429883-110464881	"Predicted intracellular proteins"	"Cholesterol metabolism, Electron transport, Lipid metabolism, Steroid metabolism, Steroidogenesis, Sterol metabolism, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 113.9;seminal vesicle: 55.6"	"Cell type enhanced"	"Detected in all"	11	"Syncytiotrophoblasts: 953.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 38.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA041630, HPA062087"	Enhanced		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA041630: AB_10793970, HPA062087: AB_2630366"	"unprognostic (1.66e-1)"	"unprognostic (1.68e-2)"	"unprognostic (5.29e-3)"	"unprognostic (4.67e-2)"	"unprognostic (2.39e-1)"	"unprognostic (4.32e-3)"	"unprognostic (1.23e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.19e-2)"	"unprognostic (4.12e-1)"	"unprognostic (3.10e-2)"	"unprognostic (5.48e-2)"	"prognostic favorable (3.58e-7)"	"prognostic favorable (2.53e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.80e-1)"	5.5	113.9	3.9	4.7	4.5	3.9	5.6	2.7	4.0	3.2	7.5	5.2	33.7	7.9	3.2	3.9	5.1	3.0	5.6	9.6	3.6	4.3	10.7	22.8	7.8	4.7	4.5	2.5	3.5	8.6	3.5	3.7	48.4	3.1	4.8	4.2	4.2	4.1	55.6	7.3	3.3	12.3	3.6	3.4	3.9	5.0	5.3	2.6	5.2	8.7	5.0	3.5	5.6	5.4	10.7	6.9	3.4	5.8	4.4	8.7	2.9	5.4	3.8	5.8	6.4	5.7	10.2	13.1	5.0	6.1	4.4	7.5	12.9	9.1	12.7	14.8	6.4	7.9	6.4	6.8	7.5	6.1	12.1	8.6	6.4	6.7	7.9	10.1	6.7	10.5	17.7	6.3	4.0	9.6	7.7	9.0	8.8	6.4	18.9	9.4	6.0	9.5	14.9	5.2	10.3	7.2	14.0	5.6	11.7	9.6	9.8	8.0	4.1	9.5	10.9	6.3	7.1	6.4	4.6	5.3	4.5	5.5	5.4	5.3	4.3	3.3	38.1	3.4	13.7	5.7	1.8	5.7	3.4	5.3	4.2	5.8	10.7	7.3	7.4	6.9	7.5	8.6	6.1	0.7	4.4	5.8	5.3	8.7	2.9	3.9	4.5	2.7	4.0	3.6	4.3	4.5	2.5	3.1	2.6	17.9	39.7	88.0	75.8	60.8	27.9	46.0	104.4	6.7	9.1	76.8	7.9	144.7	207.2	62.6	22.7	33.8	131.1	46.7	128.1	138.7	46.5	71.9	46.0	160.8	108.7	39.7	46.0	33.7	54.7	7.0	43.4	60.1	65.8	51.3	45.4	26.2	79.9	67.0	42.8	255.2	15.0	25.8	42.6	41.2	70.7	85.2	953.0	57.5	77.9	120.2
FDXR	ADXR	ENSG00000161513	"Ferredoxin reductase"	P22570	17	74862497-74873031	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Electron transport, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transport"	Oxidoreductase	"Deafness, Disease mutation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 93.9"	"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 47.2;Syncytiotrophoblasts: 38.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 30.1;Hep G2: 55.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008597, CAB009818, HPA044393, HPA053673"	Enhanced		Enhanced	Mitochondria		NA	NA			Mitochondria		"CAB008597: AB_1615557, CAB009818: AB_2102601, HPA044393: AB_2678927, HPA053673: AB_2682225"	"unprognostic (2.69e-2)"	"unprognostic (1.17e-3)"	"unprognostic (7.51e-2)"	"prognostic favorable (2.38e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.50e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.13e-1)"	1.7	93.9	2.6	2.1	3.1	1.3	1.8	8.4	2.7	2.1	4.6	3.2	6.4	2.6	2.6	23.8	8.7	6.6	6.1	1.9	3.4	1.7	2.7	4.1	4.4	1.7	2.9	3.5	7.1	3.9	2.3	1.5	2.6	3.6	3.3	2.1	0.9	5.3	4.2	7.9	5.6	2.5	2.0	4.4	9.7	2.2	32.1	3.0	3.9	2.0	7.7	3.7	3.0	3.0	5.4	7.4	4.8	6.4	10.0	15.2	5.6	4.0	21.6	3.2	3.6	2.3	3.1	30.1	4.8	5.3	2.9	5.8	6.0	3.5	9.6	0.8	2.0	1.6	8.3	2.3	6.0	0.8	9.1	5.0	7.3	3.5	55.1	6.5	1.6	25.5	10.1	6.8	3.0	1.0	2.3	14.7	3.6	11.5	1.6	4.4	17.1	6.2	3.3	1.8	3.8	4.7	3.4	5.4	5.1	2.4	6.8	1.7	4.0	3.3	7.2	3.5	3.8	15.7	1.5	6.8	2.0	17.9	3.1	2.4	4.4	0.7	2.1	5.4	2.5	6.7	1.8	6.4	4.8	6.2	4.3	5.3	5.4	5.6	7.3	7.4	2.8	4.9	6.1	2.1	10.0	3.2	1.4	15.2	5.6	2.6	3.1	8.4	2.7	3.4	1.7	2.9	3.5	3.6	3.0	3.0	4.6	3.7	12.8	8.7	4.9	3.4	5.1	21.4	5.7	8.7	3.9	47.2	5.0	9.7	5.2	2.8	14.8	0.0	6.8	14.1	6.1	4.3	5.7	12.5	18.6	3.2	6.8	12.3	4.6	12.2	5.5	3.6	5.0	3.6	10.8	10.9	8.3	21.0	4.2	16.3	4.9	0.0	6.4	7.1	7.6	15.8	38.6	8.5	17.6	13.1
FH	fumarase	ENSG00000091483	"Fumarate hydratase"	P07954	1	241497603-241519761	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Tricarboxylic acid cycle"	Lyase	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 93.4"	"Cell type enhanced"	"Detected in all"	4	"Early spermatids: 161.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017785, HPA025770, HPA025948, HPA027341"	Enhanced	Supported	Enhanced	Mitochondria		NA	NA		2800000	Mitochondria		"CAB017785: , HPA025770: AB_10599603, HPA025948: AB_10602177, HPA027341: AB_10601222"	"unprognostic (1.03e-2)"	"unprognostic (3.82e-2)"	"unprognostic (9.46e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.09e-1)"	"prognostic favorable (2.76e-7)"	"unprognostic (1.05e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.24e-2)"	14.3	28.1	15.7	10.4	20.2	9.3	13.3	15.7	24.4	10.5	22.7	9.9	16.7	23.2	13.7	10.7	17.7	10.3	9.5	59.0	22.9	13.9	35.0	93.4	9.9	13.3	15.2	19.4	9.4	13.9	25.2	11.4	14.3	18.4	12.3	24.4	10.2	18.4	20.6	65.1	13.4	21.4	14.7	14.4	11.1	17.5	14.0	11.7	13.8	12.3	45.2	13.4	13.4	11.2	16.0	26.4	4.5	18.8	10.4	13.9	8.9	29.3	24.6	23.3	21.0	22.9	27.1	37.0	36.4	28.5	41.1	25.8	35.1	18.3	18.6	24.1	27.8	18.0	41.8	35.6	27.0	35.8	21.3	11.5	17.5	26.0	30.0	20.6	40.8	15.9	19.6	16.9	23.0	26.0	14.4	25.2	41.2	53.1	24.1	29.9	14.6	35.1	27.3	24.8	42.8	52.8	29.1	25.5	83.6	39.6	24.9	30.0	26.0	30.6	36.3	23.2	16.8	27.7	27.7	24.8	18.5	23.8	32.6	60.5	21.6	23.1	22.6	20.6	46.9	26.5	4.5	12.8	2.7	9.7	18.8	12.6	16.0	11.4	9.0	26.4	14.1	13.9	12.7	0.7	10.4	15.7	13.2	13.2	8.9	15.7	20.2	15.7	24.4	22.9	13.9	15.2	19.4	18.4	11.7	35.7	27.5	27.0	18.6	17.7	23.0	151.3	33.1	30.8	22.7	22.7	13.7	91.1	66.3	49.6	161.2	17.9	46.4	23.3	39.2	43.6	21.6	16.1	18.5	73.1	45.3	33.4	17.2	11.6	12.6	20.1	22.2	26.8	23.6	29.7	35.6	28.0	29.4	35.1	25.1	58.8	32.6	38.8	21.7	82.8	44.5	16.3	138.9	12.9	60.7	16.3
GFER	"ALR, ERV1, HERV1, HPO1, HPO2, HSS"	ENSG00000127554	"Growth factor, augmenter of liver regeneration"	P55789	16	1984207-1987749	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Growth factor, Oxidoreductase"	"Cataract, Deafness, Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 165.5;Enterocytes: 236.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041227, HPA063553"	Approved		Enhanced	Mitochondria,Cytosol	"Intracellular and membrane"	NA	NA			"Mitochondria, Cytosol"		"HPA041227: AB_10795538, HPA063553: AB_2685038"	"unprognostic (5.35e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.08e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.93e-2)"	"prognostic favorable (4.06e-4)"	"unprognostic (4.93e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.09e-2)"	9.7	12.2	9.7	15.2	9.9	10.7	14.8	15.2	12.5	8.1	24.8	10.8	15.2	29.6	10.1	10.2	11.0	10.2	16.1	17.8	9.8	9.7	13.7	33.5	17.1	18.1	10.7	9.7	9.4	43.8	19.2	10.9	18.0	8.0	11.9	18.0	10.5	22.5	12.5	27.5	8.3	33.2	9.2	9.6	15.2	12.8	20.0	7.8	7.7	15.1	15.0	11.4	12.4	17.1	16.1	9.1	9.8	12.7	7.8	17.7	7.7	11.4	18.3	15.0	12.2	6.3	12.7	19.5	13.3	13.0	18.8	15.4	26.3	19.2	6.4	18.2	9.9	11.0	17.3	11.4	17.6	11.9	20.0	23.4	8.9	18.0	29.8	11.5	12.9	16.8	8.1	13.7	16.4	14.8	11.9	8.8	13.9	13.8	21.6	13.6	27.0	14.6	13.9	24.1	9.7	18.3	32.1	11.5	20.9	19.1	9.0	13.2	12.6	18.0	38.4	14.2	8.1	18.3	13.8	8.1	18.3	20.4	10.2	22.9	36.7	19.8	18.5	6.1	8.8	15.4	3.1	12.6	9.8	9.2	10.5	9.9	16.1	12.6	15.6	9.1	13.4	11.5	7.9	1.1	7.8	12.7	4.0	17.7	7.7	9.7	9.9	15.2	12.5	9.8	9.7	10.7	9.7	8.0	7.8	3.0	7.0	36.5	18.9	14.2	10.7	14.9	25.5	8.1	1.2	8.7	0.0	34.0	29.9	38.0	165.5	17.1	236.0	23.3	70.3	48.9	16.9	17.7	12.7	53.9	39.8	7.9	26.2	20.9	29.7	100.1	16.1	25.1	21.9	45.1	48.7	7.8	54.6	92.1	11.7	50.8	7.9	12.9	18.9	45.9	23.0	12.9	31.4	35.2	62.4	23.3
GRPEL2	"DKFZp451C205, FLJ23713, Mt-GrpE#2"	ENSG00000164284	"GrpE like 2, mitochondrial"	Q8TAA5	5	149345430-149354583	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 43.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018173, HPA023211"	Uncertain		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA018173: AB_1850358, HPA023211: AB_1850360"	"unprognostic (3.13e-2)"	"unprognostic (1.69e-1)"	"prognostic favorable (3.87e-5)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (3.22e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (6.16e-8)"	"unprognostic (1.34e-1)"	"unprognostic (8.16e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (4.20e-4)"	"unprognostic (3.40e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.26e-1)"	7.4	5.1	5.4	6.5	6.4	5.3	9.8	10.9	8.9	13.3	4.8	3.7	3.9	6.0	5.4	5.8	43.1	5.1	4.3	6.3	5.5	5.6	7.5	5.7	10.2	8.1	5.1	5.2	7.5	6.8	7.2	6.5	8.5	8.4	5.1	4.8	3.7	7.2	6.7	7.8	5.4	5.8	4.3	4.4	5.9	6.1	4.9	5.1	7.4	7.9	14.4	12.8	6.1	11.5	3.5	3.8	8.2	2.5	3.7	13.5	4.6	9.1	4.9	7.2	25.6	4.6	4.7	14.3	8.1	6.9	7.9	11.1	12.0	6.1	9.4	8.6	4.2	10.7	7.0	11.4	11.7	10.1	5.0	9.5	11.9	9.4	6.8	13.7	11.1	6.1	6.9	14.4	9.7	15.3	3.3	4.7	12.4	10.3	23.4	5.8	6.4	7.3	9.6	9.4	5.6	18.0	9.1	9.9	12.5	5.1	8.5	14.8	12.2	8.1	15.1	24.1	4.9	13.2	13.4	5.3	8.6	9.5	6.1	11.9	8.6	11.5	9.2	8.6	16.3	7.7	8.2	2.5	3.3	5.1	2.4	6.2	3.5	7.7	5.7	3.8	1.9	10.3	7.7	1.9	3.7	2.5	1.0	13.5	4.6	5.4	6.4	10.9	8.9	5.5	5.6	5.1	5.2	8.4	5.1	8.9	5.4	1.4	4.4	15.9	6.6	7.7	2.5	1.4	4.5	8.7	7.9	7.8	1.7	5.1	5.7	14.0	4.5	0.0	5.1	14.0	6.0	4.4	2.3	7.5	5.1	3.2	5.8	18.4	10.1	4.0	3.7	3.6	6.8	3.6	4.4	4.3	6.3	3.5	4.9	4.8	6.6	0.0	5.1	10.3	10.8	17.1	4.7	6.9	7.0	6.7
GRSF1		ENSG00000132463	"G-rich RNA sequence binding factor 1"	Q12849	4	70815782-70839945	"Predicted intracellular proteins"	"mRNA processing, tRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 101.8"	"Cell type enhanced"	"Detected in many"	9	"monocytes: 449.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036984, HPA036985"	Enhanced		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA036984: AB_2675415, HPA036985: AB_10672785"	"unprognostic (1.45e-3)"	"unprognostic (1.82e-2)"	"prognostic favorable (1.47e-5)"	"unprognostic (8.63e-2)"	"unprognostic (6.73e-2)"	"unprognostic (4.15e-3)"	"prognostic unfavorable (8.29e-5)"	"unprognostic (1.94e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.66e-2)"	"unprognostic (7.68e-2)"	"unprognostic (8.05e-2)"	"prognostic favorable (2.72e-9)"	"unprognostic (6.12e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.78e-1)"	"unprognostic (9.65e-3)"	17.9	33.4	21.3	22.3	19.9	8.8	29.0	19.1	42.5	16.8	22.7	19.7	15.0	18.1	17.2	18.2	21.7	18.9	22.9	33.3	22.9	22.6	23.9	23.6	23.7	24.6	24.8	20.2	17.3	26.9	19.6	13.7	18.3	23.6	17.7	27.1	12.0	32.1	20.9	101.8	18.7	17.2	18.1	24.1	17.3	22.5	13.6	19.1	37.0	19.7	31.1	21.7	21.1	15.4	5.7	20.0	7.6	11.6	14.3	11.7	5.6	32.3	22.1	26.0	27.0	27.6	32.3	37.4	39.3	24.9	29.7	24.4	22.5	33.3	46.8	30.1	40.4	15.4	12.4	46.0	30.7	39.8	25.4	15.1	24.6	22.7	31.1	34.1	35.9	14.2	27.1	29.6	29.9	20.9	35.9	30.5	26.1	28.1	27.2	41.2	34.6	59.1	25.3	27.7	35.4	23.4	24.4	40.5	19.9	36.6	40.5	27.2	24.5	18.5	52.8	64.8	31.8	22.9	17.7	27.8	27.8	29.3	22.9	24.7	22.7	18.0	30.1	23.0	23.4	27.0	7.6	11.6	5.2	7.6	8.8	9.5	5.7	11.2	11.7	20.0	4.9	11.2	9.5	1.6	14.3	10.5	19.3	9.3	5.6	21.3	19.9	19.1	42.5	22.9	22.6	24.8	20.2	23.6	19.1	29.8	29.3	32.1	42.4	44.4	17.5	125.4	40.8	21.4	26.1	26.2	23.6	87.9	63.0	61.2	5.7	32.2	41.3	0.0	53.0	115.0	34.8	51.4	17.3	45.7	56.0	27.0	66.2	28.8	58.2	5.3	32.2	42.5	59.1	449.1	69.7	23.1	55.3	42.1	36.7	56.1	17.4	19.4	40.1	21.9	55.1	44.2	64.5	37.9	79.0	54.6
GTPBP8	HSPC135	ENSG00000163607	"GTP binding protein 8 (putative)"	Q8N3Z3	3	112990918-113015060	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034831, HPA058631"	Approved		Enhanced	Mitochondria		No	No			Mitochondria		"HPA034831: AB_10671506, HPA058631: AB_2683783"	"unprognostic (1.98e-1)"	"unprognostic (1.02e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.99e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.00e-2)"	"unprognostic (7.18e-3)"	"unprognostic (1.80e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.21e-2)"	"prognostic favorable (3.07e-5)"	"unprognostic (7.10e-2)"	"unprognostic (7.21e-2)"	"unprognostic (4.57e-1)"	"unprognostic (2.69e-1)"	7.5	9.3	7.4	7.3	7.8	9.5	7.3	8.5	10.1	7.1	11.9	9.2	8.3	8.0	8.3	5.2	12.2	6.4	7.4	20.0	7.6	7.6	12.2	8.2	6.2	13.2	7.6	8.3	10.4	12.1	13.0	12.1	9.3	9.5	8.2	9.3	6.6	9.6	5.2	25.3	6.5	11.8	7.4	11.7	9.3	9.1	22.7	8.9	25.4	13.4	14.3	10.2	9.6	8.0	6.7	12.2	6.7	7.0	11.9	15.8	7.8	19.6	9.0	11.9	13.4	7.3	12.6	9.5	13.6	11.8	14.0	17.5	15.8	8.5	12.9	8.0	7.5	11.3	13.5	15.8	13.1	16.1	5.7	11.1	35.3	9.0	8.2	6.9	22.5	8.7	10.0	9.4	7.7	5.5	14.5	12.8	15.2	12.4	15.3	13.4	7.7	14.3	11.0	24.5	9.9	17.1	12.2	11.0	8.2	9.8	12.4	13.8	14.0	11.0	8.7	18.1	10.7	9.8	15.3	7.7	10.2	15.1	3.7	12.7	10.0	13.1	18.0	10.2	18.7	11.2	6.7	7.0	4.5	10.4	4.6	9.1	6.7	11.9	10.0	12.2	5.9	15.8	10.3	1.0	11.9	3.9	5.8	8.2	7.8	7.4	7.8	8.5	10.1	7.6	7.6	7.6	8.3	9.5	8.9	14.9	9.6	16.3	11.9	11.9	9.3	24.2	7.6	13.4	7.9	5.2	5.9	23.6	19.9	14.6	58.0	10.3	10.5	23.3	15.9	20.5	12.6	10.8	19.6	7.2	20.3	9.5	9.8	10.4	14.5	21.7	10.9	14.2	10.1	12.6	9.7	8.9	13.4	10.2	5.3	23.1	12.2	0.0	17.5	35.6	28.1	10.7	12.7	16.7	11.9	16.1
HADHA	"GBP, LCEH, LCHAD, MTPA"	ENSG00000084754	"Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha"	P40939	2	26190635-26244726	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Lyase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015536, HPA056070"	Approved		Enhanced	Mitochondria		NA	NA		2700000	Mitochondria		"HPA015536: AB_1850473, HPA056070: AB_2683026"	"unprognostic (2.02e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.67e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.16e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.81e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (3.68e-5)"	"unprognostic (7.97e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.87e-3)"	"unprognostic (2.64e-2)"	41.6	35.3	18.1	13.1	19.5	17.0	23.9	17.4	16.9	20.2	44.9	26.5	15.7	48.1	21.1	15.3	30.8	20.5	15.1	80.0	15.6	15.5	41.3	71.7	17.7	19.3	21.6	13.1	27.3	37.5	29.8	23.5	21.3	24.8	21.9	32.2	23.6	21.1	16.6	117.5	23.3	66.4	25.1	27.8	24.0	24.1	18.7	19.0	25.2	25.1	41.3	24.6	26.9	18.8	15.3	28.9	12.4	32.2	13.5	17.6	26.0	23.6	21.1	13.9	22.7	55.2	34.5	11.8	18.5	20.0	19.1	16.6	26.6	23.0	15.6	12.2	32.6	19.7	15.1	24.3	35.9	17.3	35.0	29.8	23.4	22.4	44.3	19.0	29.4	17.2	35.3	23.6	27.1	27.3	20.0	32.0	16.8	31.8	31.7	24.6	29.0	12.8	33.0	11.9	17.8	40.7	11.9	30.0	33.5	21.9	28.5	9.8	19.5	21.8	22.7	25.1	11.3	12.1	28.6	29.3	11.1	16.5	16.7	13.6	10.4	20.6	27.8	17.4	34.9	13.4	8.1	27.7	12.4	12.3	32.2	14.8	15.3	14.2	15.0	28.9	11.2	16.7	15.3	7.4	13.5	28.0	11.0	17.6	26.0	18.1	19.5	17.4	16.9	15.6	15.5	21.6	13.1	24.8	19.0	83.4	81.9	90.4	122.8	79.0	34.1	285.8	71.4	101.7	126.3	73.3	49.1	149.8	111.0	102.7	26.5	92.1	406.5	23.3	94.5	78.0	88.0	61.7	134.2	168.3	142.3	19.1	87.7	68.7	130.6	58.2	85.7	124.9	77.6	129.0	139.2	61.8	86.9	196.4	79.2	150.1	61.9	51.8	104.9	121.4	35.2	90.3	108.0	105.4	168.5	92.1
HCCS	"CCHL, MLS"	ENSG00000004961	"Holocytochrome c synthase"	P53701	X	11111301-11123078	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002946	Approved		Enhanced	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA002946: AB_1079041"	"prognostic unfavorable (8.69e-5)"	"unprognostic (6.89e-3)"	"unprognostic (8.46e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.44e-2)"	"prognostic unfavorable (1.35e-5)"	"unprognostic (9.18e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (6.17e-8)"	"unprognostic (2.66e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.93e-2)"	10.6	14.2	8.8	9.0	12.7	11.8	9.6	11.0	17.7	6.7	15.5	7.4	8.0	17.2	8.5	5.5	15.8	6.9	9.8	36.9	8.4	8.3	15.9	19.0	9.5	10.1	8.2	11.1	10.0	11.4	11.5	10.0	12.8	10.6	7.8	15.2	9.3	12.8	8.0	41.6	13.8	14.4	10.4	6.3	12.3	12.2	10.5	6.0	10.3	10.8	16.4	11.8	11.4	17.3	18.1	28.4	13.3	29.7	8.4	11.1	8.7	23.2	26.7	12.5	12.0	11.8	11.4	13.3	23.4	17.9	29.6	25.4	31.0	17.0	14.4	12.1	18.8	33.0	21.6	25.9	22.4	29.0	13.5	20.3	14.5	34.3	15.4	20.9	15.7	17.7	11.1	17.5	28.2	19.3	16.0	21.0	11.1	26.8	16.8	19.9	31.5	11.4	12.8	22.7	14.1	29.0	11.2	25.1	28.4	19.9	18.3	9.0	10.7	23.4	25.5	15.0	27.6	19.7	11.4	20.6	19.2	10.4	49.2	19.9	12.3	12.6	19.2	15.5	12.7	18.4	10.1	22.5	13.3	9.9	29.7	9.5	18.1	9.7	8.9	28.4	15.5	8.5	11.1	6.2	8.4	24.8	25.9	10.4	8.7	8.8	12.7	11.0	17.7	8.4	8.3	8.2	11.1	10.6	6.0	6.0	4.5	22.9	41.8	48.7	5.1	47.6	20.4	16.0	15.9	15.7	0.0	29.4	43.1	32.7	3.8	15.8	37.0	23.3	25.6	30.7	17.7	30.5	12.7	15.3	36.7	7.9	10.4	12.3	22.9	1.3	12.4	23.8	23.6	31.5	20.2	8.7	46.3	31.6	9.9	30.7	7.1	6.5	25.0	13.4	25.4	40.3	34.2	13.8	28.1	88.7
HEATR1	"BAP28, FLJ10359, UTP10"	ENSG00000119285	"HEAT repeat containing 1"	Q9H583	1	236549005-236604504	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046917, HPA062200"	Approved		Enhanced	"Nucleoli fibrillar center,Mitochondria"		NA	NA		120000	"Nucleoli fibrillar center"	Mitochondria	"HPA046917: AB_2679863, HPA062200: AB_2684709"	"unprognostic (2.61e-1)"	"unprognostic (1.44e-3)"	"unprognostic (6.26e-2)"	"unprognostic (1.34e-3)"	"unprognostic (7.18e-2)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (5.82e-2)"	"unprognostic (4.15e-2)"	"unprognostic (3.80e-1)"	"unprognostic (4.67e-3)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (8.08e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.27e-2)"	"unprognostic (4.00e-2)"	14.1	11.0	9.2	14.7	11.3	15.2	13.8	15.0	13.9	10.7	10.6	8.6	8.3	7.6	15.9	9.4	14.7	12.5	8.1	9.4	10.0	5.8	9.9	13.2	10.6	16.5	12.9	6.9	15.8	17.2	13.5	12.8	10.5	11.6	11.1	10.8	8.2	12.6	9.5	12.7	14.5	11.6	13.1	6.6	16.1	11.5	20.3	13.2	18.3	12.0	12.8	17.9	12.7	12.8	9.9	5.9	1.8	4.5	6.4	10.0	2.4	14.5	17.5	9.2	13.9	12.9	14.5	20.6	11.8	7.6	13.6	12.2	17.6	12.4	23.9	13.3	10.8	8.4	17.7	20.9	12.6	18.5	12.0	24.0	17.0	12.5	15.0	11.6	30.3	11.0	11.8	11.4	20.5	17.8	6.6	15.5	11.1	38.4	8.1	13.5	7.8	14.3	8.3	36.7	18.7	7.2	16.0	13.3	22.4	8.7	14.7	8.6	19.2	14.3	10.2	12.2	6.4	12.1	11.4	14.7	13.7	12.9	17.6	29.1	15.4	19.2	28.3	12.2	17.0	20.3	1.8	3.6	1.1	7.3	4.5	6.6	9.9	7.2	7.9	4.3	8.1	10.0	9.4	0.5	6.4	4.3	5.9	5.9	2.4	9.2	11.3	15.0	13.9	10.0	5.8	12.9	6.9	11.6	13.2	3.0	10.9	8.8	9.3	17.5	11.2	3.5	12.7	12.0	14.8	5.2	17.7	7.0	3.3	7.4	5.7	10.0	2.7	0.0	7.1	8.9	9.9	7.4	31.3	8.9	6.6	6.4	4.1	11.1	10.0	0.9	13.0	7.4	1.7	6.4	5.5	4.4	10.4	2.9	9.6	3.5	10.4	0.0	9.2	21.3	30.8	14.8	4.1	10.2	8.3	9.1
HIBCH		ENSG00000198130	"3-hydroxyisobutyryl-CoA hydrolase"	Q6NVY1	2	190189735-190344193	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Branched-chain amino acid catabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Proximal tubular cells: 262.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036540, HPA036541, HPA067080"	Enhanced		Enhanced	Mitochondria		NA	NA		90000	Mitochondria		"HPA036540: AB_10673355, HPA036541: AB_2675182, HPA067080: "	"unprognostic (3.60e-3)"	"unprognostic (3.88e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.36e-3)"	"unprognostic (3.38e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.88e-1)"	"prognostic favorable (1.22e-4)"	"unprognostic (7.32e-2)"	"unprognostic (1.37e-2)"	"prognostic favorable (1.04e-10)"	"unprognostic (1.34e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.18e-3)"	13.7	38.6	18.1	10.1	19.5	5.0	15.8	16.4	18.7	16.3	15.8	14.5	13.0	24.7	17.0	13.0	20.2	10.2	10.0	13.7	18.5	12.7	65.7	56.8	7.6	8.2	20.1	10.8	9.5	29.5	35.8	24.7	7.8	21.0	11.7	18.7	15.0	10.6	12.2	17.5	23.7	16.5	11.3	18.2	9.0	10.4	10.6	22.2	10.5	17.4	15.4	9.3	12.5	49.2	24.2	15.1	14.6	7.6	17.3	20.0	7.3	9.8	7.6	16.3	10.3	15.4	13.6	9.0	10.7	5.7	10.1	11.0	23.5	8.7	15.0	15.3	9.2	7.2	18.9	17.2	14.7	15.3	21.5	13.4	20.0	15.9	20.5	5.2	14.2	7.4	11.0	7.9	11.8	2.1	14.8	16.3	14.3	24.2	13.1	11.0	9.1	14.5	16.4	5.1	13.4	15.5	18.0	11.7	38.0	22.8	29.9	12.4	11.7	9.2	13.2	30.2	24.8	14.9	11.1	11.5	10.7	10.0	7.2	7.5	8.4	17.8	12.5	9.7	12.4	8.4	12.9	6.7	14.6	11.9	7.6	12.8	24.2	13.3	12.5	11.1	18.7	14.2	18.2	3.5	17.3	5.7	15.1	20.0	7.3	18.1	19.5	16.4	18.7	18.5	12.7	20.1	10.8	21.0	22.2	20.8	19.6	31.1	98.9	49.7	35.7	23.4	40.8	28.1	28.4	34.9	96.2	40.5	97.8	21.8	145.2	29.2	35.8	0.0	25.6	16.9	26.6	30.4	10.3	97.2	29.6	23.8	36.2	76.7	17.4	44.8	32.2	15.7	43.9	14.4	25.9	37.9	16.2	17.3	42.8	262.7	51.0	38.8	26.4	17.5	27.2	35.5	16.7	21.3	53.3	81.2
HINT2		ENSG00000137133	"Histidine triad nucleotide binding protein 2"	Q9BX68	9	35812960-35815354	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Distal tubular cells: 537.2;Hepatocytes: 366.2;Proximal tubular cells: 463.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA020961, HPA059109"	Supported		Enhanced	Mitochondria	"Intracellular and membrane"	NA	NA		1100000	Mitochondria		"HPA020961: AB_1850715, HPA059109: AB_2683906"	"unprognostic (9.64e-3)"	"unprognostic (1.53e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.01e-2)"	"unprognostic (5.51e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.61e-1)"	"prognostic favorable (1.66e-4)"	"unprognostic (3.71e-3)"	"unprognostic (2.87e-2)"	"prognostic favorable (2.97e-9)"	"unprognostic (4.29e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.72e-1)"	18.4	27.2	16.0	14.5	15.5	10.3	15.6	9.5	16.5	10.0	16.4	11.0	26.1	15.3	8.9	24.1	12.6	14.4	21.7	33.7	13.3	13.3	34.8	68.7	15.2	14.2	15.3	13.6	6.8	30.8	21.0	14.1	12.8	12.5	10.8	16.4	12.2	20.2	31.0	30.9	10.3	15.8	17.0	12.3	11.3	16.7	10.3	8.2	16.8	14.9	29.8	11.8	10.4	7.5	24.6	62.0	7.8	20.3	15.1	25.5	18.5	9.7	26.8	16.7	16.1	10.7	9.0	10.9	9.2	13.8	15.1	16.7	17.5	10.8	12.7	10.6	8.8	21.6	9.8	7.6	14.3	16.0	27.6	13.8	13.8	23.3	15.7	24.8	7.7	14.0	10.0	13.2	14.3	23.4	6.0	11.7	31.3	8.1	41.4	12.0	20.8	19.5	9.8	7.4	24.0	46.1	19.6	11.1	17.5	21.5	7.6	13.3	15.9	12.0	14.9	16.0	10.4	16.1	15.1	5.3	8.1	12.8	10.5	11.6	36.0	40.0	18.3	17.9	10.8	12.7	7.8	20.3	1.1	18.5	14.3	16.7	24.6	19.9	18.5	28.6	23.8	15.4	15.9	1.9	15.1	13.0	62.0	25.5	18.5	16.0	15.5	9.5	16.5	13.3	13.3	15.3	13.6	12.5	8.2	20.8	10.8	63.0	60.5	40.3	34.2	96.4	124.9	53.5	13.6	76.8	19.6	143.0	537.2	101.9	54.3	49.6	142.5	46.7	149.8	55.2	58.2	44.3	18.4	366.2	96.3	19.1	92.3	63.3	58.2	111.5	37.4	47.7	114.7	71.3	106.7	69.3	83.1	158.4	42.1	463.5	36.6	45.3	71.8	32.1	82.2	40.1	47.5	67.1	120.6	54.5
HKDC1	"FLJ22761, FLJ37767"	ENSG00000156510	"Hexokinase domain containing 1"	Q2TB90	10	69220303-69267559	"Enzymes, Predicted intracellular proteins"	Glycolysis	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 77.4"	"Cell type enhanced"	"Detected in many"	25	"Cholangiocytes: 30.6;Ductal cells: 30.8;Enterocytes: 44.0;Muller glia cells: 172.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 8.3;T-reg: 6.6"	"Lineage enriched"	"Detected in single"	29	"T-cells: 8.3"	"Cell line enhanced"	"Detected in some"		"A549: 14.8;CACO-2: 21.1;CAPAN-2: 41.7;EFO-21: 12.9;GAMG: 17.4;Hep G2: 12.2;RPTEC TERT1: 31.2"	"Region enhanced"	"Detected in some"		"cerebral cortex: 12.2"	"Low region specificity"	"Detected in all"			"HPA064198, HPA064230"	Enhanced		Enhanced	Mitochondria		No	No			Mitochondria		"HPA064198: AB_2685210, HPA064230: AB_2685219"	"unprognostic (1.29e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.47e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.05e-1)"	"unprognostic (6.31e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.23e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.10e-3)"	"unprognostic (2.19e-1)"	0.2	0.0	0.9	1.2	1.6	0.0	0.2	0.8	1.4	0.5	29.8	0.5	0.2	29.9	0.5	1.0	0.3	2.5	11.2	0.2	0.5	0.6	15.6	4.6	1.3	0.3	0.3	0.2	1.0	4.7	0.0	0.5	0.2	0.4	0.2	2.3	12.0	0.2	0.2	0.2	0.0	77.4	0.2	0.2	0.2	0.4	0.6	0.2	0.2	5.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.2	8.3	1.6	0.4	14.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	21.1	41.7	0.0	12.9	0.1	17.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	12.2	1.0	0.0	0.0	0.0	0.1	0.1	1.2	0.2	0.0	4.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.3	0.5	0.0	0.4	0.0	31.2	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.6	0.1	0.2	0.0	0.0	0.0	3.1	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.7	0.0	4.4	1.4	0.0	0.0	8.3	3.2	0.0	0.2	0.0	0.0	6.6	1.6	0.9	1.6	0.8	0.4	0.5	0.6	0.3	0.2	0.4	0.2	3.0	3.7	0.8	0.0	0.0	1.0	0.8	30.6	0.0	0.0	15.7	0.0	0.0	1.7	30.8	0.4	0.0	44.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.5	172.8	19.9	7.0	0.0	9.5	4.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	1.2	0.1
HSDL2	"C9orf99, SDR13C1"	ENSG00000119471	"Hydroxysteroid dehydrogenase like 2"	Q6YN16	9	112379937-112472410	"Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 70.5"	"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 160.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	5	"granulocytes: 23.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042890, HPA050453"	Enhanced		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA042890: AB_2678216, HPA050453: AB_2681131"	"unprognostic (3.17e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.90e-3)"	"prognostic favorable (9.23e-6)"	"unprognostic (3.94e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.15e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.82e-1)"	"prognostic favorable (9.29e-7)"	"unprognostic (1.44e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.35e-2)"	"unprognostic (7.35e-2)"	31.0	26.3	18.3	5.8	17.7	4.1	13.8	5.7	12.1	10.1	14.1	11.9	6.2	15.2	11.0	5.0	14.4	8.8	7.6	52.1	16.1	13.7	29.3	70.5	11.4	7.8	17.9	10.8	21.3	11.4	7.9	7.7	9.9	12.4	12.2	11.0	10.2	7.3	6.9	54.1	12.5	18.3	13.3	12.9	10.1	9.9	5.9	14.5	5.7	13.2	27.7	6.9	14.2	10.7	3.6	4.6	23.3	5.0	2.6	4.1	2.4	15.0	13.5	10.2	5.1	17.7	17.5	11.7	10.3	6.4	7.4	6.2	25.9	17.0	9.7	5.7	15.1	9.5	17.3	10.9	14.5	9.1	40.5	7.2	10.0	21.8	25.3	11.0	5.6	6.5	18.6	10.5	11.0	8.0	10.8	8.5	11.9	13.9	6.5	20.1	9.9	13.9	5.3	6.0	36.1	17.5	9.1	30.7	14.2	15.6	13.7	7.3	5.2	25.9	17.2	8.7	8.7	24.3	6.9	9.7	10.7	10.0	29.7	10.0	7.7	18.9	4.6	13.2	8.4	6.2	21.9	4.0	15.2	2.3	3.9	3.5	3.3	2.5	2.6	4.5	3.6	3.0	3.1	23.3	2.6	5.0	4.6	4.1	2.4	18.3	17.7	5.7	12.1	16.1	13.7	17.9	10.8	12.4	14.5	92.3	61.8	13.9	14.4	11.7	9.4	160.9	12.7	48.2	43.3	14.0	5.9	21.7	54.7	13.9	135.8	13.9	29.7	0.0	16.4	25.3	13.4	15.9	30.0	98.6	31.2	6.4	14.3	19.6	18.9	127.6	25.3	23.6	8.5	56.9	28.3	22.3	14.4	24.6	44.2	86.7	14.6	45.3	30.3	11.8	16.2	14.2	26.5	7.5	34.3	26.2
HSPD1	"GroEL, HSP60, SPG13"	ENSG00000144381	"Heat shock protein family D (Hsp60) member 1"	P10809	2	197486581-197516737	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction"	"Chaperone, Isomerase"	"Cancer-related genes, Disease mutation, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 162.6"	"Cell type enhanced"	"Detected in all"	5	"Basal glandular cells: 1171.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA001523, CAB002775, HPA050025, CAB072816"	Supported		Enhanced	Mitochondria		NA	NA		53000000	Mitochondria		"CAB002775: , CAB072816: , HPA001523: AB_1079028, HPA050025: AB_2680995"	"unprognostic (2.79e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.21e-2)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (2.59e-1)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (2.25e-4)"	"unprognostic (3.51e-2)"	"unprognostic (9.91e-2)"	"unprognostic (8.63e-3)"	"unprognostic (3.47e-2)"	"unprognostic (7.83e-3)"	"unprognostic (5.64e-3)"	"unprognostic (1.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.10e-2)"	28.5	125.2	28.7	23.4	31.8	21.0	55.9	18.2	24.3	17.4	30.3	17.8	23.3	28.9	17.5	18.5	27.2	25.3	16.3	24.0	24.2	27.8	67.1	147.5	22.4	25.3	35.5	16.1	30.2	50.6	32.5	25.9	27.1	33.6	25.9	37.2	11.9	17.6	21.0	36.4	13.7	32.0	23.6	32.4	22.7	25.2	10.9	35.8	22.7	38.7	29.4	30.3	33.3	162.6	25.6	30.3	6.2	29.3	23.1	33.5	22.2	41.2	50.8	42.6	38.2	29.2	30.6	62.0	43.0	22.7	51.8	38.0	170.3	24.9	125.5	56.1	22.4	64.2	42.2	166.7	47.4	73.5	30.8	66.9	89.1	82.2	197.1	27.5	98.7	28.0	34.5	55.0	45.9	80.9	36.5	40.6	69.3	109.7	49.2	38.0	52.8	61.2	99.9	84.2	54.3	106.3	73.7	52.6	90.6	54.4	43.2	55.8	31.7	43.1	46.7	55.2	91.1	32.3	58.6	18.1	32.2	44.7	41.4	67.9	27.6	60.7	104.2	37.8	59.7	34.5	4.5	19.7	5.3	15.5	29.3	28.8	25.6	25.0	21.8	30.3	21.0	33.5	29.0	6.2	23.1	25.8	20.2	19.7	22.2	28.7	31.8	18.2	24.3	24.2	27.8	35.5	16.1	33.6	35.8	154.9	133.3	218.4	1171.9	219.0	70.0	213.1	150.3	448.3	361.7	75.0	241.5	780.7	318.3	195.2	4.9	145.2	151.1	70.0	125.9	299.2	219.4	456.8	297.3	264.5	289.1	90.6	262.9	61.4	70.1	9.9	120.8	249.2	155.3	160.5	166.4	117.0	164.4	153.9	106.8	589.7	103.4	84.1	310.2	68.2	82.2	181.0	837.2	136.4	347.8	853.1
IARS2	FLJ10326	ENSG00000067704	"Isoleucyl-tRNA synthetase 2, mitochondrial"	Q9NSE4	1	220094102-220148041	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Cataract, Deafness, Disease mutation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024212, HPA024594, HPA024596"	Enhanced		Enhanced	Mitochondria		NA	NA		26000	Mitochondria		"HPA024212: AB_1851363, HPA024594: AB_1851368, HPA024596: AB_1851370"	"unprognostic (2.15e-2)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (2.42e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (9.24e-5)"	"unprognostic (9.48e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.16e-1)"	"unprognostic (8.87e-2)"	"unprognostic (6.27e-3)"	25.9	39.3	18.0	17.9	16.9	6.7	31.9	15.1	20.8	16.9	26.2	14.8	24.3	18.9	21.5	16.8	23.8	18.8	16.5	40.0	17.5	12.6	29.5	37.3	16.8	25.9	15.6	16.0	20.5	20.5	42.5	15.3	26.2	17.4	18.5	24.9	15.0	22.4	22.3	57.8	22.2	23.4	17.7	15.7	16.1	18.5	15.7	13.7	19.5	17.8	25.9	20.1	24.9	18.7	16.8	20.0	17.2	19.0	18.5	22.6	16.8	38.3	36.0	20.7	20.3	31.3	31.6	49.9	23.4	25.2	25.9	21.0	34.6	40.1	35.5	31.7	28.9	20.1	37.3	28.7	29.2	30.0	24.5	34.6	17.6	29.4	38.8	19.5	27.9	19.1	22.8	29.8	28.0	29.0	25.1	25.2	23.1	43.4	20.6	33.9	21.3	22.0	20.2	26.9	30.0	23.9	19.5	41.3	56.8	37.3	25.8	11.2	31.5	35.4	55.0	36.4	24.8	63.6	31.7	25.7	25.6	21.4	34.3	39.1	17.7	27.1	25.8	27.1	22.0	28.3	17.2	16.7	15.1	16.8	19.0	22.6	16.8	18.4	22.0	20.0	13.6	20.8	19.0	3.3	18.5	14.5	7.3	19.7	16.8	18.0	16.9	15.1	20.8	17.5	12.6	15.6	16.0	17.4	13.7	32.8	33.1	24.4	24.3	17.9	26.7	126.1	15.3	58.9	45.5	27.9	23.6	68.4	10.0	37.8	12.3	43.0	33.8	0.0	56.4	44.9	24.9	20.4	18.5	88.4	40.3	19.1	34.8	38.6	46.6	2.0	34.5	26.7	18.6	25.2	50.3	28.6	54.2	28.8	40.0	28.3	31.0	45.3	22.6	32.5	40.2	23.2	60.0	22.7	61.0	20.5
IDH3A		ENSG00000166411	"Isocitrate dehydrogenase 3 (NAD(+)) alpha"	P50213	15	78131498-78171949	"Citric acid cycle related proteins, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 47.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041465, HPA062971"	Supported		Enhanced	Mitochondria		No	No		2000000	Mitochondria		"HPA041465: AB_10794377, HPA062971: AB_2684913"	"unprognostic (2.33e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.76e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.01e-1)"	"unprognostic (2.29e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.69e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.42e-1)"	"prognostic favorable (6.49e-8)"	"unprognostic (1.40e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.39e-2)"	14.6	18.1	18.0	13.0	25.3	6.5	7.7	16.1	29.5	9.9	17.6	11.9	6.1	24.5	11.2	5.9	12.0	8.4	6.5	41.5	16.6	16.8	15.2	10.4	8.8	11.0	20.6	18.1	8.0	9.2	18.5	12.4	8.4	29.0	10.1	18.8	10.4	11.2	11.9	47.7	11.1	23.8	11.9	18.1	10.1	8.9	11.5	13.8	16.2	8.1	26.5	16.4	11.1	10.3	10.1	47.2	6.1	17.0	5.5	6.0	7.4	16.0	22.0	4.0	14.0	10.0	10.3	8.7	19.1	9.3	15.7	11.9	15.7	9.8	34.2	14.2	11.2	23.2	24.3	37.2	14.8	14.5	15.0	12.3	13.2	23.9	7.1	8.6	25.6	18.9	7.8	9.1	15.2	16.0	7.5	9.8	12.2	16.9	14.1	9.9	15.3	18.7	6.8	4.9	9.3	8.3	10.9	17.2	10.6	13.0	21.9	16.0	6.2	21.9	31.4	17.8	7.7	12.5	13.9	10.0	18.5	17.1	24.3	30.8	16.1	35.8	18.2	13.0	24.5	14.4	4.2	9.4	2.7	5.3	17.0	5.7	9.2	5.2	4.8	14.2	10.1	5.6	6.0	6.1	5.5	16.6	47.2	5.6	7.4	18.0	25.3	16.1	29.5	16.6	16.8	20.6	18.1	29.0	13.8	8.9	13.9	26.8	49.8	49.7	32.4	15.3	10.2	40.2	11.4	24.4	35.3	35.1	69.6	20.4	40.5	16.4	42.3	0.0	15.5	32.0	20.6	24.1	26.5	21.2	23.7	25.4	18.5	11.1	22.8	17.5	19.2	26.5	25.3	6.4	36.6	24.2	18.9	28.8	22.3	37.6	27.3	12.9	34.3	41.4	22.6	36.0	57.2	20.3	49.2	35.8
IDH3B	RP46	ENSG00000101365	"Isocitrate dehydrogenase 3 (NAD(+)) beta"	O43837	20	2658395-2664219	"Citric acid cycle related proteins, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"		"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049387, HPA054180"	Supported		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA049387: AB_2680740, HPA054180: AB_2682407"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.43e-2)"	"unprognostic (3.24e-2)"	"unprognostic (6.83e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (2.76e-2)"	"unprognostic (2.99e-1)"	"unprognostic (5.69e-2)"	"unprognostic (4.75e-3)"	"unprognostic (1.39e-2)"	"prognostic favorable (6.78e-8)"	"unprognostic (8.89e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.16e-1)"	19.5	20.0	19.4	15.5	31.7	20.6	18.5	32.1	30.5	16.4	23.9	16.9	14.5	30.5	19.2	16.7	20.7	17.9	19.2	57.3	19.8	20.0	29.7	25.2	15.1	17.6	24.0	29.4	20.2	15.2	27.6	12.2	17.0	31.2	15.4	25.6	16.2	19.3	19.5	75.5	20.9	24.9	21.5	17.1	19.2	19.9	19.6	16.0	19.7	19.1	37.7	22.5	16.7	17.4	34.7	49.4	25.8	44.7	29.5	38.6	33.9	26.5	36.0	16.5	14.4	18.2	14.4	19.0	14.3	18.3	33.8	27.0	46.4	28.0	30.0	13.1	19.6	31.2	37.5	30.4	46.4	31.1	8.3	23.8	36.4	14.0	48.0	17.9	39.6	8.0	19.0	17.9	31.5	16.6	14.9	19.9	26.0	46.0	16.8	20.5	14.6	34.4	45.4	32.0	27.4	34.2	28.2	30.1	33.7	19.4	24.9	29.8	21.5	17.6	58.5	30.1	13.3	29.3	17.6	17.7	26.4	16.6	8.9	32.8	22.9	52.4	31.7	12.4	41.0	25.0	22.2	41.7	25.8	33.9	44.7	25.6	34.7	29.4	30.7	49.4	30.6	34.4	29.8	11.9	29.5	38.3	22.9	38.6	33.9	19.4	31.7	32.1	30.5	19.8	20.0	24.0	29.4	31.2	16.0	35.7	26.2	48.5	51.6	50.5	32.7	162.9	58.6	28.1	22.7	22.7	31.4	112.2	132.6	64.7	47.2	52.0	101.0	23.3	88.6	72.5	49.7	37.2	48.4	51.2	85.2	12.7	48.7	37.4	56.7	72.9	41.7	53.5	65.8	90.2	63.3	41.3	56.4	67.7	44.6	135.3	32.3	77.6	67.4	39.5	53.0	52.4	90.7	57.9	90.9	44.0
IMMP1L	"FLJ25059, IMMP1"	ENSG00000148950	"Inner mitochondrial membrane peptidase subunit 1"	Q96LU5	11	31432401-31509645	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA038372, HPA058308"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA038372: AB_10669643, HPA058308: AB_2732620"	"unprognostic (2.39e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.17e-2)"	"unprognostic (9.67e-2)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (7.97e-4)"	"unprognostic (7.59e-2)"	"unprognostic (4.66e-3)"	"unprognostic (5.15e-3)"	"prognostic favorable (6.72e-4)"	"unprognostic (1.97e-1)"	"unprognostic (1.07e-2)"	"unprognostic (4.66e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.04e-3)"	9.1	16.6	25.4	11.6	27.8	8.8	15.4	28.4	18.5	10.0	11.3	11.7	12.8	12.1	9.6	25.6	8.4	7.7	5.1	20.4	21.7	17.4	16.2	11.9	10.7	11.2	16.1	12.1	14.0	23.8	7.2	18.2	8.7	11.4	11.2	8.3	17.4	13.6	12.0	39.8	10.1	10.3	9.3	13.2	7.6	10.8	13.8	12.6	17.6	10.0	13.3	10.8	6.8	7.5	16.4	20.0	14.8	1.7	16.9	21.7	7.8	10.2	15.0	39.6	11.7	5.3	3.6	7.4	13.6	3.0	5.7	4.4	11.4	7.9	10.7	9.5	5.8	16.5	11.9	13.6	10.3	8.6	14.4	28.8	12.6	22.4	14.5	5.7	16.5	12.2	3.0	9.2	3.3	7.4	15.9	6.1	21.7	20.2	12.9	5.4	12.7	20.7	23.7	8.0	42.7	13.2	16.3	34.2	10.4	19.4	12.7	10.9	12.5	15.8	7.9	13.5	26.8	18.0	16.9	2.9	13.4	13.3	10.4	21.7	11.8	24.4	18.6	17.6	11.3	13.1	9.0	1.7	14.8	15.6	1.6	14.5	16.4	14.0	15.5	4.0	15.0	17.7	21.7	0.3	16.9	1.6	20.0	16.6	7.8	25.4	27.8	28.4	18.5	21.7	17.4	16.1	12.1	11.4	12.6	32.8	10.5	28.2	25.1	16.3	29.6	46.2	20.4	24.1	9.1	57.6	31.4	31.7	101.2	15.6	27.8	14.6	14.3	23.3	21.0	26.9	15.5	23.7	20.9	35.9	18.2	41.3	54.3	17.8	9.5	7.0	12.4	11.6	8.5	10.8	27.6	51.1	14.4	21.0	19.4	81.2	35.9	32.3	15.3	62.7	19.8	23.8	19.8	28.7	31.9	22.3
IMMT	"HMP, Mic60, MINOS2, P87, P89"	ENSG00000132305	"Inner membrane mitochondrial protein"	Q16891	2	86143932-86195770	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Cardiomyocytes: 201.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022439, HPA036164, HPA036165"	Supported		Enhanced	Mitochondria		NA	NA		240000	Mitochondria		"CAB022439: , HPA036164: AB_2674979, HPA036165: AB_2674980"	"unprognostic (3.83e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.95e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (1.40e-1)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (5.66e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.10e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.21e-1)"	"prognostic favorable (3.51e-6)"	"unprognostic (2.06e-3)"	"unprognostic (6.35e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.82e-1)"	20.0	36.9	15.6	17.0	23.5	15.3	15.4	17.5	27.1	13.6	24.8	16.0	15.4	25.1	16.5	13.6	19.1	13.9	12.3	67.3	15.1	18.0	37.5	35.1	14.3	17.7	18.4	18.8	13.3	23.1	31.4	17.6	21.6	32.2	12.8	26.3	17.3	16.7	21.2	78.6	15.4	25.6	17.9	12.1	20.0	22.0	28.3	15.0	29.1	16.2	38.3	19.9	18.0	14.1	10.9	21.5	7.6	21.6	13.2	16.1	14.4	33.9	33.5	30.4	13.9	29.6	27.3	31.1	24.4	25.6	33.0	30.1	48.1	27.0	52.0	24.5	25.8	27.2	25.3	38.9	35.2	40.5	21.0	31.7	41.1	21.2	56.9	30.1	39.6	28.2	31.2	25.7	31.1	37.2	20.8	37.2	30.1	40.0	29.6	31.9	29.2	39.4	41.4	36.2	52.1	26.7	26.3	65.1	46.8	37.7	38.5	37.0	27.5	25.0	38.1	37.2	25.1	21.6	28.1	27.9	23.7	26.2	34.3	30.2	23.6	29.8	35.7	27.0	47.3	28.7	7.5	18.6	7.6	16.1	21.6	14.6	10.9	14.4	13.3	21.5	8.8	13.1	15.5	2.5	13.2	19.9	11.1	14.9	14.4	15.6	23.5	17.5	27.1	15.1	18.0	18.4	18.8	32.2	15.0	50.6	42.2	33.5	27.5	20.7	39.1	201.3	17.8	52.2	63.7	38.4	31.4	84.0	112.7	49.3	128.3	35.3	53.1	23.3	46.0	62.7	35.8	15.4	45.2	57.1	62.8	22.3	53.9	35.6	49.3	95.4	25.6	41.4	16.9	81.2	42.6	25.5	37.2	31.7	34.6	68.6	39.4	6.5	37.2	87.7	51.5	21.8	82.4	36.6	63.4	30.8
L2HGDH	"C14orf160, FLJ12618"	ENSG00000087299	"L-2-hydroxyglutarate dehydrogenase"	Q9H9P8	14	50237563-50312548	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 38.7;Cone photoreceptor cells: 53.0;Rod photoreceptor cells: 40.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 10.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065409, HPA069708"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA065409: AB_2685485, HPA069708: AB_2686179"	"unprognostic (1.74e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.04e-2)"	"unprognostic (4.33e-2)"	"unprognostic (8.84e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.17e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.97e-1)"	"prognostic favorable (9.75e-10)"	"unprognostic (1.24e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.02e-2)"	5.4	5.1	6.9	3.6	8.4	3.5	5.1	12.7	10.9	3.5	5.6	4.9	4.8	6.2	3.4	4.3	9.0	4.4	3.2	7.7	6.1	4.7	25.5	16.0	2.5	3.3	7.7	4.7	4.2	5.4	7.1	5.8	2.6	5.7	4.6	6.8	7.7	5.0	5.6	17.7	7.0	5.0	4.7	5.3	2.3	5.6	6.0	6.0	3.7	6.5	6.2	5.2	4.6	4.4	1.4	1.5	10.5	0.6	2.4	3.3	0.8	14.0	9.9	4.1	3.9	2.0	1.3	11.5	4.7	2.6	7.4	8.8	15.8	6.5	11.0	5.5	1.9	5.9	10.3	12.3	4.9	8.3	8.8	7.0	23.9	6.8	2.2	1.9	8.4	8.3	1.2	3.1	4.9	4.3	1.8	3.2	11.5	8.3	7.0	1.9	16.9	9.5	3.8	5.9	12.0	10.5	9.0	13.3	8.6	6.9	16.5	8.4	6.0	13.8	10.5	6.0	5.7	13.8	2.3	2.9	4.7	13.2	5.4	6.2	6.4	14.5	15.6	2.6	4.3	5.2	10.5	0.6	1.4	1.5	0.3	3.3	1.4	1.7	1.6	0.9	1.2	2.1	2.6	0.9	2.4	0.3	1.5	2.4	0.8	6.9	8.4	12.7	10.9	6.1	4.7	7.7	4.7	5.7	6.0	38.7	16.3	4.4	2.3	3.3	15.6	12.6	0.0	32.1	35.2	12.2	53.0	4.7	13.3	3.5	21.5	2.1	4.7	0.0	3.8	5.8	2.1	2.4	17.4	13.9	1.9	11.1	7.5	3.1	1.5	5.6	2.3	1.4	1.7	2.8	5.3	6.1	2.4	2.9	4.2	18.5	40.7	0.0	2.1	11.6	10.6	5.5	4.1	3.3	6.8	1.8
LONP1	"hLON, LonHS, PIM1, PRSS15"	ENSG00000196365	"Lon peptidase 1, mitochondrial"	P36776	19	5691834-5720572	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"DNA-binding, Hydrolase, Protease, Serine protease"	"Cataract, Deafness, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 78.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002034, HPA002192"	Supported		Enhanced	Nucleoplasm,Mitochondria		No	No			Mitochondria	Nucleoplasm	"HPA002034: AB_2756304, HPA002192: AB_1079695"	"unprognostic (6.52e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.66e-3)"	"unprognostic (5.56e-2)"	"unprognostic (2.71e-1)"	"unprognostic (7.57e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.11e-1)"	15.8	78.3	16.4	12.8	19.8	12.5	13.9	16.1	22.8	11.3	13.6	15.8	13.3	13.7	10.5	13.8	12.7	12.7	15.7	27.3	15.4	15.3	19.9	49.6	10.3	14.5	17.7	14.9	15.5	17.7	17.6	16.8	16.6	16.2	11.7	8.5	12.7	18.5	14.7	38.0	14.7	13.9	11.5	12.7	15.5	13.5	9.8	13.3	13.8	21.2	15.3	11.8	14.7	12.5	6.7	6.5	6.0	6.2	4.0	7.2	3.0	23.0	23.9	7.9	25.3	9.4	6.7	24.7	14.7	11.7	15.9	19.5	20.4	8.3	28.9	20.6	15.4	15.3	9.8	20.4	17.8	7.7	17.1	16.8	16.0	20.9	26.7	43.7	36.4	16.8	12.6	25.6	15.1	29.9	7.7	12.7	40.6	42.3	57.8	7.3	15.3	18.0	21.7	28.3	9.4	31.6	19.0	11.4	31.2	8.8	13.7	21.1	21.1	12.9	18.9	51.6	5.8	11.1	45.7	8.9	8.1	8.9	22.5	21.4	60.9	37.5	25.7	36.5	39.9	14.6	6.0	4.1	0.8	6.4	6.2	4.1	6.0	5.6	6.1	4.3	6.7	7.2	4.8	0.5	4.0	2.4	6.5	4.0	3.0	16.4	19.8	16.1	22.8	15.4	15.3	17.7	14.9	16.2	13.3	6.0	13.3	13.7	8.7	7.3	24.7	17.9	15.3	9.4	10.3	26.2	5.9	24.8	39.7	28.3	5.3	9.8	24.8	0.0	23.9	27.0	10.5	12.9	5.7	44.0	28.2	20.6	10.9	14.1	11.3	4.0	11.8	15.2	13.5	24.4	21.6	20.9	25.6	14.4	16.3	36.0	22.0	19.4	10.3	9.1	13.4	9.4	29.3	9.2	22.2	9.4
LRPPRC	"GP130, LRP130, LSFC"	ENSG00000138095	"Leucine rich pentatricopeptide repeat containing"	P42704	2	43886508-43996005	"Disease related genes, Predicted intracellular proteins"	"mRNA transport, Transcription, Transcription regulation, Transport"	"DNA-binding, RNA-binding"	"Disease mutation, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033786, HPA036408, HPA036409"	Enhanced		Enhanced	Mitochondria		No	No		16000	Mitochondria		"CAB033786: AB_2137450, HPA036408: AB_10670438, HPA036409: AB_2675108"	"unprognostic (1.49e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.61e-3)"	"prognostic unfavorable (1.72e-5)"	"unprognostic (1.68e-1)"	"unprognostic (8.34e-3)"	"prognostic unfavorable (2.31e-7)"	"unprognostic (1.02e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.44e-3)"	"unprognostic (7.68e-2)"	"prognostic favorable (6.65e-6)"	"unprognostic (9.07e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.00e-2)"	20.6	25.5	20.2	27.7	24.8	26.7	37.2	34.3	51.8	16.4	31.7	15.1	15.9	21.8	21.5	19.2	22.5	18.6	15.2	36.6	24.3	21.9	41.7	31.6	26.3	38.0	21.9	22.9	23.6	28.0	33.3	19.7	17.6	29.2	18.9	32.5	13.6	17.8	22.8	63.2	22.4	19.1	32.6	17.9	18.0	20.7	20.7	16.0	25.4	20.5	30.5	19.9	20.4	17.8	15.8	15.5	5.5	11.7	13.2	18.1	12.4	30.3	25.0	15.7	20.0	15.5	20.7	27.0	20.3	14.7	22.2	17.1	39.9	16.1	43.7	19.6	12.5	14.8	25.8	29.4	21.7	29.6	26.3	18.5	39.5	19.7	52.9	22.9	56.8	18.0	20.5	19.0	20.4	33.2	12.9	17.8	13.2	58.2	17.7	19.4	16.8	29.8	65.8	26.2	31.0	17.7	33.4	35.2	35.5	24.3	28.0	27.9	27.0	22.9	30.8	36.9	21.5	22.6	34.5	15.3	16.0	21.9	16.8	21.6	18.1	20.3	38.1	15.3	35.3	13.8	5.5	10.7	1.8	9.5	10.8	18.0	15.2	12.8	12.6	15.5	15.8	18.1	15.4	0.8	13.2	11.7	6.2	10.5	12.4	20.2	24.8	34.3	51.8	24.3	21.9	21.9	22.9	29.2	16.0	20.8	25.6	25.1	22.2	41.1	62.9	81.9	33.1	20.1	33.0	43.6	29.5	31.3	18.3	23.0	4.4	27.5	30.2	0.0	15.2	17.8	26.0	19.8	28.8	45.9	22.1	62.0	26.4	20.9	34.3	4.2	23.3	24.7	20.3	26.2	41.4	27.0	20.3	28.1	22.3	48.9	54.5	12.9	37.3	27.9	28.6	38.8	27.8	19.2	70.4	27.0
MALSU1	"C7orf30, mtRsfA"	ENSG00000156928	"Mitochondrial assembly of ribosomal large subunit 1"	Q96EH3	7	23298739-23311729	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"AN3-CA: 26.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020487, HPA052210"	Approved		Enhanced	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA020487: AB_1845757, HPA052210: AB_2681762"	"unprognostic (3.62e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.66e-3)"	"unprognostic (5.24e-3)"	"prognostic unfavorable (9.71e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.51e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.83e-3)"	"unprognostic (3.15e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.43e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.68e-1)"	7.9	11.3	9.5	6.9	9.4	7.6	11.0	8.6	11.1	7.9	8.4	8.3	5.8	5.1	9.2	10.2	12.3	10.1	7.6	29.8	8.8	9.1	12.5	21.2	8.2	10.2	8.9	7.2	10.3	10.1	8.0	7.8	12.6	12.7	7.9	7.8	17.2	10.6	10.3	20.1	6.7	7.0	8.9	8.1	6.9	7.5	13.7	5.6	8.5	14.8	14.9	8.0	9.2	7.5	6.1	4.8	3.5	5.4	4.2	7.3	5.1	4.8	6.1	4.5	26.3	4.4	3.1	4.5	3.7	2.7	3.5	3.2	10.2	4.1	4.9	4.1	2.4	14.3	5.0	4.4	2.3	4.3	2.4	7.9	2.9	8.3	15.7	2.9	6.4	1.8	2.6	3.6	2.9	3.2	20.9	3.1	4.5	8.7	1.3	4.4	3.4	4.4	20.0	8.2	9.1	16.4	3.8	3.7	6.5	3.4	4.4	4.1	4.9	3.1	5.0	7.7	9.1	2.5	3.8	5.5	2.8	2.5	5.3	6.6	2.0	4.8	8.5	10.6	7.9	8.7	3.4	5.4	3.5	4.4	4.0	5.0	6.1	6.1	4.9	4.7	5.7	7.3	4.9	3.4	4.2	3.3	4.8	5.7	5.1	9.5	9.4	8.6	11.1	8.8	9.1	8.9	7.2	12.7	5.6	35.7	32.4	26.7	44.7	38.8	30.2	85.9	30.6	44.2	29.6	41.8	15.7	68.8	97.8	85.3	113.0	32.3	23.8	23.3	83.4	55.2	42.4	35.4	13.9	91.2	47.7	17.5	18.5	37.4	30.7	19.1	45.8	21.4	33.7	38.7	30.2	34.9	64.5	28.1	46.3	93.2	28.6	32.3	41.9	55.6	72.8	38.6	41.6	20.8	44.3	42.7
MAOA		ENSG00000189221	"Monoamine oxidase A"	P21397	X	43654907-43746824	"Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins"	"Catecholamine metabolism, Neurotransmitter degradation"	Oxidoreductase	"Disease mutation, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 358.2;Proximal tubular cells: 497.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.0;MAIT T-cell: 1.3"	"Group enriched"	"Detected in many"	10	"monocytes: 1.0;T-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 40.4;HHSteC: 75.9;HSkMC: 19.1;hTCEpi: 21.4;RT4: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009437, HPA054807, HPA059299"	Enhanced		Enhanced	Mitochondria,Cytosol		No	No			Mitochondria	Cytosol	"CAB009437: AB_2137260, HPA054807: AB_2682607, HPA059299: AB_2683970"	"unprognostic (9.54e-3)"	"unprognostic (1.63e-1)"	"unprognostic (7.99e-2)"	"unprognostic (3.07e-1)"	"unprognostic (6.75e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.51e-2)"	"unprognostic (6.89e-3)"	"unprognostic (2.21e-1)"	"unprognostic (4.29e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.98e-3)"	72.3	11.0	8.2	10.2	7.8	0.3	35.2	3.3	6.1	12.4	85.7	2.8	10.7	53.6	12.5	6.2	36.6	12.0	14.7	37.8	6.7	8.3	77.8	45.9	34.4	5.2	11.1	6.1	14.2	24.4	9.6	1.5	79.8	8.7	26.2	39.9	6.2	49.1	12.9	12.5	11.2	90.1	23.6	3.4	2.1	19.3	5.5	4.7	0.0	68.6	9.7	3.9	35.3	35.1	0.0	0.0	0.1	1.0	0.0	1.3	0.1	0.0	0.8	0.1	2.4	40.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	4.1	1.5	5.4	0.0	0.0	0.6	1.6	0.1	4.3	75.9	0.0	4.1	19.1	21.4	0.0	11.2	0.0	4.8	0.0	0.0	0.1	1.4	0.6	0.0	0.1	0.4	4.9	1.2	0.0	0.0	0.1	5.5	31.3	0.7	1.9	0.0	0.0	0.0	0.1	0.1	0.0	2.1	0.0	2.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.3	0.0	0.1	0.3	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.1	8.2	7.8	3.3	6.1	6.7	8.3	11.1	6.1	8.7	4.7	65.5	115.2	10.9	141.7	9.7	4.4	90.1	91.7	34.8	50.0	57.6	21.6	9.7	102.8	29.5	19.6	35.3	358.2	0.0	12.0	17.7	14.2	55.4	5.7	169.3	6.2	3.2	36.6	36.8	14.9	22.5	5.2	4.0	10.1	29.7	119.4	23.2	31.4	140.8	0.0	497.3	21.7	6.5	15.1	1.1	0.4	12.5	173.1	3.1	215.1	89.9
MAVS	"Cardif, IPS-1, KIAA1271, VISA"	ENSG00000088888	"Mitochondrial antiviral signaling protein"	Q7Z434	20	3846799-3876123	"Predicted membrane proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB009187, HPA049850, HPA053524"	Enhanced		Enhanced	Mitochondria		NA	NA		230000	Mitochondria		"CAB009187: , HPA049850: AB_2680912, HPA053524: AB_2682177"	"unprognostic (1.30e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.23e-2)"	"unprognostic (2.30e-2)"	"unprognostic (5.95e-2)"	"prognostic favorable (3.81e-4)"	"unprognostic (1.92e-1)"	"prognostic favorable (4.13e-5)"	"unprognostic (4.97e-2)"	"unprognostic (3.03e-1)"	"unprognostic (3.12e-2)"	"unprognostic (7.39e-2)"	15.9	13.9	13.0	15.5	17.7	10.8	25.5	17.7	15.7	12.3	18.5	17.2	15.1	17.2	14.9	10.6	17.3	13.8	12.2	15.4	12.3	8.0	13.3	13.9	18.1	17.4	19.9	9.0	18.9	22.5	23.4	13.7	12.0	13.8	13.1	18.6	13.6	15.3	22.4	39.4	22.1	17.0	17.1	13.7	12.7	15.8	5.9	17.1	15.1	14.6	14.0	14.3	18.2	21.6	5.1	5.6	6.4	6.9	5.9	4.8	4.6	16.6	19.4	7.9	9.8	21.8	14.9	6.2	10.1	13.0	10.8	7.9	15.1	10.8	7.2	6.2	14.1	30.8	21.0	9.4	15.1	11.1	4.4	4.6	13.9	7.2	24.0	12.1	8.7	5.9	15.0	12.9	18.3	10.9	10.8	10.9	9.5	15.6	5.6	10.5	15.0	13.1	7.4	5.0	8.3	10.7	9.9	11.0	7.2	11.4	16.7	5.9	6.2	11.5	22.5	9.7	11.7	12.0	8.1	16.4	14.8	5.5	17.4	11.7	11.4	13.7	5.1	5.8	10.7	7.5	4.4	6.9	6.1	4.8	5.1	3.6	3.8	3.8	3.7	4.4	5.1	4.4	4.4	6.4	5.9	5.5	5.6	3.0	4.6	13.0	17.7	17.7	15.7	12.3	8.0	19.9	9.0	13.8	17.1	53.6	40.3	27.3	12.5	1.9	31.8	52.6	66.2	25.4	35.2	27.9	15.7	28.8	11.6	21.9	0.9	25.1	79.6	23.3	26.2	23.2	18.1	15.7	8.1	39.0	21.3	42.9	33.4	41.1	29.1	1.5	28.4	13.1	1.7	17.2	28.4	23.6	28.0	21.0	26.5	18.3	34.3	32.3	8.1	4.2	3.8	1.8	15.1	19.2	45.8	14.3
MCCC2	MCCB	ENSG00000131844	"Methylcrotonoyl-CoA carboxylase 2"	Q9HCC0	5	71587288-71658704	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Ligase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 74.3"	"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 79.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038300, HPA038301, HPA061546"	Enhanced		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA038300: AB_2675941, HPA038301: AB_10670661, HPA061546: AB_2684557"	"unprognostic (2.39e-1)"	"unprognostic (6.89e-3)"	"prognostic favorable (3.62e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.89e-2)"	"unprognostic (8.07e-2)"	"prognostic favorable (1.70e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.37e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.38e-1)"	"prognostic favorable (6.43e-8)"	"unprognostic (1.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.15e-2)"	"unprognostic (3.47e-2)"	12.4	29.4	9.2	11.8	13.6	2.7	30.5	7.9	10.0	11.2	15.3	12.2	15.1	13.0	9.7	20.0	14.5	9.1	12.3	74.3	7.6	8.1	35.6	61.9	8.4	11.6	7.8	8.0	9.6	18.9	14.1	10.3	15.1	13.4	24.6	18.1	12.8	20.6	29.4	17.6	10.8	14.1	7.8	17.0	11.0	13.6	6.9	6.9	9.4	22.2	13.3	14.3	15.7	8.5	8.8	16.7	1.7	11.5	12.9	10.2	6.7	11.9	16.5	7.1	27.1	7.6	7.8	12.1	5.7	9.6	11.8	8.5	28.9	15.2	27.7	21.0	8.3	9.2	9.9	12.3	19.0	14.8	14.7	15.7	15.0	8.5	31.7	13.3	7.4	14.3	10.0	10.0	10.8	8.6	5.3	10.3	8.0	18.9	10.4	8.1	32.6	0.1	13.6	9.3	10.5	9.3	14.5	20.4	40.7	30.6	21.6	11.2	12.4	24.9	36.9	12.1	3.5	30.6	18.9	7.5	4.8	7.5	8.7	15.3	7.5	13.8	17.2	7.9	20.7	11.9	1.7	7.4	1.6	6.1	11.5	7.9	8.8	7.9	6.9	16.7	8.6	8.0	8.7	1.2	12.9	6.8	7.4	10.2	6.7	9.2	13.6	7.9	10.0	7.6	8.1	7.8	8.0	13.4	6.9	14.9	23.4	22.9	14.2	11.7	12.8	60.9	17.8	16.0	18.2	15.7	5.9	40.3	18.3	18.3	3.1	14.2	19.6	0.0	16.1	19.0	8.9	25.3	12.7	79.8	15.6	3.2	28.4	8.0	10.8	7.4	12.7	12.2	11.8	19.0	22.7	19.0	14.2	17.5	19.1	48.4	11.4	6.5	9.1	3.9	13.3	12.0	53.2	12.9	28.8	18.5
MCL1	"BCL2L3, Mcl-1"	ENSG00000143384	"MCL1, BCL2 family apoptosis regulator"	Q07820	1	150574551-150579738	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Differentiation"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 42.1"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	12	"U-698: 335.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002781, HPA008455, HPA031125, CAB068195"	Approved		Enhanced	Mitochondria		Yes	No			Mitochondria		"CAB002781: , CAB068195: AB_2665695, HPA008455: AB_1079334, HPA031125: AB_10602026"	"unprognostic (3.82e-2)"	"unprognostic (8.79e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (7.16e-4)"	"unprognostic (3.22e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.87e-2)"	"unprognostic (4.46e-2)"	67.7	37.1	19.0	59.3	21.6	134.5	46.3	15.3	18.9	35.9	38.5	19.0	23.9	21.2	36.1	27.6	56.5	57.2	73.3	32.5	20.4	14.9	30.5	76.7	61.8	52.4	28.2	11.4	32.1	41.9	20.3	27.7	59.4	26.7	34.0	30.7	31.0	36.0	24.5	39.8	45.7	50.2	38.9	26.4	51.1	44.3	19.8	23.0	32.3	45.4	53.3	57.4	40.6	59.4	5.0	6.2	42.1	8.0	3.8	11.1	3.9	10.0	5.2	9.7	5.8	19.6	20.6	13.2	12.3	12.7	13.0	10.5	6.4	8.3	12.8	7.3	8.8	7.0	13.5	7.3	14.8	13.1	10.5	5.0	5.2	8.3	7.4	15.4	8.8	11.9	11.3	17.0	12.7	24.8	12.1	14.3	3.9	11.7	18.6	17.0	11.1	4.3	6.7	17.8	8.6	9.1	6.6	7.8	6.7	14.3	7.3	7.5	10.1	8.8	12.0	15.9	15.3	7.6	13.6	17.5	8.3	8.7	5.2	15.5	23.8	27.9	335.8	14.2	7.0	10.8	7.6	8.0	18.8	6.1	6.5	7.2	5.0	8.0	6.7	6.2	4.6	9.6	7.2	42.1	3.8	5.8	3.7	11.1	3.9	19.0	21.6	15.3	18.9	20.4	14.9	28.2	11.4	26.7	23.0	184.6	337.7	161.5	413.1	434.6	37.7	75.0	170.7	65.6	141.0	31.4	56.9	80.9	34.9	139.8	191.3	189.6	281.5	23.3	149.6	178.6	195.3	286.6	340.1	210.0	235.2	11.1	249.0	192.8	356.1	271.6	67.3	381.9	259.8	113.6	185.2	58.8	165.7	122.2	57.3	57.2	70.9	77.6	218.3	33.9	33.0	500.0	226.1	179.7	132.6	219.4
MDH2		ENSG00000146701	"Malate dehydrogenase 2"	P40926	7	76048051-76067508	"Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 175.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019714, HPA019716, HPA019848, HPA026720"	Enhanced		Enhanced	Mitochondria		No	No		47000000	Mitochondria		"HPA019714: AB_1853678, HPA019716: AB_1853680, HPA019848: AB_1853683, HPA026720: AB_1853685"	"unprognostic (3.20e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.43e-2)"	"unprognostic (5.55e-3)"	"unprognostic (8.94e-2)"	"unprognostic (6.45e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.70e-2)"	"prognostic favorable (1.49e-5)"	"unprognostic (8.57e-2)"	"unprognostic (9.64e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.66e-1)"	18.1	39.1	17.4	15.4	20.6	18.3	22.2	15.3	34.4	14.9	27.0	13.5	16.9	32.5	16.6	13.5	31.8	19.4	17.6	103.1	17.1	18.8	29.1	101.9	13.8	26.6	17.4	21.9	17.3	35.5	16.8	16.9	17.5	20.5	17.9	24.3	15.0	26.8	21.5	175.8	24.6	26.7	21.9	12.8	21.1	22.3	17.6	9.5	22.4	20.1	76.2	23.8	19.9	17.8	37.1	52.8	22.1	45.3	30.1	45.6	44.7	29.0	47.7	17.3	43.2	19.7	21.7	29.7	19.5	25.2	28.0	25.4	41.9	35.0	44.0	8.8	25.7	30.3	29.7	44.3	29.2	20.0	31.3	64.1	24.4	25.6	38.6	24.3	38.0	25.3	27.4	26.1	27.2	40.6	22.0	26.0	27.4	76.9	25.7	25.9	65.8	32.9	67.0	38.5	51.5	60.2	26.9	21.3	63.2	26.2	38.4	43.3	39.4	19.6	98.1	40.3	23.0	55.7	42.9	20.1	28.1	26.6	30.5	38.8	28.9	23.8	48.7	24.4	48.7	42.7	22.1	38.9	18.2	32.7	43.5	34.2	37.1	36.9	35.3	52.8	32.1	36.0	33.1	10.2	30.1	45.3	47.1	45.6	44.7	17.4	20.6	15.3	34.4	17.1	18.8	17.4	21.9	20.5	9.5	47.6	54.0	113.9	144.7	120.7	61.8	448.3	122.3	80.3	48.9	109.9	17.7	283.1	379.7	210.0	208.8	86.2	316.5	0.0	291.5	257.6	93.5	138.9	53.1	240.8	220.1	68.3	162.9	73.1	117.9	127.9	92.0	117.1	172.1	171.3	226.5	63.6	223.7	228.0	93.3	301.0	48.8	84.1	129.5	71.9	69.5	145.2	246.6	109.1	306.4	194.4
MIPEP	MIP	ENSG00000027001	"Mitochondrial intermediate peptidase"	Q99797	13	23730189-23889419	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 80.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 35.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030676, HPA031669, HPA031670"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA030676: AB_10598907, HPA031669: AB_10600986, HPA031670: AB_10602198"	"unprognostic (2.05e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.75e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.54e-2)"	"unprognostic (4.76e-1)"	"prognostic favorable (7.66e-12)"	"unprognostic (1.62e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.79e-1)"	"unprognostic (6.90e-3)"	7.3	14.9	6.2	7.1	12.2	4.4	11.0	4.7	10.3	8.1	12.2	12.9	12.1	8.4	9.6	20.4	14.4	17.1	11.7	16.9	8.8	5.3	24.7	12.0	8.2	8.4	5.1	8.0	8.5	14.7	8.1	15.4	5.3	9.1	10.9	13.1	9.1	12.9	10.1	16.2	22.0	8.9	11.5	4.4	6.5	9.8	13.9	4.9	8.9	10.9	15.7	11.1	11.2	8.6	9.2	6.5	1.2	10.6	9.7	10.0	3.9	7.8	8.9	4.4	10.3	10.1	13.7	9.4	5.7	8.9	8.6	7.3	11.8	15.7	9.3	5.8	4.6	7.6	19.9	10.1	12.0	10.7	5.4	6.4	4.0	4.2	10.1	8.3	9.4	2.2	6.7	15.0	8.9	7.9	7.3	10.7	7.1	7.7	1.5	13.4	5.8	6.7	5.3	6.1	35.4	9.0	7.5	11.9	8.0	19.2	5.2	10.3	3.4	6.1	10.0	12.0	5.8	10.3	5.3	5.9	5.2	4.4	8.6	6.1	1.5	2.1	5.0	9.1	4.8	6.5	0.0	3.0	1.2	7.9	3.7	10.0	9.2	7.7	7.1	6.5	7.7	7.4	7.3	0.0	9.7	10.6	5.6	5.1	3.9	6.2	12.2	4.7	10.3	8.8	5.3	5.1	8.0	9.1	4.9	14.9	7.5	0.8	5.9	35.4	3.2	80.7	15.3	36.1	10.3	8.7	5.9	8.4	24.9	20.8	6.6	3.7	5.5	0.0	9.4	7.7	4.5	5.6	2.3	5.6	8.7	14.3	5.8	2.5	2.7	5.9	6.4	4.1	5.0	3.6	6.4	5.2	8.0	8.6	8.1	18.1	10.7	0.0	5.2	9.5	19.0	36.9	4.2	2.9	12.4	3.8
MPC1	"BRP44L, CGI-129, dJ68L15.3, SLC54A1"	ENSG00000060762	"Mitochondrial pyruvate carrier 1"	Q9Y5U8	6	166364919-166383013	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 149.8;liver: 129.7"	"Cell type enhanced"	"Detected in all"	12	"Cardiomyocytes: 875.4;Distal tubular cells: 1458.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045119, HPA055790"	Enhanced		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA045119: AB_10960421, HPA055790: AB_2682923"	"unprognostic (3.30e-2)"	"prognostic favorable (1.45e-4)"	"unprognostic (5.24e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.85e-2)"	"unprognostic (7.61e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (3.27e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.11e-3)"	"unprognostic (5.64e-2)"	"prognostic favorable (4.79e-11)"	"unprognostic (4.13e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.48e-2)"	"unprognostic (8.45e-2)"	13.1	9.4	27.1	7.2	28.5	10.9	12.2	12.3	21.6	12.4	21.1	26.1	8.3	18.8	8.4	10.5	16.0	8.3	9.5	149.8	27.6	21.5	56.1	129.7	10.0	8.7	39.2	18.3	10.5	14.9	12.4	9.4	5.4	23.8	10.3	19.9	11.5	23.0	10.5	63.3	9.2	16.9	11.0	43.3	9.2	19.7	5.0	25.8	9.0	18.6	43.9	9.9	10.6	8.1	12.2	26.5	32.2	43.7	13.9	24.5	17.1	6.5	1.9	8.1	27.9	23.6	13.6	12.0	7.5	12.2	11.8	11.5	9.9	4.6	13.7	13.6	11.6	9.5	6.2	12.1	9.5	8.3	9.3	20.8	6.8	10.1	32.9	9.8	26.2	8.9	10.9	13.4	9.6	6.9	3.6	9.5	21.3	23.6	21.9	7.3	10.4	18.2	48.6	4.1	37.3	9.2	10.0	13.5	34.2	22.0	5.2	25.5	22.6	8.7	38.0	8.6	7.0	9.0	39.4	6.6	6.9	7.1	24.2	7.7	15.0	10.3	11.4	6.3	32.4	10.9	18.6	23.0	32.2	16.4	35.3	15.4	12.2	19.4	17.6	26.5	9.2	18.2	17.4	20.4	13.9	43.7	15.7	24.5	17.1	27.1	28.5	12.3	21.6	27.6	21.5	39.2	18.3	23.8	25.8	110.2	37.1	53.6	36.9	40.5	51.2	875.4	183.4	44.2	47.8	101.2	9.8	19.1	1458.9	78.7	46.1	45.8	147.2	23.3	122.5	67.4	59.4	34.7	70.3	365.8	104.2	46.1	35.7	38.6	74.2	5.6	61.5	76.9	123.2	111.8	87.8	137.3	56.8	120.7	84.5	301.3	55.1	90.5	90.6	126.5	39.4	48.8	20.4	54.3	110.8	45.7
MRPL10	"L10MT, MGC17973, MRP-L10, MRP-L8, MRPL8, RPML8"	ENSG00000159111	"Mitochondrial ribosomal protein L10"	Q7Z7H8	17	47823272-47831534	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021234, HPA029885"	Enhanced		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA021234: AB_1854098, HPA029885: AB_2673233"	"unprognostic (6.84e-3)"	"unprognostic (1.03e-1)"	"unprognostic (8.05e-2)"	"unprognostic (9.09e-3)"	"unprognostic (1.97e-1)"	"unprognostic (4.01e-3)"	"prognostic unfavorable (6.67e-4)"	"unprognostic (5.21e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.87e-2)"	20.8	23.2	18.3	23.8	25.2	17.7	34.3	22.2	25.9	19.2	24.7	11.5	24.4	21.2	22.8	26.5	20.3	25.6	28.7	44.0	18.9	18.1	21.6	26.0	29.6	39.6	18.0	19.4	42.9	34.7	17.8	12.3	19.3	16.9	17.6	19.6	16.5	18.2	27.5	43.2	15.5	17.6	37.9	21.4	19.6	23.8	18.6	13.2	19.2	20.4	26.6	21.2	26.0	19.6	17.7	20.4	11.2	18.3	11.6	31.6	17.7	12.8	28.5	12.0	12.2	28.8	26.5	22.4	11.3	19.1	19.5	16.8	54.8	17.7	20.9	26.5	14.6	12.9	12.3	17.1	22.1	17.4	20.1	27.1	16.8	15.3	38.3	24.9	15.0	9.4	29.8	19.2	23.2	32.9	23.1	18.7	20.1	22.4	21.0	15.0	25.3	15.3	18.9	19.8	22.1	27.4	12.3	23.5	23.2	21.3	12.7	14.5	23.3	8.6	9.9	24.2	23.7	29.6	15.9	11.5	17.6	14.6	11.8	15.9	36.9	28.5	16.8	15.5	11.4	11.8	11.2	17.6	8.2	31.6	18.3	29.8	15.9	21.8	27.9	20.4	17.7	18.6	21.9	7.1	11.6	14.7	12.4	24.3	17.7	18.3	25.2	22.2	25.9	18.9	18.1	18.0	19.4	16.9	13.2	6.0	9.9	19.7	19.4	11.1	14.0	30.8	12.7	4.0	12.5	14.0	5.9	74.6	39.7	34.5	17.5	17.7	16.1	23.3	47.8	49.4	18.8	14.3	8.1	12.3	36.0	30.2	8.2	18.4	26.5	24.9	22.7	16.2	15.1	35.1	19.1	17.0	35.4	10.5	22.6	32.9	10.6	6.5	35.8	15.6	29.8	10.9	64.6	59.9	28.1	15.7
MRPL45	MGC11321	ENSG00000278845	"Mitochondrial ribosomal protein L45"		17	38297023-38323218	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"AF22: 12.6;Daudi: 30.3;K-562: 18.4;REH: 14.8;RT4: 11.3;U-266/84: 17.5;U-698: 22.4"	"Low region specificity"	"Detected in all"							"HPA023373, HPA023385"	Enhanced		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA023373: AB_1854114, HPA023385: AB_1854115"	"unprognostic (8.56e-3)"	"unprognostic (4.09e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.08e-1)"	"unprognostic (9.50e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.60e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.37e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.01e-3)"	"unprognostic (3.07e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.40e-1)"	"unprognostic (8.13e-2)"	3.1	0.6	1.4	2.6	2.4	1.8	4.9	1.8	6.3	9.6	3.6	1.4	0.7	0.3	10.3	1.1	2.1	0.4	5.8	3.7	1.2		5.9	7.0	2.6	9.6	1.7	1.7	3.9	9.1	0.3	2.4	2.5	2.7	7.7	6.9	1.8	3.8	1.1	11.1	2.4	13.2	1.4	1.8	1.2	1.4	1.7	1.3	1.2	2.6	2.8	10.5	0.9	1.5	6.1	9.3	1.6	5.9	6.9	8.7	4.3	0.0	0.1	12.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.7	30.3	0.0	0.0	8.1	0.1	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.3	4.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	18.4	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	14.8	0.0	11.2	0.0	11.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	6.2	0.0	0.0	0.0	8.8	17.5	22.4	0.0	0.0	0.1	0.4	5.7	1.6	4.7	5.9	5.5	6.1	7.0	3.7	9.3	5.2	8.7	5.3	0.1	6.9	1.2	3.3	5.2	4.3											11.9	8.9	24.2	33.1	26.9	10.5	39.2	33.1	21.4	12.5	24.4	7.9	57.8	51.4	33.7	13.9	22.5	11.9	0.0	32.6	54.7	20.5	25.4	23.1	26.1	37.2	15.9	15.6	16.5	31.0	11.5	19.2	19.8	18.6	45.9	24.4	10.9	32.1	10.5	15.6	50.2	9.8	6.5	28.8	16.4	16.6	28.2	59.5	18.3	41.0	29.2
MRPS36	"DC47, MRP-S36"	ENSG00000134056	"Mitochondrial ribosomal protein S36"	P82909	5	69217760-69230129	"Predicted intracellular proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA035802, HPA056795"	Supported		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA035802: AB_10600933, HPA056795: AB_2683237"	"unprognostic (1.19e-1)"	"unprognostic (6.78e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.99e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.90e-1)"	"prognostic favorable (5.02e-6)"	"unprognostic (2.06e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.84e-3)"	13.6	13.7	16.7	9.1	21.4	12.8	13.8	10.4	24.8	8.0	16.8	4.7	12.6	17.1	9.1	11.7	14.4	8.2	10.9	42.8	17.6	13.5	34.8	26.5	17.0	12.2	16.3	14.3	8.8	21.7	11.7	10.4	9.3	17.7	10.8	17.8	6.4	9.6	9.5	29.8	8.1	20.9	13.9	11.4	8.0	13.9	6.8	10.0	10.8	12.7	22.3	11.5	9.9	9.0	27.9	24.4	24.7	27.5	21.5	34.7	14.9	15.0	14.5	10.3	14.1	18.1	18.4	27.1	13.5	13.0	17.4	21.5	20.1	16.9	16.2	28.2	11.4	39.0	15.5	17.1	20.5	17.3	19.0	17.9	11.1	17.2	22.3	21.4	11.7	15.1	19.1	14.7	16.6	7.9	18.2	12.8	16.9	13.0	12.2	15.3	16.3	17.9	18.0	7.6	13.9	17.0	10.6	17.9	24.8	29.9	17.1	14.4	14.0	13.9	20.3	23.4	17.6	15.5	17.1	9.2	7.8	13.3	17.2	23.1	12.9	21.1	21.6	13.6	22.0	10.1	24.4	20.4	24.7	21.4	27.5	23.6	27.9	24.5	23.9	24.4	22.4	22.2	23.4	22.0	21.5	24.7	24.1	34.7	14.9	16.7	21.4	10.4	24.8	17.6	13.5	16.3	14.3	17.7	10.0	107.2	66.5	83.4	83.7	72.4	23.1	309.5	66.2	80.3	67.1	83.7	13.7	104.2	339.8	101.8	99.7	60.0	188.1	70.0	121.7	153.6	58.7	76.5	55.4	177.7	110.9	27.0	89.1	47.3	85.0	30.9	59.8	70.3	101.3	140.7	126.9	34.5	120.5	134.0	65.0	323.7	35.2	71.1	78.8	34.6	32.8	67.1	103.1	62.3	150.9	95.7
MTFR1	"CHPPR, FAM54A2, KIAA0009"	ENSG00000066855	"Mitochondrial fission regulator 1"	Q15390	8	65644734-65771261	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 350.9;Late spermatids: 606.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 47.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023152, HPA056120"	Uncertain		Supported	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA023152: AB_1854176, HPA056120: AB_2683043"	"prognostic unfavorable (4.06e-4)"	"unprognostic (4.58e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.57e-2)"	"unprognostic (6.56e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.53e-1)"	"unprognostic (5.69e-3)"	"unprognostic (5.44e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (5.21e-4)"	"unprognostic (8.25e-2)"	10.7	17.7	6.6	5.5	11.7	3.9	9.5	10.1	8.8	9.7	10.7	10.8	14.2	11.1	9.9	11.9	12.3	7.2	6.2	8.7	6.8	5.5	28.4	37.7	7.1	3.9	10.3	5.4	7.9	19.1	8.0	15.0	16.2	9.7	8.1	11.2	14.8	11.0	11.5	11.7	8.3	16.2	8.8	11.3	6.5	13.2	16.8	11.7	5.4	13.0	11.2	9.3	10.5	9.7	1.7	3.1	4.3	2.8	0.8	2.9	1.7	14.1	10.6	8.4	9.8	11.7	11.5	6.8	9.3	8.6	11.6	12.3	9.0	14.8	7.9	3.0	9.0	11.3	9.3	19.1	12.7	15.7	2.8	10.3	9.8	7.8	18.1	14.6	2.5	4.8	7.8	13.7	14.9	47.7	6.6	14.1	5.8	13.3	8.2	13.4	12.7	8.6	6.0	8.9	31.3	9.5	4.4	11.6	6.6	14.3	12.8	3.8	5.6	9.3	15.9	12.4	9.0	17.6	5.6	10.6	7.1	9.8	16.7	8.1	8.0	5.2	5.8	8.6	10.4	9.3	4.3	2.8	1.2	2.0	2.5	2.9	1.7	2.6	2.2	3.1	1.4	2.6	2.9	0.7	0.8	1.2	1.9	2.5	1.7	6.6	11.7	10.1	8.8	6.8	5.5	10.3	5.4	9.7	11.7	17.9	6.0	12.0	9.6	14.9	0.0	6.4	12.7	10.7	3.4	10.4	0.0	20.7	48.0	16.4	350.9	6.4	10.7	23.3	21.3	22.9	9.7	11.6	4.7	33.1	8.6	0.0	4.6	8.6	5.4	606.6	15.5	6.1	13.5	2.8	11.8	0.0	17.5	7.0	11.3	91.0	0.0	6.5	16.5	66.0	16.8	16.9	32.7	5.0	14.1	15.2
MTHFD1L	"DKFZP586G1517, FLJ21145, FTHFSDC1"	ENSG00000120254	"Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 like"	Q6UB35	6	150865549-151101887	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"One-carbon metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Extravillous trophoblasts: 107.1;Syncytiotrophoblasts: 61.6;Urothelial cells: 39.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015006, HPA029040, HPA029041, HPA050052, HPA074911"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA015006: AB_1854178, HPA029040: AB_2672879, HPA029041: AB_2672880, HPA050052: AB_2680998, HPA074911: AB_2686723"	"unprognostic (3.66e-2)"	"prognostic unfavorable (1.68e-5)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (7.28e-4)"	"unprognostic (3.25e-1)"	"prognostic unfavorable (5.10e-4)"	"prognostic unfavorable (8.33e-5)"	"unprognostic (6.35e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.91e-1)"	"prognostic unfavorable (8.69e-5)"	10.4	10.6	8.0	12.1	8.1	12.2	7.1	32.4	10.5	6.5	6.2	7.8	10.2	3.4	8.5	7.2	6.4	8.0	7.3	10.7	7.5	7.9	9.5	6.9	17.1	11.0	12.3	7.6	22.2	13.7	7.1	9.1	15.5	8.5	5.0	9.1	12.7	3.4	10.5	2.5	5.7	4.7	10.9	10.2	8.7	5.6	13.6	6.6	6.7	12.2	5.0	11.4	8.7	5.1	1.1	3.0	0.2	0.8	1.0	5.0	0.6	12.0	10.5	13.7	33.7	3.6	12.6	33.5	19.0	20.8	19.1	23.6	21.1	11.3	44.5	12.7	29.0	11.3	12.9	21.9	18.5	23.8	18.3	19.9	18.5	18.7	19.3	22.6	33.8	3.0	14.9	23.7	18.5	33.8	17.2	31.9	24.9	43.9	23.3	19.6	25.4	16.5	7.0	14.0	12.1	9.7	19.8	10.2	19.8	12.9	5.9	13.7	10.2	25.1	11.1	15.5	13.0	3.5	23.7	24.2	12.8	28.1	28.4	26.9	19.4	18.0	46.4	21.3	31.6	16.5	0.2	0.7	0.0	0.8	0.8	1.3	0.8	1.9	2.1	3.0	1.1	1.8	1.9	0.0	1.0	0.8	1.5	5.0	0.6	8.0	8.1	32.4	9.5	7.5	7.9	12.3	7.6	8.5	6.6	0.0	1.7	10.7	5.1	5.8	0.0	2.4	2.5	4.0	2.3	14.0	0.0	18.7	6.6	10.4	19.2	7.1	0.9	0.0	15.4	107.1	15.4	4.1	0.0	1.0	21.7	0.0	1.2	3.7	2.4	3.4	0.6	10.1	33.7	1.0	2.5	0.0	15.0	0.8	7.4	12.2	0.0	0.0	6.1	0.5	6.4	3.0	61.6	3.2	3.5	39.1
MTIF2	IF-2mt	ENSG00000085760	"Mitochondrial translational initiation factor 2"	P46199	2	55236595-55269347	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 72.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006021, HPA061422"	Uncertain		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA006021: AB_2147687, HPA061422: AB_2684514"	"unprognostic (2.91e-2)"	"unprognostic (9.58e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.87e-3)"	"unprognostic (8.86e-2)"	"unprognostic (5.57e-2)"	"unprognostic (9.76e-3)"	"unprognostic (1.88e-1)"	"unprognostic (6.85e-3)"	"unprognostic (3.01e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.45e-3)"	"unprognostic (1.33e-1)"	13.8	17.8	13.6	12.0	15.8	9.6	15.5	9.4	17.7	12.0	21.1	11.2	17.7	21.0	10.0	15.9	17.5	10.6	11.2	24.5	13.5	12.1	27.4	32.2	10.6	17.5	15.5	11.8	10.4	24.6	20.2	20.2	12.5	22.6	12.2	25.1	9.7	16.3	14.3	31.5	12.3	26.9	15.0	16.9	16.3	16.3	9.0	14.6	16.1	20.6	27.1	15.2	14.5	11.6	9.6	13.9	9.4	12.8	17.2	12.7	6.9	15.5	15.1	8.9	15.3	11.1	15.2	20.5	14.3	11.5	13.8	12.1	17.9	15.1	25.6	27.2	13.1	15.5	13.9	21.2	20.6	22.9	28.4	16.3	23.6	11.8	33.0	21.2	37.1	14.0	16.7	21.4	19.1	40.0	12.3	11.0	14.4	41.7	14.7	14.3	12.9	11.4	25.0	19.0	19.5	18.6	12.1	28.7	24.7	13.4	13.8	16.1	10.2	12.7	21.1	25.8	11.4	11.2	12.4	10.9	14.5	16.6	17.2	23.4	27.6	24.6	7.0	15.3	27.8	11.4	5.4	11.0	9.4	10.1	12.8	12.6	8.3	10.3	9.4	13.9	9.6	12.5	12.7	4.2	17.2	10.7	6.8	11.7	6.9	13.6	15.8	9.4	17.7	13.5	12.1	15.5	11.8	22.6	14.6	20.8	20.5	13.7	15.4	6.8	0.0	72.4	30.6	30.8	15.9	7.0	0.0	25.4	24.9	27.1	13.6	7.9	20.9	0.0	29.3	25.7	10.8	11.5	20.8	25.5	21.3	0.0	18.5	9.2	18.0	14.8	8.3	15.7	8.5	36.1	15.7	0.0	26.3	17.5	9.9	20.7	0.0	6.5	11.7	27.4	16.2	6.5	13.6	8.3	32.1	12.4
MYO19	"FLJ22865, MYOHD1"	ENSG00000278259	"Myosin XIX"	Q96H55	17	36495633-36543435	"Predicted intracellular proteins"		"Actin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 50.4"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021415, HPA059715"	Approved		Enhanced	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA021415: AB_2266815, HPA059715: AB_2684111"	"unprognostic (3.12e-1)"	"unprognostic (2.38e-1)"	"unprognostic (8.44e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.89e-3)"	"prognostic unfavorable (8.33e-6)"	"unprognostic (1.07e-3)"	"unprognostic (1.39e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.70e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.17e-2)"	5.2	1.9	3.1	5.4	6.2	7.8	4.7	2.7	6.5	4.7	7.7	7.0	6.8	7.5	4.3	4.1	9.8	3.4	4.1	1.4	4.7		5.7	7.0	3.8	5.2	6.1	3.1	2.9	5.8	9.8	7.2	8.1	5.0	2.8	11.2	4.8	9.5	9.3	6.3	13.1	7.9	5.2	5.4	3.0	8.3	8.0	5.7	5.8	4.2	5.6	7.2	3.3	2.8	2.2	3.4	1.7	1.7	3.7	3.9	1.4	14.0	17.2	8.2	9.4	4.5	4.5	10.0	14.0	11.2	22.3	22.8	17.0	14.7	8.8	5.5	9.5	7.6	21.2	19.4	14.6	15.9	6.3	13.2	14.1	18.8	10.7	3.0	13.6	15.3	4.3	7.3	15.9	17.4	5.3	9.9	10.7	16.5	9.3	11.3	10.6	9.5	11.1	9.1	15.2	10.2	11.1	13.2	10.5	10.4	11.4	14.1	8.8	18.6	11.4	5.9	12.4	18.7	5.6	6.4	12.5	14.2	17.0	24.6	7.2	14.1	8.1	7.8	8.4	14.6	1.7	1.7	1.7	3.8	1.2	2.8	2.2	2.4	2.6	3.4	1.7	1.7	3.9	0.1	3.7	0.5	1.9	2.0	1.4											8.9	8.1	14.1	10.0	26.3	17.4	3.6	15.3	2.7	5.7	5.2	33.4	7.0	1.7	8.7	50.4	9.5	18.8	0.0	11.4	18.5	7.3	9.0	2.3	7.8	9.6	3.2	10.4	6.2	3.9	17.2	11.5	7.5	3.3	10.0	20.3	5.6	12.4	10.5	9.2	3.6	25.6	0.0	8.2	19.0	17.7	20.6	6.1	12.7	27.7	11.1
NDUFAF2	"B17.2L, mimitin, MMTN, NDUFA12L"	ENSG00000164182	"NADH:ubiquinone oxidoreductase complex assembly factor 2"	Q8N183	5	60945129-61153037	"Disease related genes, Predicted intracellular proteins"		Chaperone	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048082, HPA054776"	Supported		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA048082: AB_2680254, HPA054776: AB_2682598"	"unprognostic (7.28e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.46e-3)"	"unprognostic (2.41e-2)"	"unprognostic (2.74e-2)"	"prognostic unfavorable (2.56e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.76e-2)"	"unprognostic (8.40e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (1.79e-2)"	"unprognostic (6.10e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.66e-2)"	25.5	25.9	22.5	16.7	24.9	11.4	27.1	13.6	24.4	16.9	20.5	11.7	8.2	16.0	16.3	12.2	19.3	12.6	15.0	33.6	19.9	21.2	19.1	27.2	11.9	13.4	20.5	14.2	23.5	41.2	14.2	25.3	9.8	18.5	19.0	18.2	13.2	16.0	16.8	56.3	12.9	13.3	23.9	18.3	10.0	17.2	20.1	12.6	4.9	17.7	16.0	12.3	26.9	19.5	15.9	20.9	1.5	13.1	17.3	20.3	9.1	30.8	16.3	11.3	36.2	21.9	31.1	21.3	36.1	19.3	22.9	28.2	27.1	22.3	38.8	37.3	24.5	44.1	12.8	19.2	31.6	28.4	20.5	27.6	13.3	29.1	25.3	33.1	19.3	7.9	16.7	34.1	20.8	63.4	15.3	20.4	17.3	22.0	20.7	23.9	24.4	17.1	28.5	9.3	11.9	38.7	19.0	31.0	52.6	21.8	13.3	23.7	10.6	22.5	19.5	35.0	10.5	23.3	13.7	18.9	16.5	25.2	35.5	39.9	15.2	21.9	42.6	21.9	34.8	19.2	0.0	13.1	1.5	12.5	11.9	14.3	15.9	15.9	14.6	20.9	11.0	13.9	14.3	0.6	17.3	9.1	7.5	20.3	9.1	22.5	24.9	13.6	24.4	19.9	21.2	20.5	14.2	18.5	12.6	11.9	21.7	43.3	50.0	53.8	27.8	79.5	45.9	24.1	34.2	36.6	11.8	19.0	79.6	47.4	137.5	33.3	26.9	0.0	48.4	45.3	50.0	52.9	19.7	80.5	44.4	39.7	23.7	33.7	26.7	9.8	71.1	42.3	42.2	10.8	49.7	19.5	60.3	45.8	58.4	88.8	22.6	25.8	60.6	82.5	68.2	55.7	11.9	24.5	59.0	51.4
NDUFB6	"B17, CI"	ENSG00000165264	"NADH:ubiquinone oxidoreductase subunit B6"	O95139	9	32552999-32573184	"Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Early spermatids: 591.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044001, HPA053334"	Supported		Enhanced	Mitochondria		No	No			Mitochondria		"HPA044001: AB_10959448, HPA053334: AB_2682116"	"unprognostic (4.09e-1)"	"prognostic favorable (3.18e-4)"	"unprognostic (1.81e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.35e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.49e-1)"	"prognostic favorable (7.47e-10)"	"unprognostic (2.70e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.83e-1)"	21.9	26.8	33.9	17.7	31.8	16.0	18.7	22.6	28.3	13.7	21.9	15.5	17.3	26.5	16.8	17.4	18.6	15.4	15.9	58.6	27.6	27.9	32.8	36.6	13.9	15.4	28.4	27.2	14.1	19.5	15.4	17.8	15.5	22.9	15.1	18.2	14.6	22.7	16.1	87.2	14.6	25.5	16.4	25.9	13.5	20.0	28.9	17.1	19.2	22.2	34.4	14.5	14.1	13.5	26.0	38.8	77.4	27.3	22.2	27.5	26.5	30.2	18.6	20.7	23.7	14.1	13.2	13.3	20.3	16.6	18.8	20.8	18.2	13.7	22.6	21.2	13.9	19.5	17.2	19.5	22.4	14.1	31.0	31.3	53.7	28.6	18.8	13.8	26.7	13.9	13.6	10.9	16.9	12.9	14.2	16.9	34.7	17.1	25.5	20.9	17.5	36.0	63.1	21.9	26.0	41.4	24.8	17.4	20.9	21.0	11.4	20.9	23.6	23.5	27.0	13.6	16.2	25.5	20.8	15.0	20.5	31.1	22.6	29.7	11.4	21.2	36.6	34.3	18.9	9.6	25.0	25.8	33.3	21.0	23.1	20.2	26.0	22.4	21.6	27.6	21.8	23.0	24.3	77.4	22.2	27.3	38.8	27.5	26.5	33.9	31.8	22.6	28.3	27.6	27.9	28.4	27.2	22.9	17.1	116.1	94.0	77.4	80.5	83.7	39.2	514.3	107.0	155.2	108.1	102.9	5.9	175.9	452.6	143.9	591.4	96.3	138.7	93.5	145.0	113.2	93.0	79.2	86.8	170.4	141.7	17.5	62.0	71.8	59.8	88.6	84.8	89.6	151.8	111.8	116.6	72.0	133.2	118.5	84.5	440.9	40.8	103.5	124.6	143.8	114.3	84.6	87.1	65.4	146.3	88.4
NDUFB8	"ASHI, CI-ASHI"	ENSG00000166136	"NADH:ubiquinone oxidoreductase subunit B8"	O95169	10	100523740-100530000	"Plasma proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 742.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA003886, HPA065549"	Supported		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA003886: AB_1079463, HPA065549: "	"unprognostic (4.07e-2)"	"unprognostic (1.95e-3)"	"unprognostic (2.28e-1)"	"unprognostic (7.33e-2)"	"unprognostic (4.88e-2)"	"unprognostic (5.78e-2)"	"unprognostic (3.02e-1)"	"unprognostic (6.46e-2)"	"unprognostic (8.33e-2)"	"unprognostic (9.09e-2)"	"unprognostic (1.25e-2)"	"unprognostic (8.23e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.10e-2)"	35.2	39.8	86.7	27.0	67.4	35.6	26.1	39.3	81.5	25.4	37.7	23.8	23.1	38.8	24.7	42.3	36.8	28.8	28.2	110.0	70.6	62.8	50.4	50.6	19.8	28.1	63.9	54.1	27.7	36.3	31.5	31.4	19.9	49.9	26.6	36.2	25.7	39.7	34.5	88.5	24.3	33.8	41.5	38.9	22.1	31.5	12.0	41.4	18.3	28.3	49.2	27.8	25.2	21.5	76.6	88.6	62.2	74.4	60.5	105.9	129.7	42.2	71.3	38.5	68.3	29.2	28.4	42.6	28.9	62.8	44.4	48.1	96.6	49.3	44.8	26.1	32.3	32.8	50.7	28.8	46.9	35.4	29.4	73.6	31.5	60.5	78.2	39.6	64.3	54.3	34.9	42.4	44.3	59.8	32.2	48.5	59.6	32.7	28.5	38.2	51.3	62.0	81.0	25.8	54.4	66.6	43.3	42.1	59.1	52.0	48.4	26.7	37.4	21.3	40.5	41.9	27.6	60.3	57.6	32.5	25.4	28.8	27.1	50.5	51.7	46.9	55.6	50.5	68.2	28.3	35.1	74.4	62.2	59.0	72.9	69.5	76.6	73.6	67.8	80.4	64.1	79.8	76.7	17.1	60.5	61.4	88.6	105.9	129.7	86.7	67.4	39.3	81.5	70.6	62.8	63.9	54.1	49.9	41.4	71.5	126.9	126.6	146.5	0.0	174.3	341.7	234.4	156.6	88.7	188.5	55.0	285.1	742.8	226.5	20.4	131.5	123.8	116.8	230.9	258.4	136.0	175.3	101.1	286.9	348.6	144.6	101.8	146.7	171.1	43.8	202.0	160.0	0.0	261.5	229.2	129.5	225.4	259.6	204.4	592.8	122.1	168.1	220.6	53.7	79.5	0.0	257.3	174.0	305.7	185.2
NDUFV3	CI-10k	ENSG00000160194	"NADH:ubiquinone oxidoreductase subunit V3"	P56181	21	42879644-42913304	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 129.5"	"Cell type enhanced"	"Detected in all"	9	"Cardiomyocytes: 701.2;Late spermatids: 1042.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA019791, HPA020463, HPA030427, CAB034142"	Enhanced		Enhanced	Mitochondria		NA	NA			Mitochondria		"CAB034142: AB_2298212, HPA019791: AB_1854357, HPA020463: AB_1854358, HPA030427: AB_10603024"	"unprognostic (1.62e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.69e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.56e-2)"	"unprognostic (9.30e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.94e-1)"	18.1	14.1	16.9	11.1	17.2	15.8	14.6	11.8	23.2	12.0	15.9	11.9	14.6	15.2	15.1	15.7	15.6	12.7	15.4	54.9	14.2	11.0	15.1	24.3	10.8	12.5	14.0	18.6	16.0	17.7	13.2	13.1	11.6	19.2	13.6	11.4	12.2	19.4	21.8	129.5	15.4	13.5	16.9	16.0	13.3	14.3	20.3	13.3	6.6	11.6	18.5	10.6	13.3	11.8	9.9	22.9	16.0	22.8	10.5	8.8	10.3	9.6	11.4	11.0	18.0	13.6	11.9	13.6	19.2	11.0	11.5	9.6	20.7	11.9	10.7	15.2	7.2	15.6	10.5	12.8	16.9	7.5	6.1	15.5	35.3	13.3	16.2	21.4	12.0	18.5	13.3	14.7	11.6	18.4	10.4	14.4	7.4	27.9	14.0	13.1	18.9	8.0	18.2	14.4	21.5	22.4	13.9	8.0	33.4	15.4	12.8	8.1	8.4	19.3	22.8	12.7	6.2	19.6	15.9	16.9	10.8	7.5	13.8	13.6	20.8	13.7	12.2	14.1	21.6	16.2	3.7	21.4	16.0	8.0	22.8	8.1	8.1	7.6	6.7	22.9	9.9	8.8	7.7	3.8	10.5	19.6	11.3	8.8	10.3	16.9	17.2	11.8	23.2	14.2	11.0	14.0	18.6	19.2	13.3	50.6	37.7	43.0	46.0	17.6	69.1	701.2	89.2	92.3	27.3	85.5	64.8	46.1	195.6	69.0	416.9	34.9	128.4	140.2	87.3	49.8	41.1	75.6	30.1	285.4	97.8	54.0	75.1	62.0	81.5	1042.9	61.5	68.7	35.4	67.7	73.4	56.3	83.6	77.2	58.7	265.4	102.6	71.1	47.2	216.7	86.2	20.6	75.2	34.6	82.9	49.3
NGRN	DSC92	ENSG00000182768	"Neugrin, neurite outgrowth associated"	Q9NPE2	15	90265659-90278141	"Predicted intracellular proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Ciliated cells: 103.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041367, HPA076267"	Approved		Supported	"Nucleoplasm,Cytokinetic bridge,Mitochondria"	"Intracellular and membrane"	Yes	No			Mitochondria	"Nucleoplasm, Cytokinetic bridge"	"HPA041367: AB_10796668, HPA076267: "	"unprognostic (2.82e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.94e-2)"	"unprognostic (5.00e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.93e-2)"	"unprognostic (5.22e-2)"	"unprognostic (7.22e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.68e-3)"	"unprognostic (3.21e-1)"	13.3	21.3	49.2	11.0	43.2	19.4	18.7	27.6	61.5	18.5	15.6	13.8	8.4	9.3	18.9	21.0	13.1	15.2	14.1	19.1	38.9	42.2	11.2	13.3	15.3	11.9	38.9	37.7	19.4	18.9	21.1	17.1	12.3	30.9	15.5	12.1	11.4	14.4	14.5	47.6	17.7	11.3	12.4	25.7	14.0	13.9	13.8	14.0	3.8	23.3	15.4	11.4	12.7	15.4	5.2	2.4	6.0	3.1	4.2	4.8	2.5	2.9	7.4	9.8	15.4	8.6	3.7	1.2	4.2	3.3	4.0	2.9	3.5	1.7	4.7	2.8	5.0	3.4	4.9	9.5	2.4	5.8	1.9	8.8	4.5	4.5	5.4	5.5	5.2	3.4	5.1	8.7	3.7	4.8	3.8	3.6	4.8	5.6	5.8	2.4	3.5	4.9	2.2	4.6	3.6	4.4	7.5	5.5	2.3	4.2	13.1	9.8	12.3	8.1	6.5	3.5	7.0	2.6	7.4	5.8	9.6	4.1	6.2	7.5	3.8	20.0	5.0	4.2	5.4	7.8	6.0	2.3	3.6	3.2	3.1	4.0	3.5	3.1	2.7	1.2	5.2	3.7	4.4	5.0	4.2	1.9	2.4	4.8	2.5	49.2	43.2	27.6	61.5	38.9	42.2	38.9	37.7	30.9	14.0	17.9	20.6	6.7	10.6	6.4	10.7	7.8	2.5	103.1	36.4	5.2	9.8	5.1	5.0	27.1	1.5	8.4	7.3	0.0	20.6	3.7	5.0	7.7	19.7	3.4	3.7	15.9	25.4	5.5	4.0	2.2	8.3	5.9	8.5	17.2	15.6	13.3	25.7	17.5	8.1	6.7	10.4	12.9	8.6	4.8	3.6	4.4	5.6	8.5	15.7	6.4
OCIAD2	MGC45416	ENSG00000145247	"OCIA domain containing 2"	Q56VL3	4	48885019-48906937	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Pancreatic endocrine cells: 896.7;Proximal tubular cells: 1166.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 56.2;U-251 MG: 66.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040979, HPA041090"	Enhanced		Enhanced	Mitochondria		No	No			Mitochondria		"HPA040979: AB_10795497, HPA041090: AB_10796236"	"unprognostic (4.29e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.76e-2)"	"prognostic favorable (7.37e-4)"	"unprognostic (3.49e-2)"	"unprognostic (1.66e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.00e-1)"	"prognostic favorable (6.56e-4)"	"prognostic unfavorable (6.89e-4)"	"unprognostic (1.38e-1)"	"prognostic favorable (2.67e-5)"	"unprognostic (1.10e-1)"	"unprognostic (8.54e-2)"	"unprognostic (8.24e-3)"	"prognostic favorable (2.34e-4)"	4.0	10.7	24.5	15.7	18.3	4.7	8.1	3.7	14.0	7.2	23.0	1.9	14.0	41.6	8.9	19.5	12.4	7.7	22.3	7.2	19.9	11.7	51.6	43.6	6.6	10.7	9.7	9.9	3.7	13.2	9.4	18.7	2.9	8.8	8.8	17.3	6.6	18.3	12.9	1.8	9.0	37.5	5.2	4.1	5.2	27.9	4.1	5.7	24.9	14.9	5.8	13.3	9.3	8.5	29.7	22.9	32.7	0.6	27.1	60.8	26.1	34.4	18.4	0.2	0.0	0.0	0.0	0.5	9.0	4.1	4.8	4.6	0.0	42.8	6.0	40.1	5.1	43.2	11.1	5.1	56.2	5.0	14.0	3.8	0.0	13.5	0.0	4.5	16.9	0.0	2.6	25.7	0.0	11.0	14.2	20.1	24.2	0.0	3.0	5.1	13.0	28.3	11.4	17.7	39.1	24.9	6.4	0.0	9.9	49.9	22.7	39.8	12.1	12.9	4.4	0.9	0.1	4.5	4.2	33.4	0.0	37.2	0.2	66.8	8.5	9.7	19.0	28.7	0.0	0.0	32.7	0.6	12.4	20.4	0.2	27.0	29.7	38.4	29.2	3.4	27.0	50.2	33.6	2.1	27.1	0.2	22.9	60.8	26.1	24.5	18.3	3.7	14.0	19.9	11.7	9.7	9.9	8.8	5.7	26.8	63.5	79.5	119.3	96.9	7.4	32.5	201.2	73.6	62.6	167.5	27.5	30.6	184.1	416.6	0.8	82.3	395.2	46.7	497.9	9.4	14.8	156.3	35.8	172.0	35.7	1.6	294.2	16.5	3.7	1.2	4.6	15.3	62.4	17.2	244.9	20.9	896.7	160.4	20.1	1166.8	52.0	0.0	20.8	0.9	2.2	114.8	12.8	114.6	155.7	207.5
OGDH	E1k	ENSG00000105953	"Oxoglutarate dehydrogenase"	Q02218	7	44606572-44709066	"Citric acid cycle related proteins, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 99.3"	"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 100.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019514, HPA020347"	Supported		Enhanced	Mitochondria		No	No		53000	Mitochondria		"HPA019514: AB_1854772, HPA020347: AB_1854773"	"unprognostic (1.96e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.39e-1)"	"unprognostic (5.64e-3)"	"unprognostic (3.02e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.45e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.30e-2)"	"prognostic favorable (2.22e-14)"	"unprognostic (1.53e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.23e-2)"	"unprognostic (5.88e-3)"	18.9	20.8	12.3	14.5	18.5	8.7	11.0	14.3	23.7	10.1	19.4	15.9	13.5	29.0	16.2	11.1	19.5	11.1	11.8	73.9	11.3	12.8	28.8	14.8	13.0	11.1	14.2	11.7	9.8	13.0	25.5	11.0	14.5	22.2	12.3	13.3	22.3	23.7	15.9	99.3	15.6	35.5	16.4	10.1	12.1	14.9	11.3	11.0	11.3	17.8	39.8	15.8	13.0	10.8	7.2	13.4	7.5	20.4	11.2	25.7	11.6	10.8	22.8	13.7	20.8	21.2	23.3	13.3	17.0	16.6	19.3	16.9	20.7	22.5	47.8	20.2	24.7	39.0	33.8	27.0	25.4	18.9	27.9	7.1	14.5	46.1	10.2	10.8	17.9	16.3	21.6	19.3	27.4	19.7	14.2	26.2	16.0	16.7	14.3	20.4	15.3	17.7	10.3	12.6	30.2	25.7	17.0	9.6	53.6	22.2	32.4	23.4	11.2	24.5	34.1	10.6	25.9	20.2	18.0	20.6	13.9	12.6	24.2	19.6	13.0	24.9	26.4	25.3	20.3	25.3	4.8	12.1	7.3	11.7	17.7	12.8	7.2	13.5	11.7	13.4	5.9	5.8	7.0	7.5	11.2	20.4	6.6	25.7	11.6	12.3	18.5	14.3	23.7	11.3	12.8	14.2	11.7	22.2	11.0	6.0	22.7	20.4	11.1	17.3	20.1	100.7	15.3	12.0	9.1	45.4	17.7	19.4	26.6	13.2	43.1	14.2	61.4	0.0	14.8	14.3	16.4	14.4	20.8	17.5	29.3	58.8	22.4	14.1	22.4	20.0	10.9	21.9	20.3	21.6	29.2	15.4	16.7	21.0	16.3	38.9	22.2	19.4	18.2	9.1	20.0	23.1	30.7	13.8	27.6	14.2
OXCT1	"OXCT, SCOT"	ENSG00000083720	"3-oxoacid CoA-transferase 1"	P55809	5	41730065-41870519	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 108.8"	"Group enriched"	"Detected in many"	5	"Cardiomyocytes: 212.2;Distal tubular cells: 159.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 56.9;SiHa: 74.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012047, HPA061425"	Enhanced		Enhanced	Mitochondria	"Intracellular and membrane"	NA	NA		1000000	Mitochondria		"HPA012047: AB_1854857, HPA061425: AB_2684515"	"unprognostic (4.26e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.82e-2)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (7.42e-3)"	"unprognostic (1.74e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.62e-1)"	"prognostic favorable (1.86e-8)"	"unprognostic (2.66e-2)"	"unprognostic (9.99e-2)"	"unprognostic (5.86e-3)"	"unprognostic (2.28e-3)"	21.9	8.0	17.3	7.5	30.3	5.8	9.5	26.6	36.8	6.7	9.2	8.3	10.7	4.4	8.6	8.7	13.1	6.9	7.5	108.8	19.3	15.2	25.3	1.2	4.2	9.5	13.1	25.7	7.2	3.0	20.9	8.4	2.8	21.2	12.5	10.4	6.6	8.5	14.7	13.4	10.7	6.5	17.0	8.9	5.2	14.6	6.2	5.3	22.8	13.0	10.7	11.8	8.0	7.5	8.0	4.6	3.3	1.6	7.5	15.6	5.1	7.9	0.3	6.6	7.9	20.5	11.0	0.0	14.3	9.1	11.9	7.2	1.2	5.4	20.7	3.5	10.9	6.1	4.7	18.0	12.9	14.0	17.7	2.1	14.5	56.9	2.7	8.9	28.2	4.9	10.3	3.5	11.6	19.6	5.8	10.8	18.9	2.9	26.7	13.6	1.0	23.5	1.3	1.4	0.0	5.7	18.7	18.5	15.6	9.7	0.6	6.6	6.8	74.0	0.0	8.7	0.6	0.1	6.1	6.5	9.5	12.4	16.2	11.5	4.4	3.6	0.8	14.3	20.7	7.2	1.0	1.0	3.3	9.1	1.1	10.9	8.0	9.2	9.8	4.6	6.1	10.8	8.9	0.3	7.5	1.6	1.8	15.6	5.1	17.3	30.3	26.6	36.8	19.3	15.2	13.1	25.7	21.2	5.3	6.0	8.6	7.5	12.0	13.2	13.1	212.2	7.6	5.3	18.2	10.4	2.0	5.2	159.2	4.7	14.3	5.6	2.3	0.0	0.6	9.8	8.4	11.2	9.2	0.0	29.1	12.7	12.7	4.9	1.0	5.6	5.8	4.4	15.1	3.6	13.4	11.3	3.9	3.5	7.1	11.3	19.5	12.9	15.6	36.7	14.9	18.9	5.7	17.3	15.5	5.2
PC	PCB	ENSG00000173599	"Pyruvate carboxylase"	P11498	11	66848233-66958376	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Gluconeogenesis, Lipid biosynthesis, Lipid metabolism"	"Ligase, Multifunctional enzyme"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 41.1;liver: 76.0"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 192.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 2.6;monocytes: 3.8;T-cells: 2.9"	"Cell line enhanced"	"Detected in many"		"HeLa: 28.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033742, HPA043922, HPA058765"	Enhanced		Enhanced	Mitochondria		Yes	No		96000	Mitochondria		"CAB033742: AB_2283532, HPA043922: AB_2678732, HPA058765: AB_2683812"	"unprognostic (2.10e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.36e-2)"	"unprognostic (8.24e-3)"	"unprognostic (3.67e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.63e-1)"	"prognostic unfavorable (7.86e-5)"	"unprognostic (1.54e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (8.22e-5)"	"unprognostic (8.58e-3)"	"unprognostic (5.67e-2)"	"unprognostic (9.15e-3)"	"unprognostic (1.05e-1)"	41.1	10.7	11.1	2.8	14.6	3.1	12.9	13.1	14.9	2.4	3.8	10.7	21.4	5.6	2.1	2.4	5.0	2.7	2.9	4.0	11.3	8.9	18.7	76.0	2.1	1.6	15.5	11.5	4.4	4.3	19.4	4.0	4.1	10.9	5.4	3.1	3.4	24.2	24.4	5.7	2.8	6.7	1.8	9.4	1.5	3.3	6.1	13.1	0.6	4.2	2.5	2.5	2.2	2.1	0.6	2.6	0.0	3.8	0.3	2.9	2.0	2.9	9.1	3.4	8.3	13.9	5.5	3.5	1.9	7.9	3.6	3.5	4.5	3.3	0.0	3.8	2.9	4.8	3.9	3.8	21.0	1.1	1.8	5.3	4.5	28.3	17.3	10.9	0.0	5.9	21.0	5.4	2.9	6.6	2.3	2.9	7.9	8.5	0.0	1.2	19.4	5.1	2.4	6.4	7.7	7.6	3.8	7.0	1.8	3.3	0.9	7.4	10.5	17.6	9.4	7.2	2.6	7.7	1.2	3.2	4.0	3.7	4.7	2.1	2.0	2.3	0.0	4.1	2.9	3.4	0.0	3.8	0.0	1.2	0.9	1.4	0.2	0.5	1.9	2.6	0.6	2.9	1.6	0.0	0.3	0.5	1.0	1.5	2.0	11.1	14.6	13.1	13.6	11.3	8.9	15.5	11.5	10.9	13.1	0.0	4.8	2.2	1.1	1.1	4.7	3.7	10.2	0.0	1.2	3.5	2.0	15.6	1.7	3.1	15.2	1.4	18.6	0.0	1.6	3.5	1.9	2.4	9.2	192.6	11.2	0.0	8.6	4.3	6.9	39.9	0.6	1.6	5.0	32.5	4.2	9.2	2.3	7.0	3.9	37.8	4.7	0.0	1.4	6.0	4.2	0.5	21.3	1.3	6.0	1.1
PCK2	"PEPCK, PEPCK2"	ENSG00000100889	"Phosphoenolpyruvate carboxykinase 2, mitochondrial"	Q16822	14	24094053-24110598	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Gluconeogenesis	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"intestine: 156.3;liver: 115.1"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 152.4;Hepatocytes: 291.7;Proximal tubular cells: 166.4"	"Cancer enhanced"	"Detected in all"		"liver cancer: 91.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 35.3;hTCEpi: 34.3;SK-MEL-30: 32.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB018734, HPA051162, HPA053502"	Enhanced		Enhanced	Mitochondria		NA	NA		3300000	Mitochondria		"CAB018734: AB_2160168, HPA051162: AB_2681368, HPA053502: AB_2682171"	"unprognostic (3.38e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (2.81e-4)"	"unprognostic (3.91e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.71e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.17e-1)"	8.2	2.5	1.0	4.9	1.9	1.0	4.3	1.3	1.3	1.3	69.7	1.4	6.9	51.8	1.3	8.5	4.5	1.2	4.2	2.6	1.5	1.0	26.4	115.1	6.0	4.4	1.7	1.2	1.8	8.5	3.4	1.7	1.2	1.8	2.0	5.4	1.9	11.5	4.9	1.0	2.7	156.3	1.1	1.7	6.7	3.3	3.9	1.3	1.3	5.8	1.9	4.6	2.8	1.9	8.8	10.8	2.4	15.1	1.5	6.5	3.9	5.5	3.1	0.9	5.9	3.7	3.7	15.0	6.9	8.3	5.8	9.4	5.1	6.4	14.1	0.8	10.6	1.9	8.1	6.0	8.9	4.8	7.2	0.2	2.5	1.7	27.5	35.3	4.9	11.1	4.3	34.3	3.6	8.9	1.6	4.6	16.4	7.2	26.1	2.2	23.9	1.2	2.5	1.0	12.5	4.2	2.8	3.4	8.0	1.7	8.6	3.7	5.9	5.3	6.8	32.5	0.9	9.2	7.6	0.8	1.2	6.7	1.8	1.9	17.9	5.6	3.5	3.5	7.7	3.1	0.1	8.2	2.4	3.1	15.1	3.4	8.8	3.5	3.5	10.8	6.1	2.2	2.0	1.0	1.5	14.4	1.9	6.5	3.9	1.0	1.9	1.3	1.3	1.5	1.0	1.7	1.2	1.8	1.3	11.9	22.0	24.4	8.8	3.0	4.1	1.2	20.4	2.7	3.4	17.4	0.0	3.4	29.9	17.2	49.9	3.5	152.4	0.0	67.0	11.6	5.3	6.8	1.1	291.7	56.2	0.0	8.7	10.4	15.0	15.5	3.1	14.5	6.8	29.7	43.0	5.6	27.0	63.4	2.8	166.4	5.4	0.0	5.1	8.6	0.9	4.3	2.5	9.6	63.5	11.9
PHB2	"Bap37, BCAP37, p22, REA"	ENSG00000215021	"Prohibitin 2"	Q99623	12	6965327-6970825	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB014889, CAB026335, HPA039874"	Supported		Enhanced	Mitochondria		NA	NA		780000	Mitochondria		"CAB014889: , CAB026335: AB_2283865, HPA039874: AB_2616448"	"unprognostic (4.64e-3)"	"unprognostic (4.32e-2)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (3.80e-4)"	"unprognostic (3.07e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.17e-2)"	"unprognostic (5.61e-2)"	36.2	46.2	20.0	41.5	21.3	33.5	37.1	21.6	29.7	42.7	48.6	19.8	42.8	40.0	46.3	36.2	55.6	37.7	29.1	44.3	17.9	17.2	36.0	72.8	24.0	64.9	18.8	18.8	68.9	92.3	28.0	22.1	27.4	17.2	48.6	39.5	25.8	62.7	29.1	72.9	39.5	46.3	56.0	17.5	36.6	37.5	20.5	19.0	57.2	50.4	77.4	45.7	46.4	39.9	36.4	47.6	20.9	35.9	38.1	41.6	34.4	36.9	35.7	30.0	40.6	24.3	42.5	67.0	26.2	33.8	46.4	36.8	56.4	38.9	77.0	11.6	25.3	28.7	30.2	54.7	46.2	37.6	42.7	45.7	40.4	23.1	52.9	40.9	65.1	29.8	43.8	31.6	29.4	64.1	46.8	45.5	22.5	36.0	17.7	32.7	36.7	59.8	59.6	114.6	32.2	31.9	42.0	48.1	47.8	37.1	41.6	15.5	53.6	21.1	60.4	67.7	63.9	9.5	52.2	27.4	20.0	32.8	15.8	55.2	17.8	21.6	79.2	27.0	34.0	28.4	20.9	30.0	14.6	30.8	35.9	37.3	36.4	35.3	35.8	47.6	34.8	32.0	31.8	12.4	38.1	30.4	44.4	41.6	34.4	20.0	21.3	21.6	29.7	17.9	17.2	18.8	18.8	17.2	19.0	44.7	42.0	120.9	90.2	66.1	40.4	39.9	81.5	40.2	38.7	33.2	37.3	183.0	97.8	103.8	2.2	69.9	132.2	46.7	140.2	226.3	64.5	78.8	63.4	148.3	144.5	17.5	96.5	85.3	105.7	4.4	90.0	74.4	69.2	134.3	123.4	72.7	115.8	66.6	64.7	112.8	33.1	71.1	81.1	32.6	58.9	66.7	142.2	78.4	212.2	93.2
PMPCA	"Alpha-MPP, INPP5E, KIAA0123"	ENSG00000165688	"Peptidase, mitochondrial processing alpha subunit"	Q10713	9	136410570-136423761	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"			"Disease mutation, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021648, HPA063735"	Supported		Enhanced	Mitochondria		NA	NA		6500	Mitochondria		"HPA021648: AB_1855491, HPA063735: AB_2685108"	"unprognostic (9.80e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.01e-2)"	"unprognostic (8.19e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.32e-2)"	"prognostic favorable (8.00e-5)"	"unprognostic (9.47e-3)"	"prognostic favorable (2.14e-6)"	"unprognostic (4.27e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.54e-2)"	15.2	27.3	19.8	14.6	23.8	20.1	13.2	20.3	24.3	12.3	15.1	13.0	10.4	18.6	14.2	14.1	16.5	13.6	14.9	37.0	15.6	14.8	17.0	48.3	12.3	18.4	15.2	21.9	15.5	18.2	14.7	19.5	15.6	16.8	15.2	11.9	12.8	20.3	17.1	56.7	17.5	17.0	13.8	14.1	18.9	16.3	23.2	12.5	14.0	15.0	19.8	15.3	13.1	13.4	25.5	30.1	17.0	25.1	32.1	30.8	28.2	14.4	27.2	13.0	26.2	9.9	14.5	20.0	15.1	12.2	21.2	15.4	31.0	17.3	20.3	15.9	15.3	11.3	33.9	24.0	22.1	9.4	29.1	29.0	16.3	35.0	37.4	17.4	21.2	14.2	21.2	15.3	16.5	8.5	12.0	17.9	18.9	41.3	13.4	13.1	40.1	20.0	27.3	26.5	25.9	25.7	24.9	18.4	44.9	14.5	10.4	26.7	17.6	20.3	29.0	17.6	9.3	39.5	28.9	14.7	15.1	16.2	12.4	19.2	8.3	10.9	21.8	19.9	18.5	13.5	15.4	25.1	17.0	27.2	24.4	26.4	25.5	25.7	29.3	30.1	23.7	30.8	26.9	5.9	32.1	23.2	15.3	24.3	28.2	19.8	23.8	20.3	24.3	15.6	14.8	15.2	21.9	16.8	12.5	14.9	25.3	23.9	29.5	24.5	22.5	31.3	10.2	13.4	18.2	21.0	21.6	90.0	41.4	28.9	19.7	20.2	19.7	0.0	26.4	41.5	17.6	17.8	24.3	54.0	33.8	17.5	20.0	20.3	17.4	12.4	17.5	14.1	15.1	21.6	22.3	19.3	25.1	17.3	21.2	37.9	25.3	38.8	16.9	32.8	39.5	23.5	86.8	23.0	30.4	23.5
PMPCB	"MPPB, MPPP52"	ENSG00000105819	"Peptidase, mitochondrial processing beta subunit"	O75439	7	103297422-103329511	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040674, HPA074168"	Approved		Enhanced	Mitochondria		No	No		57000	Mitochondria		"HPA040674: AB_10961998, HPA074168: AB_2686671"	"prognostic favorable (2.79e-4)"	"unprognostic (3.11e-1)"	"unprognostic (7.18e-3)"	"unprognostic (3.03e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.67e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.42e-3)"	"prognostic favorable (2.95e-8)"	"unprognostic (2.59e-2)"	"unprognostic (9.79e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.39e-2)"	29.1	41.8	31.8	23.0	34.3	41.5	31.6	41.1	38.4	29.0	26.9	21.6	28.2	35.1	32.0	25.9	27.9	26.9	23.5	41.4	27.7	20.1	45.9	47.2	21.9	31.3	32.6	35.0	36.8	40.6	41.1	33.9	24.8	34.2	31.6	31.5	20.8	30.6	31.0	31.5	31.6	31.0	25.7	27.8	27.9	33.6	31.3	35.9	37.2	33.2	24.2	30.0	30.7	27.9	19.5	18.4	9.7	16.1	12.9	21.9	15.7	12.4	18.0	21.2	28.6	12.9	26.2	16.0	11.6	20.0	23.5	28.0	19.2	14.3	32.0	18.6	19.7	25.1	16.2	25.5	18.7	22.4	11.2	30.4	11.1	30.9	25.6	15.7	15.2	13.1	23.9	17.4	18.3	17.7	22.5	12.4	24.1	21.4	32.6	21.4	28.9	25.1	35.8	26.0	24.8	22.6	17.6	14.9	32.5	22.0	22.3	26.7	32.6	15.6	46.2	22.8	22.4	18.9	20.4	10.2	20.7	24.9	36.9	21.5	25.0	31.9	24.6	15.4	24.5	16.3	9.7	14.1	9.3	14.7	16.1	16.1	19.5	17.1	14.7	18.4	14.3	21.5	17.4	4.4	12.9	13.6	9.4	21.9	15.7	31.8	34.3	41.1	38.4	27.7	20.1	32.6	35.0	34.2	35.9	29.8	31.7	53.2	52.9	32.5	29.3	64.2	28.1	49.5	40.9	26.2	21.6	104.2	61.3	64.5	72.7	34.3	36.7	0.0	64.0	49.3	41.1	31.6	58.9	46.5	48.7	22.3	26.0	24.5	42.2	18.6	48.1	38.4	25.3	93.8	43.0	33.6	54.8	42.1	46.7	96.5	33.4	64.7	42.9	84.6	53.0	32.9	104.5	57.5	55.1	47.7
PNKD	"BRP17, DKFZp564N1362, DYT8, FKSG19, FPD1, KIAA1184, KIPP1184, MGC31943, MR-1, PDC, PKND1, TAHCCP2"	ENSG00000127838	"Paroxysmal nonkinesigenic dyskinesia"	Q8N490	2	218270392-218346793	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease mutation, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 431.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010134, HPA017068"	Approved		Enhanced	Mitochondria		NA	NA		31000	Mitochondria		"HPA010134: AB_1079645, HPA017068: AB_1855495"	"unprognostic (3.15e-3)"	"unprognostic (1.80e-2)"	"unprognostic (5.86e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.81e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.51e-2)"	"unprognostic (3.29e-1)"	"unprognostic (7.67e-2)"	"prognostic unfavorable (5.13e-5)"	"unprognostic (7.98e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.44e-3)"	21.8	28.3	33.2	15.9	41.0	13.4	16.4	26.6	51.1	29.8	27.5	14.3	28.9	18.1	14.6	37.0	13.3	28.3	30.4	37.3	31.0	26.5	42.4	107.0	23.4	34.2	33.2	23.6	18.1	18.8	22.3	15.6	28.1	26.8	34.8	25.1	15.9	27.3	27.1	33.8	12.9	15.9	16.6	25.7	18.0	29.5	23.3	20.6	11.6	29.7	15.3	16.3	19.0	13.4	64.0	32.7	44.9	35.4	38.4	43.3	38.9	15.3	20.2	14.8	23.2	22.3	18.9	27.4	9.7	21.0	23.1	26.0	33.1	15.2	18.0	19.5	16.1	25.5	16.0	28.5	18.2	16.2	37.4	35.6	26.3	37.0	48.9	24.4	16.9	11.7	25.7	18.0	15.7	4.6	15.5	24.9	14.3	19.3	23.6	20.4	44.2	22.0	40.5	14.7	35.6	20.7	21.7	14.9	15.1	26.5	23.4	14.4	12.1	6.9	47.4	27.5	16.6	15.7	16.5	15.3	9.6	16.5	11.3	13.2	9.8	10.0	19.4	24.4	28.0	11.6	33.7	35.4	44.9	32.1	34.1	30.4	64.0	35.1	38.3	32.7	52.0	38.8	37.3	9.8	38.4	31.0	30.4	43.3	38.9	33.2	41.0	26.6	51.1	31.0	26.5	33.2	23.6	26.8	20.6	65.5	73.4	56.6	80.2	49.0	53.5	126.7	104.4	100.4	62.6	186.7	5.9	149.0	431.0	54.5	7.7	70.9	168.7	0.0	43.7	85.9	107.8	126.2	56.5	206.0	114.9	33.4	116.6	73.1	82.4	10.5	95.5	48.6	129.9	72.1	149.8	127.6	39.4	144.0	116.7	212.9	34.8	90.5	76.9	45.9	44.3	54.5	64.6	55.8	176.1	86.0
PTCD3	"DKFZp666K071, FLJ20758"	ENSG00000132300	"Pentatricopeptide repeat domain 3"	Q96EY7	2	86106182-86142157	"Predicted intracellular proteins, Ribosomal proteins"	"Translation regulation"	"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041154, HPA041382"	Supported		Supported	Mitochondria		NA	NA			Mitochondria		"HPA041154: AB_10795488, HPA041382: AB_10795695"	"unprognostic (1.16e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.37e-2)"	"unprognostic (9.30e-3)"	"unprognostic (2.40e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.92e-3)"	"unprognostic (2.06e-2)"	"unprognostic (4.78e-2)"	"unprognostic (3.78e-1)"	"unprognostic (7.42e-3)"	"unprognostic (5.49e-3)"	"unprognostic (1.26e-1)"	"prognostic favorable (6.77e-4)"	"unprognostic (3.69e-1)"	"unprognostic (7.79e-2)"	"prognostic favorable (6.86e-4)"	13.9	18.6	18.5	12.2	23.2	18.0	14.5	24.5	22.7	13.0	17.5	19.7	11.3	14.3	15.2	15.5	12.7	13.6	9.6	35.0	17.7	16.6	18.0	21.9	11.7	15.4	20.2	19.0	20.2	13.8	17.9	22.7	13.2	21.4	13.0	19.7	11.4	11.1	12.9	45.4	14.2	14.2	13.4	17.9	15.8	14.8	22.8	20.5	20.4	14.9	13.1	15.3	12.4	13.0	13.4	9.4	6.3	11.1	11.9	14.7	7.5	7.8	18.9	11.2	9.4	8.4	8.8	13.5	17.3	7.0	9.2	9.3	35.1	7.6	19.7	6.1	9.1	9.9	14.5	22.6	8.9	11.8	8.8	19.9	15.6	11.8	29.0	8.7	12.6	11.9	10.4	6.5	7.0	12.6	9.7	8.0	14.8	16.2	7.5	8.1	7.3	10.4	15.1	10.2	15.6	12.1	14.1	15.9	14.9	12.6	15.8	12.3	7.5	7.6	12.7	14.8	11.0	6.7	7.8	5.6	7.3	7.9	7.5	9.5	17.7	22.8	16.0	7.1	14.5	5.6	3.4	8.6	6.3	11.6	5.9	13.6	13.4	10.5	12.2	9.4	13.4	14.7	10.7	0.3	11.9	11.1	9.4	11.8	7.5	18.5	23.2	24.5	22.7	17.7	16.6	20.2	19.0	21.4	20.5	53.6	27.4	22.3	21.6	23.1	60.5	94.8	17.8	24.1	42.1	22.7	62.8	46.9	21.6	16.2	23.2	22.4	21.0	0.0	10.3	21.6	24.3	12.7	32.4	38.0	18.9	35.0	29.9	22.7	15.0	17.5	25.0	13.2	8.5	16.2	21.0	49.5	14.2	22.4	18.4	24.4	63.1	12.9	16.5	90.5	54.4	21.7	30.7	24.5	35.3	17.5
PTPMT1	"DUSP23, MOSP, PLIP"	ENSG00000110536	"Protein tyrosine phosphatase, mitochondrial 1"	Q8WUK0	11	47565430-47573461	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Late spermatids: 522.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA043932, HPA060060"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA043932: AB_2678738, HPA060060: "	"unprognostic (6.61e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.37e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (3.04e-5)"	"unprognostic (3.29e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.93e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.68e-3)"	"unprognostic (1.21e-1)"	"unprognostic (5.39e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.75e-1)"	24.0	24.5	22.3	13.1	23.2	19.8	23.3	16.5	25.2	15.7	14.8	18.5	17.5	14.6	14.7	21.4	14.3	16.9	17.9	17.1	18.5	21.9	20.1	21.8	25.1	16.7	23.1	16.2	15.7	39.3	18.3	18.7	21.8	14.4	15.8	11.5	20.1	26.4	19.5	23.4	11.2	13.1	12.7	17.6	14.7	16.9	44.6	10.3	10.8	19.9	15.7	15.0	11.0	11.5	20.4	40.8	22.1	24.4	15.4	17.5	16.8	22.2	12.6	1.5	10.1	11.7	9.0	4.3	13.1	12.4	13.1	12.5	20.9	11.9	16.0	14.5	9.8	12.2	19.1	10.4	13.6	14.0	19.5	31.3	7.4	25.8	26.3	17.2	14.3	9.8	8.9	15.5	6.1	18.8	10.1	9.3	15.9	18.8	12.3	9.6	42.0	12.2	18.5	9.4	3.8	23.4	22.4	8.5	13.7	15.8	14.3	9.4	11.5	19.9	7.3	11.8	6.6	33.8	15.4	10.0	9.7	15.0	15.7	19.7	18.7	12.5	10.9	7.6	12.4	5.9	6.0	24.4	22.1	16.0	20.9	15.4	20.4	15.2	17.3	27.7	18.0	15.2	14.4	1.9	15.4	19.4	40.8	17.5	16.8	22.3	23.2	16.5	25.2	18.5	21.9	23.1	16.2	14.4	10.3	20.8	25.4	25.3	13.5	15.9	13.5	5.3	48.4	41.5	22.7	38.4	3.9	63.4	61.3	87.9	188.7	19.1	21.4	0.0	74.6	54.2	24.4	20.5	16.2	36.5	56.1	4.8	30.1	30.1	29.8	522.3	43.1	32.4	43.9	60.5	41.0	48.4	92.6	28.1	43.9	62.0	11.6	19.4	21.2	109.7	21.3	15.2	64.2	24.9	61.2	18.6
RMDN3	"FAM82A2, FAM82C, FLJ10579, PTPIP51, RMD3"	ENSG00000137824	"Regulator of microtubule dynamics 3"	Q96TC7	15	40735884-40755851	"Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Differentiation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 113.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009975, HPA074840"	Supported		Enhanced	"Cytokinetic bridge,Mitochondria"		Yes	No			Mitochondria	"Cytokinetic bridge"	"HPA009975: AB_1078811, HPA074840: "	"unprognostic (2.54e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.35e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.50e-3)"	"unprognostic (2.78e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.78e-2)"	"unprognostic (5.94e-3)"	"prognostic favorable (6.70e-8)"	"unprognostic (1.71e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.79e-3)"	"unprognostic (2.04e-3)"	22.9	17.3	29.0	12.4	26.4	16.0	15.5	22.6	29.6	15.2	14.6	20.7	9.3	34.4	10.2	10.5	14.9	15.4	14.7	12.1	27.2	21.1	14.7	28.4	27.8	11.1	26.0	29.3	12.0	21.6	17.6	7.3	15.3	18.4	14.1	6.7	10.6	25.3	13.4	12.7	12.9	39.6	9.6	29.4	9.8	14.4	12.2	22.9	7.8	16.1	11.6	8.5	13.6	10.4	7.6	25.5	2.5	9.7	28.1	14.4	10.6	8.4	7.7	9.3	16.0	7.7	7.3	16.2	22.0	8.6	15.7	11.5	27.7	9.5	7.2	29.4	11.3	11.0	29.2	10.3	16.4	0.6	18.9	14.7	23.1	22.6	13.6	29.0	15.5	18.5	14.1	14.8	11.0	9.2	6.6	10.5	14.4	24.2	20.0	5.9	17.1	11.6	10.0	7.4	20.7	15.4	18.3	11.2	16.7	11.5	14.3	22.4	8.2	17.5	23.7	8.1	3.2	18.5	16.9	16.4	17.1	12.2	22.8	18.4	15.3	17.8	11.5	12.1	16.5	18.6	1.9	6.2	2.5	14.4	8.2	12.6	7.6	10.5	13.0	6.8	6.7	8.2	8.9	1.0	28.1	9.7	25.5	9.1	10.6	29.0	26.4	22.6	26.9	27.2	21.1	26.0	29.3	18.4	22.9	29.8	25.5	4.5	14.2	14.0	19.2	7.0	10.2	26.8	21.6	17.4	3.9	36.6	1.7	25.3	2.0	16.5	16.9	0.0	19.5	23.1	16.9	15.9	18.5	30.9	113.0	17.5	4.7	17.8	15.6	3.1	15.5	10.9	18.6	11.8	11.5	20.0	17.9	14.4	13.4	13.3	15.2	6.5	11.4	31.1	42.8	10.5	52.5	18.5	18.8	19.0
SDHA	"FP, SDH2, SDHF"	ENSG00000073578	"Succinate dehydrogenase complex flavoprotein subunit A"	P31040	5	218241-256700	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, Cardiomyopathy, Disease mutation, FDA approved drug targets, Leigh syndrome, Primary mitochondrial disease, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 100.1;skeletal muscle: 114.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034929, HPA041981, HPA064582"	Enhanced		Supported	Nucleoli,Mitochondria		No	No		780000	Mitochondria	Nucleoli	"CAB034929: AB_2183443, HPA041981: AB_2677779, HPA064582: AB_2685293"	"prognostic unfavorable (6.00e-4)"	"unprognostic (1.93e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (9.53e-8)"	"unprognostic (1.11e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.79e-1)"	17.6	31.4	15.3	11.5	20.3	10.6	12.8	18.8	29.0	10.2	29.4	17.3	10.0	44.3	11.3	12.1	15.3	12.6	14.8	100.1	15.8	14.5	36.5	55.4	10.7	11.7	19.6	19.3	14.5	14.7	23.2	9.5	9.2	29.7	10.7	24.6	14.5	17.3	12.0	114.0	11.5	39.9	16.5	13.2	13.9	21.2	14.6	14.8	15.7	12.5	39.6	12.5	13.2	11.1	28.3	31.9	29.1	29.2	27.1	48.9	32.4	18.7	30.4	12.5	20.4	21.6	16.2	34.0	14.5	18.4	25.0	25.5	32.9	25.6	23.2	45.8	16.5	18.9	24.3	22.1	29.6	14.8	49.4	20.2	11.8	84.1	42.8	13.4	14.7	15.4	16.1	19.0	18.6	9.9	19.9	27.0	16.6	19.0	19.3	11.7	28.7	19.4	39.7	4.3	20.5	38.6	25.1	18.2	45.0	53.1	24.9	13.8	7.9	68.2	44.1	17.9	8.1	26.7	18.6	19.5	18.5	18.2	11.0	11.9	20.6	8.8	17.1	17.9	21.2	11.7	17.8	24.4	29.1	36.4	29.2	32.1	28.3	34.8	35.1	31.9	24.5	34.5	31.7	5.9	27.1	24.1	20.5	48.9	32.4	15.3	20.3	18.8	29.0	15.8	14.5	19.6	19.3	29.7	14.8	32.8	63.8	52.9	58.0	54.4	45.7	238.2	76.5	58.9	40.9	71.5	96.2	94.1	121.0	78.8	32.8	37.6	207.8	0.0	39.4	87.2	53.2	29.4	42.7	135.6	60.4	95.3	45.6	43.0	39.1	20.2	63.3	43.9	86.0	78.5	75.8	40.3	44.9	92.8	52.3	129.8	77.8	77.6	45.0	66.5	55.1	31.5	129.4	59.9	128.8	78.3
SFXN1	"FLJ12876, SLC56A1"	ENSG00000164466	"Sideroflexin 1"	Q9H9B4	5	175477062-175529742	"Predicted intracellular proteins, Predicted membrane proteins"	"Amino-acid transport, One-carbon metabolism, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 66.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"granulocytes: 34.2;T-cells: 16.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019543, HPA063745"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA019543: AB_1856789, HPA063745: AB_2685111"	"unprognostic (4.77e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.62e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.59e-2)"	"unprognostic (8.58e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.30e-2)"	"unprognostic (4.98e-1)"	"unprognostic (1.08e-3)"	"unprognostic (4.23e-2)"	5.6	14.0	15.2	12.0	20.9	12.9	8.1	20.7	24.5	6.5	18.8	7.9	5.3	13.2	6.5	6.0	12.6	6.6	7.1	9.4	14.5	18.3	28.3	66.8	5.3	17.0	15.3	17.0	13.6	9.7	7.4	11.8	10.4	15.1	7.6	12.5	5.7	7.7	8.0	11.7	6.3	13.4	8.1	15.0	8.2	10.1	5.0	11.0	13.9	7.7	7.3	17.8	11.3	9.1	4.5	3.0	34.2	2.6	4.8	16.0	5.6	10.2	32.6	16.7	18.1	5.7	12.4	26.9	26.3	11.1	22.2	21.5	40.8	20.8	21.5	20.5	13.7	27.4	13.2	31.9	45.8	24.1	52.5	26.7	15.8	29.4	17.8	8.4	30.8	20.0	10.1	9.0	24.6	10.8	13.2	17.0	20.0	22.6	17.1	16.1	36.0	35.9	2.4	13.1	17.4	10.7	30.2	17.1	23.0	8.4	40.4	28.5	18.2	25.3	24.0	12.8	14.4	11.6	10.2	16.5	17.6	27.9	12.9	34.2	21.8	25.6	49.1	28.9	27.8	18.3	34.2	2.1	10.4	11.3	2.6	9.4	4.5	16.0	12.6	3.0	3.8	12.7	12.9	0.6	4.8	1.7	1.4	12.7	5.6	15.2	20.9	20.7	24.5	14.5	18.3	15.3	17.0	15.1	11.0	3.0	15.7	26.8	27.4	17.3	52.5	14.8	12.7	13.4	11.4	17.4	45.2	35.0	21.6	24.5	0.9	12.0	58.5	23.3	16.4	61.7	22.4	20.3	9.2	86.9	14.8	73.1	30.0	7.4	9.4	2.0	43.7	8.0	10.1	7.2	18.2	24.5	26.6	17.5	32.9	46.2	47.8	25.8	27.4	3.0	3.0	18.9	25.9	42.7	18.0	23.5
SFXN3	"SFX3, SLC56A3"	ENSG00000107819	"Sideroflexin 3"	Q9BWM7	10	101031234-101041244	"Predicted membrane proteins"	"Amino-acid transport, One-carbon metabolism, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 97.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008028, HPA048105"	Approved		Enhanced	Mitochondria		NA	NA		81000	Mitochondria		"HPA008028: AB_1079938, HPA048105: AB_2680265"	"unprognostic (2.55e-1)"	"unprognostic (3.32e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.82e-2)"	"unprognostic (4.94e-3)"	"prognostic unfavorable (3.79e-4)"	"unprognostic (3.84e-3)"	"unprognostic (8.46e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.09e-3)"	"unprognostic (1.04e-3)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (4.94e-4)"	"unprognostic (3.56e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.71e-1)"	14.4	8.1	11.5	8.7	13.9	4.1	10.7	40.2	22.9	14.5	19.0	15.5	13.6	24.4	13.8	17.7	6.5	14.9	12.9	11.3	12.5	9.8	9.2	3.4	16.4	5.4	18.3	13.7	10.6	7.0	17.1	6.9	16.2	18.4	8.8	8.4	9.1	8.4	13.8	2.7	15.7	44.8	19.9	13.7	8.3	8.2	5.6	16.9	4.3	7.5	5.1	5.5	10.7	11.2	2.2	15.7	8.9	14.8	4.3	9.8	8.3	15.2	5.9	0.6	1.8	16.0	17.0	1.6	9.3	32.9	11.9	9.6	9.7	16.8	0.6	8.9	21.7	10.0	11.2	2.8	20.3	5.2	4.2	3.6	1.8	9.8	7.0	11.0	1.4	14.8	11.7	3.0	10.4	9.9	33.2	26.0	4.4	0.1	0.5	19.3	2.5	0.6	2.2	0.7	5.6	14.3	1.4	11.7	4.1	17.5	2.4	3.2	15.9	5.1	0.6	13.8	4.4	4.9	10.8	21.4	10.5	8.3	9.3	4.5	2.4	0.9	0.0	25.6	8.2	8.4	8.9	14.8	7.1	9.8	11.1	7.5	2.2	6.7	6.6	15.7	1.0	4.1	5.1	2.8	4.3	6.1	2.5	7.0	8.3	11.5	13.9	40.2	22.9	12.5	9.8	18.3	13.7	18.4	16.9	11.9	4.0	0.9	4.8	12.4	61.6	2.4	12.7	18.7	3.4	5.2	45.2	0.9	1.7	28.4	54.3	14.7	10.8	0.0	13.5	37.4	14.4	3.9	13.9	0.8	32.6	9.5	5.2	17.2	20.0	97.0	16.1	21.3	32.1	7.2	5.7	7.8	29.0	5.8	13.8	12.3	23.1	12.9	13.0	1.1	0.5	9.5	9.2	13.1	2.5	2.6
SLC25A24	"APC1, DKFZp586G0123"	ENSG00000085491	"Solute carrier family 25 member 24"	Q6NUK1	1	108134036-108200849	"Predicted intracellular proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA028519, HPA063636"	Enhanced		Enhanced	Mitochondria		NA	NA		8900	Mitochondria		"HPA028519: AB_10603890, HPA063636: AB_2685068"	"unprognostic (1.94e-2)"	"unprognostic (7.30e-3)"	"prognostic favorable (1.01e-4)"	"unprognostic (7.11e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.91e-1)"	"unprognostic (8.54e-4)"	"unprognostic (1.51e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.15e-3)"	"unprognostic (6.18e-2)"	"unprognostic (6.76e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.29e-1)"	19.8	10.8	3.0	13.1	3.3	3.8	25.2	2.3	4.5	15.9	26.6	3.9	9.6	13.6	12.4	11.8	11.4	9.0	16.1	12.4	2.8	3.3	15.3	2.9	17.8	10.8	3.0	2.7	13.5	7.2	13.2	7.7	10.4	5.3	12.4	18.2	9.8	11.2	9.7	7.4	6.9	42.4	9.7	4.0	17.0	9.0	5.1	1.5	10.3	13.7	10.8	9.4	10.8	18.2	2.9	4.8	4.4	7.1	1.7	4.3	2.1	24.2	5.4	16.6	5.1	11.4	15.1	8.3	8.5	10.0	15.1	16.7	6.6	8.1	0.0	7.8	15.6	6.7	9.5	4.9	13.7	20.5	6.0	2.5	1.5	8.1	3.2	9.5	3.9	3.2	11.2	9.7	8.8	11.3	9.8	11.5	3.5	4.1	8.2	19.1	15.9	2.2	0.8	9.8	10.0	6.2	4.1	21.7	7.2	10.2	12.5	3.2	5.5	12.0	8.6	11.2	16.4	8.3	6.9	7.8	8.6	4.4	15.3	9.1	2.3	1.3	0.0	2.9	7.1	5.1	2.8	4.9	4.4	2.3	5.7	2.9	2.9	2.7	2.3	4.8	2.3	1.3	2.3	0.6	1.7	7.1	1.4	4.3	2.1	3.0	3.3	2.3	4.5	2.8	3.3	3.0	2.7	5.3	1.5	50.6	26.7	15.9	17.7	13.9	14.1	12.9	20.4	57.6	36.4	17.4	7.9	5.8	18.3	29.1	2.2	20.4	70.3	0.0	32.1	55.2	18.8	10.7	21.9	0.4	48.5	9.5	17.4	36.8	51.2	2.1	18.1	43.2	21.9	26.2	43.1	8.9	48.3	51.2	17.0	19.3	31.4	51.8	17.9	4.3	1.3	13.0	5.1	13.1	47.4	29.8
SLC25A31	"ANT4, DKFZP434N1235"	ENSG00000151475	"Solute carrier family 25 member 31"	Q9H0C2	4	127730378-127774299	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	687	"testis: 68.6"	"Cell type enriched"	"Detected in some"	9	"Spermatocytes: 113.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"hTCEpi: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA015064, HPA016841, HPA046835, HPA071684"	Uncertain		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA015064: AB_1847691, HPA016841: AB_1847690, HPA046835: AB_2679831, HPA071684: AB_2686431"					"unprognostic (8.15e-2)"									"unprognostic (1.62e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.32e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	68.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	113.2	11.9	0.0	0.0	0.0	0.0	0.0
SOD2		ENSG00000112096	"Superoxide dismutase 2"		6	159669057-159745186	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"blood: 254.9;skeletal muscle: 475.1"	"Cell type enriched"	"Detected in some"	8	"Hofbauer cells: 286.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	11	"neutrophil: 254.9"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 254.9"	"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 182.1;GAMG: 70.6;HSkMC: 80.3"									"HPA001814, CAB002013"	Supported		Enhanced	Mitochondria		NA	NA			Mitochondria		"CAB002013: , HPA001814: AB_1080134"	"unprognostic (2.47e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.76e-2)"	"unprognostic (7.14e-2)"	"prognostic unfavorable (1.72e-4)"	"unprognostic (8.12e-2)"	"unprognostic (4.14e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.82e-1)"	77.8	28.6	6.2	82.8	13.8	147.9	32.5	3.6	12.5	13.1	25.6	5.7	3.6	9.1	13.3	16.6	20.3	12.6	19.9	42.4	5.8	6.4	157.4	197.5	33.9	52.7	14.3	2.6	31.8	24.9	6.9	7.0	10.0	16.1	27.1	6.1	6.4	39.9	7.4	475.1	9.0	8.1	27.9	25.5	18.4	13.8	13.6	7.3	3.0	36.8	20.8	11.8	43.4	52.8	2.3	5.8	254.9	22.7	0.9	4.5	15.0	3.6	4.6	4.1	9.4	26.6	44.5	2.1	5.3	182.1	6.5	15.1	9.5	2.1	7.5	16.0	5.9	70.6	6.3	4.3	4.6	4.9	7.3	8.9	7.9	7.8	16.2	19.8	7.5	3.4	80.3	7.7	20.6	15.4	4.6	3.3	4.8	10.8	9.0	6.2	3.9	6.2	4.8	6.9	4.4	5.8	8.4	5.6	6.9	12.1	6.0	7.8	3.0	11.2	5.7	2.3	1.6	3.5	3.6	3.1	19.2	6.9	10.1	9.2	3.8	9.8	9.0	21.1	5.8	2.4	6.2	19.2	9.4	2.2	14.9	2.4	2.3	3.1	2.2	5.8	1.8	2.6	2.1	254.9	0.9	22.7	0.8	4.5	15.0	6.2	13.8	3.6	12.5	5.8	6.4	14.3	2.6	16.1	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.9	0.0	0.0	0.0	0.0	286.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.8	0.0	0.0	0.0
SUCLA2		ENSG00000136143	"Succinate-CoA ligase ADP-forming beta subunit"	Q9P2R7	13	47745736-48037968	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Ligase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 89.0"	"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 204.8;Late spermatids: 235.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039435, HPA039536, HPA061528"	Enhanced	Supported	Enhanced	Mitochondria		NA	NA		6600	Mitochondria		"HPA039435: AB_10673144, HPA039536: AB_2676561, HPA061528: AB_2684553"	"unprognostic (5.66e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (7.59e-14)"	"unprognostic (3.53e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.29e-1)"	"prognostic unfavorable (1.22e-4)"	21.6	18.5	19.2	8.6	22.1	5.2	17.5	29.7	32.4	15.3	15.7	11.7	15.6	24.5	12.7	12.1	14.6	11.3	9.4	42.1	20.0	21.6	34.0	12.9	7.9	11.4	22.6	19.1	14.4	10.8	19.8	14.9	12.2	28.7	16.2	16.5	8.9	13.9	14.8	89.0	10.0	22.7	14.7	18.3	9.7	12.3	8.0	15.4	15.6	16.9	25.6	10.2	11.0	12.6	17.1	29.5	12.4	25.0	23.4	25.2	17.2	15.7	18.3	23.3	13.9	26.7	20.1	14.0	24.2	27.1	25.2	17.1	32.5	18.0	22.2	18.5	23.6	15.1	22.0	30.7	23.0	31.9	21.2	26.3	24.9	17.4	21.0	18.6	25.1	14.6	19.0	27.1	17.1	20.3	21.0	18.5	25.7	16.8	8.0	25.0	10.9	25.9	28.8	24.1	54.9	23.4	22.1	21.3	17.2	36.4	15.3	12.9	15.4	20.1	18.7	14.2	26.8	16.5	22.4	14.1	14.0	9.0	19.9	16.7	8.4	13.0	25.8	8.7	18.4	20.5	5.7	24.5	12.4	17.6	25.0	21.2	17.1	19.7	21.6	29.5	16.3	25.2	24.9	4.5	23.4	20.0	24.3	21.6	17.2	19.2	22.1	29.7	32.4	20.0	21.6	22.6	19.1	28.7	15.4	23.8	12.6	14.3	29.8	28.7	43.5	135.6	17.8	20.1	17.0	29.6	11.8	41.8	139.3	28.6	204.8	21.5	31.6	0.0	15.6	35.7	34.0	31.8	33.4	11.5	26.3	42.9	18.5	18.4	16.2	235.9	34.2	23.7	40.5	27.9	17.8	38.6	17.5	36.8	43.5	98.7	33.0	38.8	40.8	31.2	27.2	27.7	43.6	13.1	28.8	31.9
TACO1	CCDC44	ENSG00000136463	"Translational activator of cytochrome c oxidase I"	Q9BSH4	17	63600872-63608365	"Disease related genes, Predicted intracellular proteins"	"Translation regulation"	Activator	"Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 76.5;Proximal tubular cells: 101.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021626, HPA021643, HPA024294"	Enhanced		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA021626: AB_1846148, HPA021643: AB_1846149, HPA024294: AB_1846150"	"unprognostic (1.26e-1)"	"unprognostic (2.92e-2)"	"unprognostic (4.55e-3)"	"unprognostic (9.82e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.30e-3)"	"unprognostic (2.83e-1)"	"unprognostic (8.09e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.38e-2)"	"prognostic favorable (3.73e-4)"	"unprognostic (1.35e-1)"	"unprognostic (4.12e-3)"	"unprognostic (5.21e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.60e-2)"	8.3	11.3	8.7	6.3	11.1	4.9	6.9	6.4	14.2	5.9	12.1	7.6	6.2	13.0	7.6	7.2	7.5	6.7	10.1	21.2	7.6	8.6	20.7	42.5	7.0	7.3	9.3	7.2	6.0	10.7	8.3	5.7	7.5	9.3	6.4	11.4	8.1	11.4	6.9	37.5	6.1	15.7	6.9	6.5	7.3	8.0	8.1	6.2	8.7	8.7	15.9	8.1	6.3	5.1	8.9	9.9	7.9	8.1	16.6	13.6	7.9	17.3	27.4	8.8	9.1	7.7	11.1	11.8	12.7	12.1	25.7	20.5	18.0	10.4	14.3	9.8	14.6	17.9	16.0	19.3	18.6	24.3	7.6	26.9	14.1	14.0	31.4	21.3	16.6	9.9	13.5	13.0	22.2	23.6	9.6	13.3	11.0	19.1	10.9	12.0	31.3	19.3	12.6	7.6	18.8	28.5	12.2	21.7	17.9	15.0	12.2	13.5	14.8	8.7	29.0	24.2	12.1	24.1	13.0	11.7	18.4	13.9	12.5	22.4	11.9	11.6	17.0	14.0	11.4	13.3	2.1	8.1	7.9	9.5	7.5	10.6	7.1	13.6	9.5	9.9	8.9	12.8	10.3	1.4	16.6	6.6	6.4	9.0	7.9	8.7	11.1	6.4	14.2	7.6	8.6	9.3	7.2	9.3	6.2	3.0	4.6	12.3	7.4	2.3	7.5	50.4	10.2	6.7	5.7	14.0	2.0	28.9	46.4	24.0	12.5	12.8	41.2	0.0	23.8	23.1	9.4	8.0	9.2	76.5	23.2	6.4	13.3	10.4	10.3	37.7	10.9	8.5	10.1	29.7	21.7	13.2	23.6	24.1	10.6	101.0	10.4	19.4	9.0	23.2	15.5	3.8	16.6	11.5	31.0	5.7
TBRG4	"Cpr2, FASTKD4, H_TD2522F11.8, KIAA0948"	ENSG00000136270	"Transforming growth factor beta regulator 4"	Q969Z0	7	45100100-45112047	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020582, HPA050430"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA020582: AB_1857804, HPA050430: AB_2681125"	"unprognostic (2.22e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.46e-3)"	"unprognostic (1.41e-2)"	"unprognostic (9.29e-3)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (3.15e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.83e-1)"	"unprognostic (4.53e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.66e-3)"	"unprognostic (3.91e-2)"	"unprognostic (3.84e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.52e-1)"	13.7	16.8	10.8	16.0	15.6	14.9	13.0	12.9	22.1	10.5	20.8	15.6	14.1	21.8	14.2	8.2	20.1	12.8	12.4	26.2	9.8	10.0	20.9	27.7	10.5	17.0	10.6	8.9	15.6	16.9	11.3	10.1	16.2	14.7	13.6	14.1	10.8	14.2	12.4	42.6	16.9	17.8	13.9	9.9	16.2	14.0	22.5	9.5	15.0	13.8	23.7	20.3	14.5	13.3	15.8	20.1	10.9	24.2	9.7	21.0	17.5	13.0	30.4	9.7	21.3	8.8	8.2	19.6	10.6	9.8	20.6	17.1	32.9	18.4	25.0	16.4	10.8	28.5	34.2	22.6	24.2	10.5	12.9	21.1	17.1	19.9	22.4	14.7	19.5	17.7	10.8	22.5	19.6	14.1	7.3	12.6	21.5	47.4	12.6	12.6	22.0	19.8	44.7	30.8	29.3	24.3	17.6	12.5	36.4	12.1	13.4	19.3	18.3	10.8	60.2	20.9	13.2	26.8	32.5	9.8	15.3	18.5	9.3	17.2	22.7	22.6	36.5	14.1	28.1	34.4	7.4	13.3	10.9	18.4	24.2	17.6	15.8	15.4	17.8	20.1	12.3	21.0	19.9	1.0	9.7	20.4	7.5	14.6	17.5	10.8	15.6	12.9	22.1	9.8	10.0	10.6	8.9	14.7	9.5	3.0	18.9	26.9	23.8	31.1	14.5	24.1	15.3	5.3	9.1	19.2	0.0	53.3	36.5	29.7	12.3	11.7	28.7	0.0	16.1	61.7	16.9	15.1	13.9	27.7	30.7	11.1	21.4	10.4	12.6	14.5	15.3	17.8	16.9	45.9	30.0	14.0	25.4	21.0	11.0	36.6	12.9	12.9	19.4	46.1	32.2	25.6	40.0	17.0	44.5	25.9
TEFM	"C17orf42, FLJ22729"	ENSG00000172171	"Transcription elongation factor, mitochondrial"	Q96QE5	17	30897336-30906820	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023788, HPA053044"	Approved		Enhanced	Mitochondria		No	No			Mitochondria		"HPA023788: AB_1848818, HPA053044: AB_2682023"	"unprognostic (1.22e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.11e-3)"	"unprognostic (3.31e-2)"	"unprognostic (7.89e-2)"	"unprognostic (3.75e-1)"	"prognostic unfavorable (9.20e-4)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (8.64e-4)"	"unprognostic (2.11e-1)"	"unprognostic (6.18e-3)"	"unprognostic (9.39e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.23e-1)"	"unprognostic (8.37e-3)"	7.0	9.6	11.8	10.2	13.7	4.0	11.1	23.3	16.6	7.5	8.1	7.4	7.2	10.6	8.6	9.6	9.7	7.6	6.8	12.7	10.1	6.9	13.0	12.3	6.9	10.0	15.4	8.5	10.5	7.3	10.8	16.8	10.4	10.6	10.6	10.3	8.6	7.9	10.4	7.7	8.5	9.1	9.6	11.0	13.7	7.4	5.7	13.3	8.6	10.7	6.7	9.8	7.9	11.8	6.7	6.4	4.9	10.0	4.3	6.7	4.8	6.1	9.9	5.9	7.4	4.6	6.0	5.1	6.1	5.1	13.7	11.4	6.5	2.9	7.9	6.0	4.5	7.2	8.7	10.9	4.4	11.9	2.5	13.6	3.8	9.9	6.5	4.9	6.9	4.9	4.5	5.2	7.8	3.0	3.7	5.8	5.5	8.5	7.1	9.0	4.4	5.9	10.1	4.4	7.1	5.1	3.1	10.4	6.2	10.2	5.8	10.1	3.0	5.5	4.4	5.2	5.7	9.9	4.7	4.0	5.3	6.3	6.0	5.8	3.4	5.7	5.5	4.2	5.7	5.2	3.5	6.6	4.9	4.6	10.0	5.8	6.7	5.6	4.2	6.4	6.4	6.7	6.6	1.9	4.3	7.3	5.8	5.7	4.8	11.8	13.7	23.3	16.6	10.1	6.9	15.4	8.5	10.6	13.3	14.9	11.7	4.2	7.2	3.7	18.6	4.4	10.2	17.4	9.1	8.7	7.9	22.7	21.6	11.8	8.8	6.8	5.1	0.0	7.5	14.1	6.6	4.6	4.7	9.0	17.4	15.9	5.2	12.3	9.1	4.4	7.5	10.2	6.8	14.4	6.2	17.1	10.5	5.8	7.1	13.4	18.2	19.4	8.4	23.6	17.0	3.8	14.9	5.4	7.3	3.5
TFAM	"TCF6, TCF6L2"	ENSG00000108064	"Transcription factor A, mitochondrial"	Q00059	10	58385022-58399221	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"Early spermatids: 617.4;Late spermatids: 619.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA040648, HPA063684"	Supported		Enhanced	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA040648: AB_10795635, HPA063684: AB_2685089"	"unprognostic (5.30e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.34e-3)"	"prognostic unfavorable (8.73e-4)"	"unprognostic (1.10e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.24e-2)"	"prognostic favorable (2.74e-4)"	"unprognostic (1.99e-2)"	"unprognostic (5.39e-2)"	"prognostic favorable (2.22e-5)"	"unprognostic (1.31e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.76e-2)"	19.3	21.2	11.1	21.0	12.1	28.5	15.3	15.4	13.9	16.8	21.0	7.7	12.5	17.6	20.7	12.1	17.4	15.3	11.0	15.9	10.2	11.2	22.4	31.4	11.5	21.5	12.5	10.7	18.4	14.3	12.3	23.9	22.2	12.9	17.2	14.7	9.2	16.3	10.6	21.7	10.2	18.7	16.1	10.8	21.0	14.5	40.2	11.6	35.4	22.2	14.8	18.4	16.6	11.8	13.1	14.1	7.2	9.5	14.3	13.1	6.8	21.5	12.3	13.9	14.4	4.1	5.1	15.9	9.8	9.8	12.3	13.8	43.3	23.2	43.0	14.4	4.5	9.3	16.9	25.4	13.8	19.6	18.3	22.6	16.3	9.4	16.1	6.4	41.2	13.4	5.1	6.4	15.0	13.8	5.9	10.6	12.9	38.4	19.9	8.6	11.8	32.6	16.2	26.3	9.9	12.9	26.0	30.0	19.3	7.6	14.6	18.6	12.8	19.6	27.4	24.1	11.9	29.7	12.3	8.1	9.2	29.4	10.5	26.3	20.2	30.8	54.2	11.8	31.8	6.9	1.0	9.5	3.7	8.5	9.0	11.0	12.2	10.3	8.9	11.5	13.1	13.1	10.4	7.2	14.3	7.2	14.1	8.5	6.8	11.1	12.1	15.4	13.9	10.2	11.2	12.5	10.7	12.9	11.6	50.6	24.7	36.3	36.6	44.5	22.3	31.1	43.3	37.5	61.4	19.2	15.7	83.2	74.6	32.4	617.4	32.7	10.6	23.3	38.6	59.4	34.2	33.1	27.8	54.6	37.5	36.5	14.9	23.9	17.8	619.6	38.3	33.8	21.9	26.2	34.1	37.2	30.5	21.0	29.0	61.4	19.4	25.8	30.9	42.9	56.9	47.8	43.8	30.2	47.6	24.4
TFB2M	"FLJ22661, FLJ23182, Hkp1"	ENSG00000162851	"Transcription factor B2, mitochondrial"	Q9H5Q4	1	246540560-246566324	"Predicted intracellular proteins"	"rRNA processing, Transcription, Transcription regulation"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028482, HPA028554, HPA030265"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA028482: AB_2672633, HPA028554: AB_2732441, HPA030265: AB_10696209"	"unprognostic (4.38e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.79e-3)"	"unprognostic (5.63e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.13e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.46e-1)"	"unprognostic (6.81e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.44e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.53e-2)"	10.6	23.1	4.2	7.2	8.4	15.5	9.0	8.4	9.9	7.0	8.9	6.5	9.4	8.2	9.5	7.2	9.5	6.9	8.5	11.3	4.3	5.5	15.5	42.3	5.9	8.7	4.8	5.7	6.5	19.7	5.6	7.8	10.5	7.6	8.9	9.6	5.9	13.6	8.9	21.4	8.7	10.3	6.8	6.5	9.0	9.6	8.7	5.7	13.0	15.6	7.3	12.0	9.1	6.5	10.6	11.0	1.2	7.5	12.6	10.4	4.5	12.6	12.2	4.7	8.4	5.9	8.5	16.6	9.3	9.6	10.6	9.8	14.8	12.3	22.7	14.6	9.4	6.9	11.0	11.4	9.9	14.7	8.8	4.4	11.5	7.5	13.0	9.8	20.2	10.4	8.4	11.9	9.1	10.3	5.8	8.2	8.1	33.1	7.8	9.1	5.9	10.2	9.1	21.1	22.2	12.5	10.2	9.4	27.5	9.6	14.0	10.5	21.3	9.0	16.4	30.8	5.5	11.9	19.5	6.0	7.4	9.0	10.4	24.3	22.6	37.7	17.9	9.1	20.0	9.3	0.2	4.7	1.2	8.4	4.8	10.4	10.6	7.5	8.8	11.0	10.4	9.6	8.2	1.0	12.6	7.5	9.5	10.3	4.5	4.2	8.4	8.4	9.9	4.3	5.5	4.8	5.7	7.6	5.7	6.0	6.5	9.3	11.9	47.4	3.0	15.1	2.5	8.1	17.0	15.7	9.8	20.8	24.9	11.2	1.0	11.7	6.8	0.0	13.3	23.0	10.8	10.8	13.9	32.0	10.9	0.0	10.9	6.2	9.7	1.9	6.1	7.6	5.0	5.4	12.1	4.5	9.1	8.6	4.2	28.3	3.6	12.9	16.0	7.2	22.3	39.3	17.6	8.7	19.0	9.2
TIMM10	"TIM10, TIM10A, TIMM10A"	ENSG00000134809	"Translocase of inner mitochondrial membrane 10"	P62072	11	57528463-57530803	"Predicted intracellular proteins"	"Protein transport, Translocation, Transport"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039946	Supported		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA039946: AB_10673023"	"unprognostic (9.34e-3)"	"unprognostic (1.16e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.40e-3)"	"unprognostic (7.62e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.96e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.15e-2)"	22.2	19.5	29.1	16.7	28.5	18.3	27.4	14.8	34.3	16.6	21.6	17.1	25.9	16.8	13.7	29.1	20.2	16.0	15.4	25.2	25.1	22.7	26.7	41.3	13.1	25.1	27.2	24.6	13.0	25.8	18.3	14.3	13.8	19.9	14.4	23.1	15.8	23.8	20.2	32.3	15.3	12.4	17.2	21.0	20.1	15.9	20.5	16.1	18.4	18.5	25.9	29.8	13.6	12.1	45.1	38.8	5.9	22.6	16.5	33.4	32.4	27.1	41.5	19.5	18.7	17.0	14.5	24.7	23.3	18.8	37.3	21.3	30.5	23.9	51.8	26.9	20.7	32.6	20.9	27.7	27.1	33.8	17.6	20.5	32.8	15.9	39.3	18.0	43.0	37.1	13.6	22.0	36.1	25.2	9.9	23.0	34.6	36.3	23.7	27.3	57.9	23.1	57.6	20.5	23.7	44.7	38.9	41.2	45.2	18.9	18.9	15.9	20.4	24.6	49.1	29.8	20.1	36.7	16.5	14.4	21.5	40.3	36.9	44.7	33.2	43.4	41.7	19.9	21.7	35.8	5.9	22.6	5.0	19.9	21.4	22.8	45.1	24.5	21.9	38.7	41.9	33.4	29.1	1.3	16.5	19.8	38.8	21.3	32.4	29.1	28.5	14.8	34.3	25.1	22.7	27.2	24.6	19.9	16.1	11.9	8.3	59.6	36.7	109.2	16.9	112.2	84.1	14.7	31.8	41.8	3.9	61.1	179.1	67.1	101.9	57.3	85.0	70.0	108.7	85.9	56.1	50.4	51.9	191.0	112.4	7.9	25.9	41.1	52.6	211.2	42.8	77.1	77.6	106.4	36.8	30.6	73.4	48.9	48.1	130.8	11.8	12.9	87.7	92.4	50.6	113.3	33.1	41.5	65.1	45.8
TIMM17A	"TIM17, TIM17A"	ENSG00000134375	"Translocase of inner mitochondrial membrane 17A"	Q99595	1	201955491-201970661	"Cancer-related genes, Predicted membrane proteins"	"Protein transport, Translocation, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA010083	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA010083: AB_10602899"	"prognostic unfavorable (1.98e-5)"	"unprognostic (3.28e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.80e-3)"	"unprognostic (7.58e-2)"	"unprognostic (4.15e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.64e-2)"	"unprognostic (8.54e-3)"	"unprognostic (2.02e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.81e-1)"	16.6	27.6	22.7	18.7	23.2	16.9	16.8	16.3	29.3	16.5	19.3	9.9	19.2	17.2	15.0	24.1	17.9	11.8	10.7	39.0	32.3	19.6	25.1	53.7	13.5	15.3	20.6	27.0	11.2	18.7	21.5	14.8	17.4	25.0	14.5	21.8	11.7	24.8	17.1	42.1	11.5	13.0	19.6	13.4	14.4	16.3	13.7	14.2	11.3	21.6	30.4	18.9	15.9	12.7	17.6	28.9	16.0	24.9	15.9	20.6	17.8	26.4	27.0	24.5	29.3	20.7	21.7	41.4	42.3	30.3	34.8	31.3	31.6	27.6	36.7	15.6	36.2	25.5	21.2	44.9	25.3	37.5	26.9	28.1	20.2	35.9	29.9	21.4	43.1	21.8	25.0	28.2	35.5	29.8	25.1	36.3	23.2	51.0	20.6	40.8	16.9	23.1	23.4	31.1	26.7	14.6	22.9	28.5	46.0	42.7	25.2	37.0	26.2	25.9	66.4	39.1	32.5	36.7	29.3	29.0	23.3	24.7	27.0	43.9	31.3	33.7	30.8	24.8	32.9	25.9	8.9	19.0	16.0	13.6	24.9	17.5	17.6	14.9	17.2	28.9	12.7	14.2	16.7	4.4	15.9	24.7	19.3	20.6	17.8	22.7	23.2	16.3	29.3	32.3	19.6	20.6	27.0	25.0	14.2	35.7	37.0	55.2	74.7	81.9	22.9	117.0	40.8	46.8	42.1	36.6	33.4	102.6	116.0	97.2	44.4	41.4	33.9	0.0	74.9	170.0	67.6	57.0	54.3	165.4	105.8	33.4	32.6	35.6	45.4	26.9	31.1	72.6	50.6	99.2	41.2	32.7	83.8	23.0	36.0	93.3	25.4	25.8	62.2	38.1	50.8	86.4	222.1	56.4	49.3	91.8
TIMM44	TIM44	ENSG00000104980	"Translocase of inner mitochondrial membrane 44"	O43615	19	7926718-7943920	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043052, HPA073108"	Supported		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA043052: AB_10795713, HPA073108: "	"unprognostic (1.75e-1)"	"unprognostic (7.44e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.45e-2)"	"unprognostic (5.81e-3)"	"unprognostic (8.78e-2)"	"unprognostic (2.42e-1)"	"unprognostic (8.81e-2)"	"unprognostic (2.07e-3)"	"unprognostic (8.93e-2)"	"unprognostic (1.80e-2)"	"unprognostic (6.01e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.18e-2)"	12.8	15.3	11.8	13.0	12.4	7.5	12.7	16.2	17.2	10.8	15.3	8.5	14.1	16.1	12.1	11.8	19.4	10.8	12.6	39.2	12.9	10.3	13.5	19.7	9.0	9.2	11.7	7.7	13.8	20.2	7.4	10.3	8.9	12.3	10.8	6.3	8.5	17.3	21.4	48.8	12.6	10.5	17.7	9.0	12.2	12.2	9.4	11.6	5.8	12.5	26.6	8.8	13.0	9.4	9.0	16.2	10.1	12.2	9.6	12.1	8.4	18.5	10.8	5.8	10.2	10.1	9.4	8.5	11.2	9.1	15.5	14.1	23.8	4.0	27.2	12.9	9.3	12.4	13.0	23.8	12.5	3.9	12.7	36.2	13.6	9.2	20.0	24.8	16.3	5.7	11.0	16.1	13.2	16.4	5.3	9.8	17.5	25.0	9.7	6.7	18.8	14.2	10.7	16.8	17.9	46.0	15.0	8.3	12.7	6.8	12.0	13.9	7.2	9.9	13.5	31.7	5.2	8.3	15.9	5.2	7.4	11.6	18.7	21.1	19.1	24.0	26.4	5.2	23.7	12.5	10.1	11.7	3.7	12.1	12.2	10.7	8.7	11.1	11.2	16.2	9.0	10.7	10.4	0.6	9.6	7.2	13.2	9.4	8.4	11.8	12.4	16.2	17.2	12.9	10.3	11.7	7.7	12.3	11.6	32.8	13.1	36.5	29.5	24.7	51.6	31.9	30.6	10.7	12.5	27.9	39.3	33.9	56.3	37.7	8.0	22.3	35.7	0.0	36.8	32.1	23.8	24.1	32.3	52.9	31.0	49.3	38.5	21.5	16.7	9.9	33.9	18.0	20.3	11.8	35.3	22.0	38.9	24.6	27.6	29.0	55.4	32.3	29.2	35.1	33.3	17.3	27.2	20.3	48.5	25.1
TIMMDC1	"C3orf1, FLJ22597"	ENSG00000113845	"Translocase of inner mitochondrial membrane domain containing 1"	Q9NPL8	3	119498532-119525090	"Predicted intracellular proteins, Predicted membrane proteins"		Chaperone	"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053214, HPA055846"	Uncertain		Enhanced	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA053214: AB_2682081, HPA055846: AB_2682941"	"unprognostic (3.95e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (9.60e-2)"	"unprognostic (6.25e-2)"	"unprognostic (3.39e-1)"	"unprognostic (4.67e-3)"	"unprognostic (1.05e-1)"	"unprognostic (3.87e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.05e-1)"	13.6	17.2	18.1	10.4	16.7	5.9	13.8	8.6	16.2	16.4	12.2	20.4	21.5	9.2	13.3	19.4	18.5	13.6	14.9	43.9	15.9	15.4	22.8	20.5	13.0	15.9	20.9	11.9	11.8	12.5	20.4	17.4	21.4	16.4	15.2	14.5	14.0	14.3	21.6	37.2	16.0	15.3	12.7	21.9	14.3	12.3	13.3	15.6	9.9	19.9	20.3	14.5	16.7	11.1	12.4	13.8	16.3	15.5	8.5	15.8	15.5	14.3	13.5	6.7	5.8	26.2	17.7	15.2	4.2	14.1	12.2	14.0	9.1	8.8	10.5	7.3	14.8	8.4	6.8	16.9	13.7	20.0	8.8	6.1	7.7	6.3	10.2	13.8	6.0	5.1	15.5	21.1	9.8	12.8	7.8	17.2	9.9	10.5	10.1	22.4	17.8	6.3	12.7	9.0	12.1	16.8	5.3	4.7	13.8	18.3	7.2	8.9	16.6	4.3	6.6	16.1	9.5	10.8	16.5	8.6	6.9	5.2	6.3	7.3	6.5	6.1	14.3	11.7	15.3	10.8	6.8	13.8	16.3	8.4	13.0	10.1	12.2	8.3	10.3	13.8	12.4	10.4	9.0	3.4	8.5	15.5	11.9	15.8	15.5	18.1	16.7	8.6	16.2	15.9	15.4	20.9	11.9	16.4	15.6	23.8	35.3	16.0	40.6	33.3	24.2	144.4	40.8	61.6	37.5	38.4	13.7	129.0	127.6	61.0	5.3	55.2	40.2	23.3	54.8	92.7	41.0	35.4	40.4	45.5	75.0	20.6	27.6	31.3	30.4	5.2	43.7	39.7	42.2	83.0	41.1	57.9	47.3	40.1	51.2	112.8	25.9	71.1	52.6	99.3	50.0	36.8	148.4	31.6	44.9	43.4
TMEM71	FLJ33069	ENSG00000165071	"Transmembrane protein 71"	Q6P5X7	8	132685007-132760712	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 65.7;lymphoid tissue: 31.3"	"Group enriched"	"Detected in many"	5	"Cardiomyocytes: 14.8;Kupffer cells: 23.3;Macrophages: 22.7;T-cells: 41.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 65.7"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 65.7"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 8.2;HDLM-2: 33.0;Karpas-707: 7.0;U-937: 19.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA058401, HPA070655"	Uncertain		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA058401: AB_2683707, HPA070655: AB_2686292"	"unprognostic (1.39e-3)"	"unprognostic (7.27e-2)"	"unprognostic (8.82e-2)"	"unprognostic (3.10e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.91e-3)"	"unprognostic (4.18e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.62e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.90e-2)"	"unprognostic (6.29e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.73e-1)"	4.2	1.1	1.4	8.2	1.5	20.8	5.4	0.7	1.2	2.5	9.9	0.8	0.4	1.2	1.0	2.0	4.8	1.9	4.1	25.5	1.8	1.2	1.9	2.3	8.3	20.9	2.2	0.8	1.9	2.9	0.0	1.4	1.0	1.7	2.2	2.2	5.8	5.8	1.3	1.3	1.3	7.2	2.2	4.2	18.2	2.9	0.9	1.4	31.3	2.2	2.5	10.6	7.0	2.8	1.4	8.2	65.7	13.5	2.9	14.8	8.4	0.2	0.0	3.2	0.0	0.0	0.0	0.0	0.8	8.2	0.3	0.6	0.0	0.0	0.0	0.3	2.5	0.0	0.0	0.0	0.2	0.9	33.0	0.0	0.0	0.0	0.0	0.2	2.2	0.0	0.0	0.0	0.0	1.3	0.9	0.6	4.2	0.0	7.0	1.4	0.0	1.6	1.3	0.7	0.0	0.2	0.1	1.1	0.4	3.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	1.2	0.4	0.5	0.7	3.4	0.0	1.6	0.0	5.8	19.5	2.4	12.5	13.5	23.9	8.0	3.9	14.8	1.4	5.9	5.6	8.2	1.3	9.0	6.5	65.7	2.9	3.2	0.2	0.7	8.4	1.4	1.5	0.7	1.2	1.8	1.2	2.2	0.8	1.7	1.4	0.0	4.8	4.2	1.0	0.8	0.0	14.8	0.0	4.0	3.4	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	1.3	0.1	1.1	0.0	3.1	0.0	0.0	1.3	23.3	3.6	0.0	22.7	5.0	0.0	0.0	1.1	0.1	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.2	0.3	0.2	41.5	0.0	5.1
TNRC18	"CAGL79, KIAA1856, TNRC18A"	ENSG00000182095	"Trinucleotide repeat containing 18"	O15417	7	5306790-5425414	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Bipolar cells: 56.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 17.6"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 17.6"	"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA020730, HPA024251"	Uncertain		Supported	"Nucleoplasm,Nuclear membrane,Mitochondria,Cytosol"		NA	NA			"Nucleoplasm, Nuclear membrane, Mitochondria"	Cytosol	"HPA020730: AB_2670506, HPA024251: AB_2671498"	"unprognostic (1.66e-1)"	"unprognostic (3.17e-3)"	"unprognostic (2.67e-3)"	"unprognostic (4.44e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.11e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.29e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.34e-2)"	17.9	11.8	18.1	17.9	17.2	29.4	20.6	35.1	23.6	35.0	29.9	16.7	17.9	16.4	36.0	19.5	19.6	27.5	29.2	13.6	14.2	9.6	15.6	11.8	19.2	12.9	15.5	16.7	30.3	18.4	36.9	14.7	19.7	13.2	25.4	15.1	25.2	17.0	24.4	13.6	18.9	16.9	40.1	12.6	15.3	21.4	14.0	16.6	7.2	20.6	12.8	9.4	27.0	21.4	2.0	4.3	17.6	3.2	2.6	1.5	0.1	21.7	19.4	16.2	13.6	13.7	16.3	41.9	15.5	14.6	8.6	9.2	8.0	19.2	14.9	15.3	22.7	19.2	24.4	9.3	18.5	7.3	6.5	5.9	9.4	16.6	12.9	11.9	31.0	34.9	16.4	21.9	17.1	19.9	12.5	9.6	13.5	13.4	8.4	10.9	36.1	7.3	38.0	1.4	14.3	14.9	8.1	8.0	11.0	7.0	27.8	7.1	16.9	12.0	31.9	11.5	7.6	33.3	32.2	24.0	24.9	35.1	14.8	11.1	12.1	12.5	14.1	14.0	22.1	29.0	9.4	3.2	2.7	1.4	1.2	1.0	1.6	1.0	0.8	1.1	2.0	0.7	1.5	17.6	2.6	1.5	4.3	1.4	0.1	18.1	17.2	35.1	23.6	14.2	9.6	15.5	16.7	13.2	16.6	8.9	31.9	1.4	3.1	8.2	56.8	6.2	15.3	6.7	11.4	14.0	2.0	12.8	1.7	4.5	12.0	10.7	16.9	0.0	5.5	3.6	11.3	4.6	13.9	22.9	9.5	47.7	30.1	29.4	40.0	12.0	17.0	11.9	5.0	3.6	27.0	23.8	8.0	5.8	18.7	4.2	3.7	19.4	11.9	0.5	2.0	7.8	8.4	6.4	21.8	2.6
TOMM20	"KIAA0016, MAS20, MOM19, TOM20"	ENSG00000173726	"Translocase of outer mitochondrial membrane 20"	Q15388	1	235109336-235128936	"Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005585, HPA011562"	Supported		Enhanced	Mitochondria		NA	NA			Mitochondria		"CAB005585: AB_628381, HPA011562: AB_1080326"	"unprognostic (1.30e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.66e-2)"	"unprognostic (4.49e-2)"	"unprognostic (8.65e-3)"	"unprognostic (1.17e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.16e-3)"	"unprognostic (5.05e-2)"	"unprognostic (7.08e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.97e-1)"	27.2	35.0	46.3	15.3	60.2	32.7	52.8	40.0	66.2	36.1	25.5	28.4	29.0	24.4	34.5	39.0	28.0	40.0	27.9	33.9	47.1	48.7	41.2	35.2	24.2	33.6	42.5	40.5	50.9	63.6	38.6	25.4	27.1	48.2	34.0	28.2	23.5	47.8	30.7	33.4	33.0	21.3	33.8	54.5	19.0	27.2	16.3	23.0	18.0	58.7	28.4	21.9	36.2	28.9	15.9	20.9	16.4	13.8	9.8	22.6	14.2	35.9	19.0	25.0	21.0	19.7	39.8	38.8	25.9	22.4	24.4	17.8	24.5	25.4	43.8	34.5	22.4	6.9	28.8	27.7	25.1	32.2	10.5	59.2	26.7	25.4	46.3	33.0	59.8	16.1	35.5	34.5	24.4	33.7	33.2	26.4	17.2	56.0	16.2	26.7	10.5	25.4	27.1	56.2	24.0	10.3	31.1	19.1	56.7	27.4	25.9	32.9	77.1	20.1	28.2	55.1	10.7	43.6	65.8	23.3	21.5	13.0	27.1	54.9	38.4	36.1	32.1	25.2	28.7	36.3	16.4	12.4	4.1	13.9	12.9	17.1	15.9	18.1	17.3	15.1	12.7	22.6	17.6	3.9	9.8	13.8	20.9	15.5	14.2	46.3	60.2	40.0	66.2	47.1	48.7	42.5	40.5	48.2	23.0	128.1	138.6	191.4	199.9	237.5	49.8	120.5	135.0	99.0	162.7	47.1	27.5	147.0	135.9	142.1	230.8	135.2	112.6	46.7	180.7	308.9	116.9	237.5	153.6	148.6	144.2	47.7	154.1	102.5	169.4	269.0	143.5	148.5	141.7	101.0	251.0	122.3	199.7	133.3	144.2	188.2	47.6	103.5	156.9	79.9	69.4	250.1	166.8	109.0	224.1	238.8
TOMM22	TOM22	ENSG00000100216	"Translocase of outer mitochondrial membrane 22"	Q9NS69	22	38681948-38685421	"Predicted membrane proteins"	"Protein transport, Translocation, Transport"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA003037	Supported		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA003037: AB_1080329"	"unprognostic (5.54e-2)"	"unprognostic (5.04e-3)"	"unprognostic (2.74e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (2.90e-5)"	"unprognostic (1.01e-1)"	"unprognostic (4.28e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.64e-2)"	"unprognostic (7.39e-2)"	"unprognostic (5.44e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.99e-1)"	"unprognostic (7.86e-2)"	"unprognostic (1.64e-1)"	27.6	26.2	25.6	30.1	24.3	29.5	29.4	17.6	28.2	22.2	26.8	14.7	22.4	28.0	20.1	25.6	34.1	24.4	23.8	31.6	23.2	21.0	29.4	46.0	18.1	32.1	24.0	19.8	27.8	47.5	10.9	12.6	27.6	18.5	21.0	32.8	15.8	31.4	26.7	38.2	24.6	29.7	22.8	20.0	27.7	23.3	24.7	11.3	44.2	27.4	40.4	33.5	24.1	30.2	22.5	29.7	6.9	22.9	18.0	21.3	28.6	19.9	11.8	18.1	19.2	13.4	12.5	19.6	16.6	11.5	24.3	18.3	21.4	12.0	20.3	13.7	16.2	16.7	16.6	27.5	25.1	19.6	17.5	30.2	27.3	9.3	20.5	17.5	72.2	19.4	17.1	17.9	21.8	14.3	12.7	17.8	19.9	20.6	16.3	16.1	15.5	21.6	33.6	27.8	26.5	24.1	24.1	23.5	19.2	16.1	14.7	21.3	14.1	19.3	24.6	18.8	12.9	17.0	23.9	18.0	14.9	28.0	13.6	24.9	22.5	27.2	31.4	18.7	25.1	20.3	4.7	22.9	6.9	16.9	22.0	21.3	22.5	18.3	17.8	29.7	18.0	18.7	20.0	2.2	18.0	18.1	25.8	21.1	28.6	25.6	24.3	17.6	28.2	23.2	21.0	24.0	19.8	18.5	11.3	23.8	38.6	136.2	98.0	148.4	29.1	63.5	89.2	22.7	36.4	68.0	15.7	155.1	189.0	110.6	102.3	74.4	68.7	23.3	115.2	191.6	75.3	74.7	74.8	86.3	145.2	27.0	100.8	54.6	102.5	107.7	51.2	105.1	108.0	150.5	120.6	48.5	110.8	66.6	51.2	199.7	22.3	71.1	82.1	92.7	139.6	183.8	113.4	104.6	157.8	129.1
TOMM40	"C19orf1, D19S1177E, PER-EC1, PEREC1, TOM40"	ENSG00000130204	"Translocase of outer mitochondrial membrane 40"	O96008	19	44890569-44903689	"Predicted intracellular proteins, Transporters"	"Ion transport, Protein transport, Transport"	Porin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036231, HPA036232"	Supported		Enhanced	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA036231: AB_2675010, HPA036232: AB_2675011"	"unprognostic (2.14e-1)"	"unprognostic (9.58e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.75e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.13e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.86e-3)"	"unprognostic (5.30e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.87e-1)"	16.0	25.3	13.6	16.9	15.6	19.7	20.6	17.7	27.0	10.2	20.5	10.9	10.1	20.0	11.8	10.5	22.9	13.5	11.4	21.5	15.3	14.9	16.5	36.9	15.1	22.3	15.6	13.3	18.2	19.2	16.2	11.9	15.3	20.2	11.2	16.7	11.5	11.5	13.5	32.3	14.7	15.1	11.6	11.9	12.7	12.6	12.3	8.8	14.2	11.6	18.6	15.6	10.9	12.5	7.3	7.0	5.1	6.8	4.7	8.7	2.0	30.8	52.3	19.1	26.3	7.1	6.4	24.3	22.2	12.3	42.1	30.2	56.8	21.4	45.6	23.9	14.6	23.9	33.4	49.5	31.9	19.2	17.6	44.9	30.6	20.5	44.7	15.2	39.0	27.5	10.1	18.1	32.6	20.7	7.9	14.5	22.0	48.2	15.9	16.4	38.5	42.3	28.7	33.4	44.1	32.6	43.3	21.7	26.5	19.3	42.9	29.8	19.1	23.6	49.8	15.8	11.1	16.7	39.6	11.9	29.2	29.6	20.3	57.8	17.2	35.6	44.7	21.6	41.5	30.7	0.7	5.5	5.1	4.7	6.8	5.2	7.3	4.5	6.5	7.0	4.2	7.9	8.7	1.1	4.7	5.9	6.9	4.8	2.0	13.6	15.6	17.7	27.0	15.3	14.9	15.6	13.3	20.2	8.8	14.9	5.3	28.9	52.0	77.6	63.2	14.2	30.6	0.0	10.3	29.6	27.5	84.7	33.2	54.9	9.5	29.3	31.6	23.3	33.2	145.9	33.4	37.4	19.5	20.8	91.8	66.7	28.2	11.1	20.4	5.6	24.7	36.1	37.1	39.7	43.5	43.9	41.3	28.8	23.0	28.3	55.9	19.4	40.6	53.5	60.1	78.2	61.0	26.6	93.2	64.9
TOMM70	"KIAA0719, Tom70, TOMM70A"	ENSG00000154174	"Translocase of outer mitochondrial membrane 70"	O94826	3	100363431-100401398	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 22.5;Extravillous trophoblasts: 28.8;Proximal tubular cells: 36.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014589, CAB017156, HPA048020"	Enhanced		Enhanced	Mitochondria		NA	NA		120000	Mitochondria		"CAB017156: , HPA014589: AB_1858185, HPA048020: AB_2680234"	"unprognostic (2.74e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.69e-3)"	"unprognostic (2.12e-2)"	"unprognostic (5.96e-2)"	"unprognostic (2.06e-3)"	"unprognostic (5.01e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.21e-1)"	"unprognostic (9.73e-3)"	"unprognostic (5.38e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.53e-1)"	"unprognostic (3.34e-2)"	"unprognostic (6.98e-3)"	21.7	16.1	16.2	12.4	52.4	9.6	21.3	23.6	26.5	16.9	18.2	12.5	13.8	19.4	17.4	15.0	20.8	14.2	12.2	25.2	16.5	19.8	24.9	40.7	10.5	13.5	16.1	20.6	21.7	18.0	20.1	17.1	15.5	29.0	19.0	20.6	13.3	14.5	19.4	42.8	13.3	17.8	22.3	14.0	12.1	14.8	14.7	15.6	18.7	20.5	19.9	16.6	22.3	22.5	4.3	3.0	2.5	2.5	5.6	5.4	1.8	23.5	16.5	14.1	20.2	20.0	21.8	18.4	20.3	17.2	18.5	19.2	23.4	13.6	28.2	17.8	17.0	16.7	23.4	25.4	18.5	27.4	10.7	11.8	32.4	11.0	22.7	12.5	39.4	14.9	19.4	17.1	16.5	26.9	16.5	13.5	13.9	23.0	23.1	22.0	17.4	26.6	15.9	19.4	36.5	35.3	24.5	28.6	30.0	15.0	17.8	25.6	21.3	14.7	23.6	26.4	14.1	30.6	22.4	12.1	16.4	21.7	9.1	15.0	25.2	35.9	48.0	15.7	23.9	12.4	2.2	2.2	2.5	4.1	2.2	5.1	4.3	5.1	4.5	2.9	3.1	5.3	5.4	0.6	5.6	2.5	3.0	2.0	1.8	16.2	52.4	23.6	26.5	16.5	19.8	16.1	20.6	29.0	15.6	6.0	20.6	0.0	0.0	0.0	0.0	0.0	0.0	18.7	20.5	14.0	0.0	22.5	10.0	17.3	0.0	0.0	0.0	0.0	16.9	28.8	0.0	0.0	7.0	0.0	19.6	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	10.0	0.0	0.0	19.2	0.0	0.0	36.3	0.0	0.0	0.0	0.0	0.0	0.0	13.6	0.0	0.0	0.0
TRAP1	"HSP75, HSP90L"	ENSG00000126602	"TNF receptor associated protein 1"	Q12931	16	3651639-3717597	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041082, HPA044227"	Enhanced		Enhanced	Mitochondria		NA	NA		1100000	Mitochondria		"HPA041082: AB_2677291, HPA044227: AB_2678864"	"unprognostic (1.18e-1)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.80e-4)"	"unprognostic (7.10e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.52e-2)"	"unprognostic (9.61e-2)"	"unprognostic (8.58e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.54e-1)"	"unprognostic (7.69e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.68e-2)"	"unprognostic (9.90e-2)"	"unprognostic (3.82e-2)"	19.1	20.3	19.1	15.9	29.7	14.2	17.5	21.1	38.5	16.8	23.0	18.1	13.1	18.6	17.1	14.2	34.4	28.5	20.8	40.0	22.1	20.4	24.6	62.6	12.3	20.6	17.1	30.7	23.5	54.7	18.3	13.6	15.5	23.2	15.4	17.8	16.4	19.7	13.7	80.3	31.2	14.1	20.9	12.3	15.2	19.7	20.0	15.1	16.4	16.0	39.8	21.2	17.2	18.2	20.0	24.6	1.3	17.0	12.7	22.3	13.8	19.1	48.1	10.0	26.4	11.1	11.4	29.7	11.6	10.6	27.0	17.0	59.8	27.4	61.7	22.1	11.2	7.3	36.1	39.0	29.1	11.9	23.6	42.6	18.0	41.3	41.8	19.1	32.2	12.4	13.4	20.3	21.4	33.6	9.8	18.5	21.0	56.4	22.5	8.8	62.6	23.1	23.9	18.5	22.8	24.5	53.2	21.0	85.1	20.0	14.3	47.7	18.2	12.1	44.8	23.3	8.4	32.4	23.4	10.4	11.4	20.3	19.9	16.9	24.1	26.5	48.5	7.1	26.0	15.5	0.0	10.8	0.3	11.7	17.0	22.3	20.0	17.1	14.8	24.6	13.9	20.3	17.1	1.3	12.7	12.3	3.6	14.2	13.8	19.1	29.7	21.1	38.5	22.1	20.4	17.1	30.7	23.2	15.1	20.8	17.4	12.6	35.8	22.6	26.7	1.7	43.3	20.1	14.8	29.6	9.8	94.7	74.6	58.6	17.5	15.5	13.6	0.0	47.2	42.8	18.6	22.2	16.1	41.4	41.2	44.5	34.1	14.1	14.2	10.0	15.3	15.9	11.8	36.1	32.9	17.6	32.3	3.5	20.1	84.4	17.9	19.4	30.1	35.4	77.7	24.6	56.2	10.2	65.0	31.9
TTC19	"FLJ20343, MGC19520"	ENSG00000011295	"Tetratricopeptide repeat domain 19"	Q6DKK2	17	15999380-16045015	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Electron transport, Respiratory chain, Transport"		"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023010, HPA052380"	Enhanced		Enhanced	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA023010: AB_1858429, HPA052380: AB_2681806"	"unprognostic (1.04e-2)"	"unprognostic (4.90e-3)"	"unprognostic (2.87e-2)"	"unprognostic (4.80e-3)"	"unprognostic (8.09e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.84e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.30e-3)"	"unprognostic (5.14e-2)"	"prognostic favorable (5.67e-4)"	"unprognostic (1.31e-1)"	"unprognostic (3.22e-1)"	"unprognostic (4.85e-2)"	"unprognostic (2.24e-1)"	8.5	13.6	10.3	10.1	16.6	16.4	11.2	16.5	22.6	10.1	13.8	10.3	10.5	18.7	11.1	8.9	9.3	9.9	11.8	13.4	17.0	10.4	15.4	13.2	10.8	7.9	9.2	15.3	12.7	24.8	11.5	15.5	10.1	15.7	12.0	9.6	13.1	14.0	12.7	8.6	13.9	16.1	7.2	8.9	8.3	13.3	6.3	6.8	6.0	18.7	8.0	8.4	10.0	10.9	3.5	2.8	9.0	2.0	1.7	3.3	1.0	6.9	5.9	6.0	10.1	5.1	5.0	4.5	5.9	4.1	2.8	3.0	5.8	12.4	9.9	13.1	3.3	3.8	8.9	8.2	6.8	3.4	16.1	13.9	8.1	7.3	4.9	7.9	8.1	12.5	5.1	5.6	2.3	9.7	7.4	5.9	11.2	4.8	7.1	5.8	6.6	8.7	5.0	9.9	9.3	4.1	13.1	6.7	7.0	8.9	8.3	6.3	4.7	7.6	8.1	14.9	19.1	6.9	3.5	10.9	3.8	1.6	5.4	7.4	5.8	2.5	4.6	9.1	9.1	8.7	9.0	2.0	3.8	2.0	2.0	3.3	2.8	2.5	3.3	2.5	3.5	2.8	3.1	1.7	1.7	1.6	2.8	2.6	1.0	10.3	16.6	16.5	22.6	17.0	10.4	9.2	15.3	15.7	6.8	38.7	30.5	47.9	58.4	93.5	137.2	30.7	33.1	18.7	28.4	43.6	135.5	60.2	59.7	46.3	34.1	65.0	53.6	46.7	35.9	32.8	37.1	61.4	31.1	29.4	22.9	122.3	43.8	28.8	19.2	4.8	38.0	31.9	52.3	30.7	45.4	81.2	37.0	52.6	31.5	37.9	170.0	45.3	31.9	17.6	28.1	102.0	54.8	55.3	51.6	61.7
TUFM	"EF-TuMT, EFTu"	ENSG00000178952	"Tu translation elongation factor, mitochondrial"	P49411	16	28842411-28846408	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Elongation factor"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018991, HPA024087, CAB075730, CAB075731, CAB075732"	Enhanced		Enhanced	Mitochondria		NA	NA		2800000	Mitochondria		"CAB075730: AB_2665736, CAB075731: AB_2665737, CAB075732: AB_2665738, HPA018991: AB_1858458, HPA024087: AB_1858459"	"unprognostic (1.40e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.55e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.23e-3)"	"unprognostic (8.05e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (2.69e-6)"	"unprognostic (5.26e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.22e-2)"	"unprognostic (7.36e-2)"	27.3	47.8	28.8	32.3	31.3	27.2	40.4	22.3	41.4	25.3	41.7	27.1	34.4	44.0	26.6	22.3	40.0	32.7	37.6	69.2	25.6	25.8	45.6	68.4	28.6	46.2	33.1	24.4	25.9	75.0	48.3	22.7	23.0	27.3	23.4	37.6	25.4	40.9	33.1	77.3	28.1	36.1	26.2	25.8	28.4	36.9	47.0	21.5	32.5	37.0	55.4	33.9	26.8	23.3	30.6	57.3	21.7	44.2	25.5	38.8	45.4	29.3	55.9	17.9	37.4	26.0	23.9	36.8	21.5	25.1	34.4	32.6	60.2	32.5	66.1	39.8	21.5	19.7	57.6	42.4	41.7	20.6	26.3	64.9	25.2	45.2	72.8	30.9	45.1	23.5	30.5	33.0	37.1	37.0	22.4	40.9	36.7	56.5	26.1	24.9	59.8	43.2	44.1	40.1	36.1	34.7	59.9	32.5	96.1	29.7	28.8	31.4	38.4	18.8	67.2	29.4	15.4	40.0	36.8	26.0	20.6	24.0	25.4	32.8	39.9	41.3	28.8	26.3	56.7	26.9	21.7	44.2	19.5	31.3	42.3	34.8	30.6	29.7	32.7	57.3	27.5	28.5	29.5	9.1	25.5	31.6	34.9	38.8	45.4	28.8	31.3	22.3	41.4	25.6	25.8	33.1	24.4	27.3	21.5	65.5	70.3	105.7	207.8	149.3	93.5	117.0	178.3	137.9	64.8	167.5	82.5	299.6	283.5	183.0	309.9	94.4	289.0	23.3	252.4	240.7	112.6	188.4	103.9	224.8	230.1	69.9	142.6	95.8	162.5	472.6	101.2	129.8	131.6	183.1	194.4	129.6	169.5	172.7	105.0	374.4	91.2	84.1	142.8	184.3	182.3	136.4	240.1	147.2	348.8	236.5
TXN2	MT-TRX	ENSG00000100348	"Thioredoxin 2"	Q99757	22	36467036-36482030	"Disease related genes, Predicted intracellular proteins"	"Electron transport, Transport"		"Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA000994, CAB008681"	Approved		Enhanced	Mitochondria		No	No			Mitochondria		"CAB008681: AB_1623682, HPA000994: AB_1080267"	"unprognostic (5.11e-2)"	"unprognostic (4.40e-3)"	"unprognostic (4.40e-3)"	"unprognostic (1.07e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.28e-2)"	"unprognostic (4.02e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.17e-2)"	"prognostic favorable (2.04e-4)"	"prognostic favorable (1.17e-6)"	"unprognostic (1.49e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.05e-1)"	22.1	69.9	33.4	24.7	33.2	23.5	41.9	23.2	51.1	23.0	25.9	20.8	24.5	36.9	19.8	22.7	28.7	26.9	27.6	60.1	28.0	28.6	33.4	51.7	27.9	35.5	30.3	31.7	35.0	51.1	30.8	17.3	19.6	30.4	21.6	26.2	24.6	25.0	27.5	72.3	21.0	28.1	26.3	35.6	25.2	26.7	19.1	21.2	16.2	29.2	37.3	23.0	23.0	19.8	31.7	51.3	14.4	43.3	32.0	30.0	45.1	14.4	19.7	21.6	36.9	32.5	35.4	24.8	19.9	31.1	33.5	38.1	23.9	15.3	36.5	18.4	30.9	14.6	22.0	41.4	34.0	19.5	25.0	36.0	41.6	26.9	35.2	27.4	50.0	39.8	47.3	27.0	28.0	21.9	28.1	30.3	20.4	43.5	30.2	29.9	21.3	22.7	38.8	17.5	44.7	26.0	20.8	22.8	25.3	33.9	23.5	30.1	30.4	20.0	43.9	35.7	18.0	30.9	48.5	23.8	37.4	29.2	20.5	19.4	24.6	17.4	35.5	33.7	31.2	21.2	5.2	40.8	7.1	25.7	43.3	26.8	31.7	25.6	27.0	51.3	29.0	30.0	27.9	14.4	32.0	35.2	39.1	24.8	45.1	33.4	33.2	23.2	51.1	28.0	28.6	30.3	31.7	30.4	21.2	56.6	49.0	65.6	79.6	74.1	107.9	96.0	79.0	53.5	53.4	66.3	37.3	190.8	257.0	78.1	16.6	64.6	168.3	0.0	93.1	240.7	63.4	47.2	68.1	102.9	150.9	109.7	86.0	69.3	73.9	27.8	52.3	81.0	74.2	82.0	111.4	131.5	75.1	94.7	47.7	140.1	54.1	19.4	58.7	50.5	41.1	78.4	173.2	69.9	151.3	64.8
UQCRC2	"QCR2, UQCR2"	ENSG00000140740	"Ubiquinol-cytochrome c reductase core protein 2"	P22695	16	21952660-21983660	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007998, HPA019146"	Enhanced		Enhanced	Mitochondria		NA	NA		4000000	Mitochondria		"HPA007998: AB_1858648, HPA019146: AB_1858649"	"unprognostic (1.33e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.49e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.26e-2)"	"unprognostic (6.91e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.43e-2)"	"prognostic favorable (6.58e-9)"	"unprognostic (2.33e-1)"	"unprognostic (9.78e-3)"	"unprognostic (4.67e-3)"	"unprognostic (7.36e-2)"	22.7	26.8	20.6	17.1	32.7	20.5	21.3	29.2	33.7	17.7	38.4	17.4	19.5	45.0	20.8	18.6	28.7	20.0	19.1	94.9	19.8	19.3	35.1	35.8	15.9	23.6	20.9	28.5	21.9	20.8	36.6	20.2	17.8	29.6	17.7	40.5	18.5	22.1	20.2	103.9	22.2	42.0	30.4	16.5	16.5	29.3	10.3	19.2	25.2	21.4	70.0	22.9	27.9	20.0	20.0	30.6	14.3	29.3	18.7	25.7	27.4	19.3	21.2	13.1	8.7	14.7	20.6	18.6	18.8	15.3	17.2	17.5	34.3	19.1	38.3	16.9	16.1	12.8	35.3	21.3	18.8	19.9	17.5	19.7	21.7	18.7	48.4	15.5	27.5	54.9	24.0	23.6	13.4	18.5	17.6	22.5	21.3	23.4	20.1	18.6	25.6	28.6	17.9	14.4	24.5	16.4	33.5	30.5	41.9	25.8	22.8	18.2	13.3	26.6	33.6	20.2	16.6	38.4	29.3	19.9	12.2	11.5	11.9	16.7	14.5	10.5	34.0	20.0	29.3	13.9	14.3	24.7	12.8	16.9	29.3	21.9	20.0	20.5	18.6	30.6	15.8	22.8	20.8	9.1	18.7	27.6	13.2	25.7	27.4	20.6	32.7	29.2	33.7	19.8	19.3	20.9	28.5	29.6	19.2	59.6	42.0	98.3	164.9	80.5	95.9	481.5	84.1	72.3	54.6	68.0	82.5	196.5	386.3	104.6	67.7	84.2	282.6	23.3	96.2	128.0	82.0	92.1	91.1	104.1	172.2	65.2	109.2	63.3	130.3	64.8	63.3	104.5	124.9	144.3	181.4	81.7	88.0	175.6	91.2	254.0	122.1	77.6	118.3	52.3	51.5	77.2	232.7	106.2	298.0	149.1
UQCRQ	"QCR8, QP-C, UQCR7"	ENSG00000164405	"Ubiquinol-cytochrome c reductase complex III subunit VII"	O14949	5	132866560-132868031	"Disease related genes, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 174.9"	"Cell type enhanced"	"Detected in all"	7	"Cardiomyocytes: 3256.1;Hepatocytes: 4283.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046693, HPA053323"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA046693: AB_10968453, HPA053323: AB_2682112"	"unprognostic (3.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.92e-2)"	"prognostic favorable (4.23e-4)"	"unprognostic (1.09e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.72e-2)"	"unprognostic (7.31e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.81e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.37e-2)"	26.4	38.4	43.2	24.5	34.2	20.9	30.9	18.0	37.5	22.5	49.7	13.8	44.0	42.5	15.4	41.8	32.1	15.3	42.7	111.1	33.2	31.7	48.8	112.5	18.8	21.5	42.0	30.4	12.3	64.6	14.0	23.1	17.0	30.5	32.0	44.8	19.7	44.6	39.6	174.9	16.4	40.5	21.2	25.4	15.2	37.4	16.1	20.8	14.3	24.6	71.5	16.8	22.6	20.5	56.6	95.8	67.9	99.9	53.8	56.7	106.3	45.5	63.7	37.6	91.0	56.4	45.9	32.6	33.1	46.7	53.0	66.1	89.7	53.3	18.7	70.0	43.3	67.4	46.2	34.3	80.6	45.6	34.2	72.0	24.8	100.5	70.5	49.0	28.1	42.8	48.9	56.2	37.8	52.2	35.5	41.3	40.4	31.7	60.4	55.5	86.2	64.6	64.9	26.7	85.4	57.6	42.4	41.7	80.5	68.5	89.0	63.1	52.5	40.9	46.2	70.6	27.0	68.8	64.9	25.7	48.6	61.4	39.8	66.8	66.8	88.7	33.5	64.6	52.5	48.3	67.9	99.9	61.1	47.0	76.6	48.3	56.6	54.9	53.5	87.4	46.0	53.6	51.5	47.4	53.8	70.2	95.8	56.7	106.3	43.2	34.2	18.0	37.5	33.2	31.7	42.0	30.4	30.5	20.8	232.3	318.2	275.9	309.6	309.4	83.7	3256.1	1189.8	321.2	221.8	746.8	113.9	633.7	1536.9	621.2	357.1	305.7	1715.1	233.6	826.7	362.7	374.6	615.6	285.5	4283.6	668.1	68.3	527.7	324.1	428.0	786.4	261.5	374.1	678.2	396.8	861.3	232.4	704.3	1273.0	271.5	1804.0	170.0	181.1	456.8	296.8	123.0	449.3	470.6	222.6	1052.4	401.6